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Abstract 
Many biologically active molecules contain one or more nitrogen atoms. Consequently, C-
N bond formation is a crucial area in the development of pharmaceuticals. The main part 
of this thesis is devoted to environmentally benign syntheses of different nitrogen 
scaffolds. Iridium and ruthenium catalysts have been employed for the N-alkylation of 
amines with either alcohols or amines. 
  
Synthesis of secondary amines  
 
Self-condensation of primary amines afforded secondary amines in good to high yields. 
The reaction is catalyzed by the commercially available [Cp*IrCl2]2 complex. The 
procedure is environmentally benign as it is performed in the absence of both solvent and 
additives and the only by-product is ammonia. Additionally, the work-up procedure is a 
simple distillation of the product directly from the reaction mixture.  
 
Synthesis of piperazines 
 
In the Madsen group it has previously been demonstrated that condensation of diamines 
and diols catalyzed by [Cp*IrCl2]2 furnishes the piperazine skeleton. The only by-product 
of the reaction is water. The substrate scope was extended and the limitations of the 
reaction were studied. It was established that the Thorpe-Ingold effect plays a central role 
in the reaction, as ethyleneglycol and 1,2-ethylenediamine failed to produce piperazine. 
Introduction of a C-substituent on one or both of the starting materials gave C-
substituted piperazines in high yields. Synthesis of N-benzylpiperazine from 
ethyleneglycol and N-benzylethylenediamine was also successful. Self-condensation of 
ethanolamine was unsuccessful due to polymerization of the starting material. o-
Phenylenediamine was a difficult substrate as it furnished an equimolar mixture of 
1,2,3,4-tetrahydroquinoxaline and 2-benzimidazolemethanol in the reaction with 
ethylene glycol. Ammonium tetrafluoroborate as the nitrogen source in reaction with 1,2-
cyclohexanediol afforded the morpholine derivative. Finally, attempts to switch to 
ruthenium catalysis were unsuccessful since neither a RuCl3-PPh3 complex nor a RuCl3-
xantphos complex was able to catalyze the reaction between 1,2-diaminocyclohexane 
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and ethylene glycol. Mechanistic experiments of the iridium catalyzed reactions revealed 
that the Voigt isomerization of the α-imino alcohol intermediate to the corresponding α-
imino ketone plays a significant role. 
 
Synthesis of indoles 
 
Anilines and vicinal diols were reacted in the presence of a ruthenium complex (RuCl3 
with PPh3 or xantphos) to give indoles in good yields. In this case water and dihydrogen 
are the only by-products. When unsymmetrical diols were employed the corresponding 
indole with the largest substituent in the 2-position was favoured. It is believed to 
proceed through a Bischler-like reaction pathway. Mechanistic experiments were 
conducted and emphasized the importance of the Voigt reaction in the formation of the 
product. 
 
Protein folding 
During an external stay at The Scripps Research Institute, San Diego, California, USA, 
folding of the well-known protein CI2 was studied. Several mutants were synthetically 
prepared via folding assisted ligation. One segment was synthesised as the C-terminal 
thioester by Boc-SPPS and the other segment as a C-terminal acid by Fmoc-SPPS. The sites 
of mutation were all in the α-helical region of the protein and the mutation choices were 
alanine and Aib, which both posses a high α-helical propensity. Hereby, it was believed 
that more stable proteins would be obtained. Folding of the mutants was studied in terms 
of thermodynamics and kinetics by guanidine hydrochloride denaturation monitored by 
fluorescence. The results were unfortunately unreliable due to errors in the 
spectrofluorometer.  
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Resumé 
Mange biologisk aktive molekyler indeholder et eller flere nitrogen atomer. Derfor er 
dannelse af C-N bindinger et yderst vigtigt felt indenfor udvikling af medicin. Hoveddelen 
af denne afhandling omhandler miljøvenlige synteser af forskellige nitrogenindeholdende 
byggeblokke. Iridium og ruthenium katalysatorer er blevet anvendt til N-alkylering af 
aminer med enten alkoholer eller aminer. 
 
Syntese af sekundære aminer  
 
Selvkondensation af primære aminer gav sekundære aminer in gode eller høje udbytter. 
Reaktionen er katalyseret af det kommercielt tilgængelige [Cp*IrCl2]2 kompleks. 
Proceduren er miljøvenlig, da den udføres uden tilstedeværelse af solvent eller additiver, 
og det eneste biprodukt er ammoniak. Ydermere er oparbejdningsmetoden en simpel 
destillation af produktet direkte fra reaktionsblandingen. 
 
Syntese af piperaziner 
 
I Madsen-gruppen er det tidligere blevet påvist, at kondensation af diaminer og dioler 
katalyseret af [Cp*IrCl2]2 giver piperaziner, og det eneste biprodukt er vand. 
Substrattolerancen er blevet udvidet og begrænsningerne af reaktionen er blevet 
undersøgt. Det blev fastslået, at Thorpe-Ingold effekten spiller en central rolle i 
reaktionen, da ethylenglykol og 1,2-ethylendiamin ikke som forventet gav piperazine. 
Indførelse af en C-substituent på det ene eller begge af udgangsstofferne gav C-
substituerede piperaziner i høje udbytter. Syntese af N-benzylpiperazin ud fra 
ethylenglykol og N-benzylethylendiamin var ligeledes succesfyldt. Selvkondensation af 
ethanolamin til piperazin fejlede pga. polymerisering af udgangsstoffet. o-
Phenylethylendiamin var et vanskeligt udgangsstof, da det gav en ækvimolær blanding af 
1,2,3,4-tetrahydroquinoxalin og 2-benzimidazolmethanol i reaktion med ethylenglykol. 
Ammonium tetrafluoroborat som nitrogenkilde gav i reaktion med 1,2-cyklohexandiol 
morfolinderivatet. Endeligt blev det forsøgt at anvende ruthenium katalyse, men det var 
uden succes, da hverken et RuCl3-PPh3 kompleks eller et RuCl3-xantphos kompleks var i 
stand til at katalysere reaktionen mellem 1,2-diamincyclohexan og ethylenglykol. 
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Mekanistiske eksperimenter af de iridiumkatalyserede reaktioner afslørede at Voigt 
isomeriseringen af α-iminoalkohol-intermediatet til den tilsvarende α-iminoketon spiller 
en væsentlig rolle.  
 
Syntese af indoler 
 
Reaktion mellem aniliner og vicinale dioler under tilstedeværelse af et 
rutheniumkompleks (RuCl3 med PPh3 eller xantphos) gav indoler i gode udbytter. I dette 
tilfælde er vand og dihydrogen de eneste biprodukter. Når asymmetriske dioler blev 
anvendt, var den tilsvarende indol med den største substituent i 2-positionen favoriseret. 
Det menes at forløbe via et Bischler-ligende reaktionsforløb. Mekanistiske eksperimenter 
blev udført og understregede vigtigheden af Voigt reaktionen under dannelsen af 
produktet. 
 
Proteinfoldning 
Under et eksternt ophold ved The Scripps Research Institute, San Diego, Californien, USA 
blev foldning af det velkendte protein CI2 studeret. Adskellige mutanter blev syntetisk 
fremstillet via foldningsassisteret ligering. Det ene segment blev syntetisert som en C-
terminal thioester via Boc-fastfase peptid syntese og det andet som en C-terminal syre via 
Fmoc-fastfase peptid syntese. Alle de muterede enheder er at finde i proteinets α-helix, 
og valget af mutant var alanin eller Aib, som begge besider en høj tilbøjelighed til at 
danne α-helixer. Hermed var det antaget, at mere stabile proteiner ville kunne opnås. 
Foldning af mutanterne med henblik på termodynamik og kinetik blev undersøgt gennem 
guanidinhydroklorid denaturering monitoreret af fluorescens. Desværre var resultaterne 
uanvendelige pga. fejl i spektrofluorometeret.  
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1 Introduction 
1.1 Green chemistry 
Recently, the term ‘green’ has been used to great extend. It often refers to the areas of 
fuel (cars, planes and ships) and electrical power (coal, wind and nuclear). Most people do 
not consider the amounts of products that they are surrounded by which are directly 
linked to chemical synthesis. Chemicals are found in a large variety of products such as 
food, clothes, furniture, toys, drugs, shampoos, toothpastes, etc. One can choose the type 
of transportation and hereby directly affect the environment. However, it is more difficult 
to have a direct influence on the choice of products in the household despite the growing 
range of organic products. For instance, shampoos and wash detergents are made by a 
several manufacturers. Some have focused on the cheapest production process, which 
often to some extend ignore the effect of the production on the environment. Others 
have great focus on the environment both in terms of the production as well as when the 
product is exposed in the nature. Hereby, the consumer can directly choose to support 
environmentally friendly products and productions or not. Unfortunately, in regards to 
pharmaceuticals there is not such a choice. Often there is only one manufacturer, unless 
the patent has expired and a generic drug is available, but there is never a choice 
between a less and a more environmentally friendly drug. The responsibility lies therefore 
completely with the pharmaceutical companies as well as manufacturers of bulk and fine 
chemicals. Fortunately, they do have focus on green chemistry1-4 as productions of these 
three product types are associated with large amounts of waste. A way to describe this 
waste problem is the E factor (= environmental factor), which was defined by Roger 
Sheldon in 1992 as kilogram waste per kilogram product.5 In table 1 some of these E-
factors are listed.  
 
Table 1. E-factors in chemical industries.6,7 
Product Production per year (ton) E factor 
Oil refining 106-108 <0.1 
Bulk chemicals 104-106 <1-5 
Fine chemicals 102-104 5 -<50 
Pharmaceuticals 10-103 25-<100 
   
The numbers strongly indicate the need for improvements. Not only are the E factors high 
(in particular for pharmaceuticals) but the production sizes are also large and in turn this 
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makes the total amount of waste enormous. It should be noted that the E factor does not 
take into account the nature of the waste. Not all types of waste are a potential problem 
and in some cases the waste can be sold as a chemical to other industries or reused in the 
given process.  
 
Waste is obviously a major concern in a chemical production, nevertheless other aspects 
of green chemistry should be taken into account. In the pharmaceutical industry, that has 
the highest E factor, the synthetic pathway to the final product should be carefully 
chosen.8 In 1998 Anastas and Warner described “the twelve principles of green 
chemistry”:9 
 
1. It is better to prevent waste than to treat or clean up waste after it is formed. 
2. Synthetic methods should be designed to maximize the incorporation of all 
materials used in the process into the final product. 
3. Wherever practicable, synthetic methodologies should be designed to use and 
generate substances that possess little or no toxicity to human health and the 
environment. 
4. Chemical products should be designed to preserve efficacy of function while 
reducing toxicity. 
5. The use of auxiliary substances (e.g. solvents, separation agents, etc.) should be 
made unnecessary whenever possible and, innocuous when used.  
6. Energy requirements should be recognized for their environmental and economic 
impacts and should be minimized. Synthetic methods should be conducted at 
ambient temperature and pressure. 
7. A raw material feedstock should be renewable rather than depleting whenever 
technically and economically practical.  
8. Unnecessary derivatization (blocking group, protection/deprotection, temporary 
modification of physical/chemical processes) should be avoided whenever 
possible.  
9. Catalytic reagents (as selective as possible) are superior to stoichiometric 
reagents.  
10. Chemical products should be designed so that at the end of their function they do 
not persist in the environment and break down into innocuous degradation 
products.  
11. Analytic methodologies need to be further developed to allow for real-time in-
process monitoring and control prior to the formation of hazardous substances. 
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12. Substances and the form of a substance used in a chemical process should be 
chosen so as to minimize the potential for chemical accidents, including releases, 
explosions, and fires.  
 
In an industrial setting each of the twelve principles should be revised carefully. However, 
in this thesis focus will predominantly lie on the following: 
 
• Minimizing the number of chemical transformations 
• Ensure good atom economy10 
• Aiming for a low E-factor 
• Minimizing hazardous chemicals/solvents 
• Employment of catalytic reactions 
• Short reaction time 
 
1.2 Amines in the pharmaceutical industry 
Organic compounds containing nitrogen are very important in the pharmaceutical 
industry. A total of 12 out of the 20 top selling drugs (in the US) in 2010 contained an 
“amine” function (linear, cyclic or heteroaromatic – not including biologically 
manufactured pharmaceuticals).11 These are shown in table 2. In particular the cyclic 
amines are of great importance as they represent 50% of the top 20 selling drugs in the 
US.  
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Table 2. Amine containing pharmaceuticals. 
#a Chemical structure #a Chemical structure 
1 
 
2 
 
3 
 
5 
 
6 
 
7 
 
8 
 
9 
 
13 
 
15 
 
17 
 
19 
 
a:
 
The numbers indicate the position on the list of the 20 top selling drugs  
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1.3 Privileged structures 
The term ‘privileged structure’ was introduced by Evans in 1988.12 A privileged structure 
is a molecular scaffold that is highly represented in biologically active compounds.12-14 The 
substructure must be an essential core of the molecule for it to be considered a privileged 
structure. E.g. a simple amine is not considered a privileged structure despite its wide 
occurrence in biologically active compounds.14 During the years many privileged 
structures have been identified such as benzodiazepines, purines, benzyl- and 
spiropiperidines, indoles, benzimidazoles, benzofuranes and -pyranes, biphenyltetrazoles, 
piperazines and cyclic  peptides.12-17 
 
This thesis will describe synthesis of the simple symmetric secondary amine as well as the 
privileged structures indoles and piperazines (figure 1).  
 
Figure 1. The chosen scaffolds. 
 
 
Primarily the work done in the area of carbon-nitrogen bond formation by metal catalysis 
will be described. Focus is on reaction of amines in either self-condensation reactions or 
in reaction with alcohols to produce the compounds illustrated in figure 1. 
 
1.4 Metal-catalyzed hydrogen transfer reaction of amines and alcohols 
The reactions examined in this thesis are all metal-catalyzed hydrogen transfer reactions; 
more specifically they are N-alkylation of amines with alcohols or amines by the 
“borrowing hydrogen methodology”. A generalized example is illustrated in scheme 1.   
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    Scheme 1. N-alkylation of amines with alcohols (or amines). 
 
This type of transformation has been studied for several decades with different catalysts. 
Attention has predominantly been given to the reaction between amine and alcohol. The 
metals that have shown the most promising results are ruthenium and iridium. 
Ruthenium was one of the front runners with the first publications in 198118,19 and in 
2003 the first iridium catalyzed reaction was published20. Ruthenium catalysts are 
generally cheaper compared to iridium catalysts. Initially, the reaction conditions for the 
ruthenium catalyzed reactions were rather harsh and often the substrate scope was 
limited and therefore iridium catalysis was investigated.21  
 
Besides the obvious formation of secondary and tertiary amines the method is also used 
for synthesis of heterocycles such as pyrrolidines, piperidines, azepanes, piperazines, 
indoles, quinolines, quinoxalines and benzimidazoles.21-24 Much attention is given to the 
discovery of a catalytic system and optimum reaction conditions that furnish products 
with a wide range of substituents. Additionally, focus is on environmentally benign 
methods. So far there have been several reports on methods with a limited substrate 
scope. For instance, in syntheses of non-cyclic amines not all catalytic systems (or 
reaction conditions) allow all types of substrates. Some methods are not compatible with 
aryl amines, while others do not work with secondary alcohols. 
 
In table 3 to 6 all known N-alkylations of amines with alcohols are listed, according to the 
best of our knowledge. Table 3 describes the formation of linear secondary and tertiary 
amines, table 4 the formation of N-heterocycles, table 5 the formations of aromatic N-
heterocycles and finally all transformations involving ammonia or ammonium salts are 
listed in table 6. 
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Table 3. Formation of linear secondary and tertiary amines. 
# Amine Alcohol Product Ru-catalyst Ir-catalyst 
1   
 
RuCl2(PPh3)3
18,25 
RuCl3/P(OBu)3
26 
[RuCl(PPh3)2(CH3CN)3]
+[BPh4]
-27 
[Ru(p-cymene)Cl2]2
28,29 
[Cp*IrCl2]2
20,30 
[IrCl2Cp*(NHC)]
31 
[Ir]/P,N- 
ligand32-35 
[Cp*Ir(NH3)3][I]2
36 
2  
  
RuCl2(PPh3)3
18 
[Cp*IrCl2]2
20 
[Cp*Ir(NH3)3][I]2
36 
3 
 
 
 
Ru(cod)(cot)37 
RuCl2(PPh3)3
37 
[Ir]/P,N- 
ligand32-35  
4    
RuH2(PPh3)4
38 
[Ru(p-cymene)Cl2]2
28,29,39 
[Cp*IrCl2]2
20,30 
[IrCl2Cp*(NHC)]
31 
Cp*Ir(NH3)3][I]2
36 
5   
 
RuCl2(PPh3)3
40 
Ir-Pincer41 
[IrCl2Cp*(NHC)]
31 
6  
  
RuH2(PPh3)4
38 
Ru3(CO)12/ligand
42 
[Cp*IrCl2]2
20 
[IrCl2Cp*(NHC)]
31 
7 
   
Ru3(CO)12/ligand
43,44 
[Ru(p-cymene)Cl2]2
28,45 
[Cp*IrCl2]2
30 
[IrCl2Cp*(NHC)]
31 
8 
   
RuCl2(PPh3)3
46 
RuCl3/dppf
47 
[Ru(p-cymene)Cl2]2
28,29,45
 
Ru3(CO)12/ligand
44 
Shvo48 
[Cp*IrCl2]2
30,49
 
[Cp*Ir(NH3)3][I]2
36
 
Ir-Pincer41 
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 Table 4. Formation of N-heterocycles. 
# Amine Alcohol Product Ru-catalyst Ir-catalyst 
1 
 
 
 
RuCl2(PPh3)3
50 
RuH2(PPh3)4
38
 
[Ru(p-
cymene)Cl2]2
28,29
 
[Cp*IrCl2]2
49,51-54
 
[Cp*Ir(NH3)3][I]2
36
 
 
2 
 
 
 
RuH2(PPh3)4
38
   - 
3 
 
- 
 
RuH2(PPh3)4
38
   - 
4 
 
 
 
RuCl2(PPh3)3
55
 
RuCl3/PBu3
55
 
Ru-complex56 
  - 
5 
  
 
Ru3(CO)12/PBu3
57   - 
6 
 
- 
 
  - [Cp*IrCl2]2
58
 
7 
 
- 
 
  - [Cp*IrCl2]2
59
 
8 
 
- 
 
  - [Cp*IrCl2]2
60 
 
Table 5. Formation of aromatic N-heterocycles. 
# Amine Alcohol Product Ru-catalyst Ir-catalyst 
1 
 
 
 
X=NH,O: RuCl2(PPh3)3
61 
X=NH:Ru(PPh3)3(CO)H2/ligand
62 
X=O: Shvo63 
 
2 
 
 
 
X=C: RuCl2(PPh3)3
64 
X=N:RuCl2(PPh3)3
65, 66
 
- 
3 
 
 
 
RuCl2(PPh3)3
67, 68 [Cp*IrCl2]2
60
 
Introduction 
 
9 
 
4 
 
 
 
  - [Cp*IrCl2]2
69
 
5 
 
 
 
  - IrCl3/BINAP
70 
6 
   
RuCl2(PPh3)3
71   - 
7 
   
RuCl3/PBu3
64   - 
8 
 
 
 
  - IrCl3/BINAP
70 
 
 Table 6. Transformations with ammonia and ammonium salts. 
 Amine Alcohol Product Ru-catalyst Ir-catalyst 
1    Ru/ligand
72     - 
2  
  
Ru3(CO)12/ligand
73 
Ru(CO)ClH(PPh3)3/ligand
74 
 - 
3    
  - 
[Cp*Ir(NH3)3][I]2
75
 
 
4  
  
  - 
[Cp*Ir(NH3)3][I]2
75
 
 
5   
 
  - [Cp*IrCl2]2
76, 77 
6  
  
  - [Cp*IrCl2]2
76, 77 
7   
 
  - [Cp*IrCl2]2
76 
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1.4.1 Proposed reaction mechanism  
Ruthenium and iridium catalyzed N-alkylation of amines with alcohols involve the same 
key steps (scheme 2). Firstly, the alcohol is oxidized to the carbonyl, then a reaction with 
the amine to give the imine upon removal of water, and finally reduction of the imine to 
the secondary amine (tertiary amine if the starting material is a secondary amine).  
 
 
Scheme 2. General pathway of metal catalyzed reaction between alcohols and amines. 
 
The reaction mechanism for N-alkylation of amines with amines has not been proposed 
with substantial evidence, but it is believed that it proceeds via similar key steps (more 
details in chapter 2).  
 
1.4.1.1 Iridium 
The most commonly used iridium catalyst for N-alkylation of amines with alcohols is 
[Cp*IrCl2]2 (figure 2).
78  
                     
Figure 2. Structure of [Cp*IrCl2]2. 
 
                              
 
 
This 18 electron iridium dimer has to break down to the 16 electron monomer to be able 
to coordinate the alcohol. Computational studies have shown that in solution the 
monomer is slightly favored.79  
 
The first part of the mechanism, which involves oxidation of the alcohol to the 
corresponding aldehyde or ketone, has been studied separately (Oppenauer-type 
oxidation). Initially, Yamaguchi and co-workers reported the capability of [Cp*IrCl2]2 to 
Introduction 
 
11 
 
oxidize primary alcohols and benzylic alcohols.80 The yields of the resulting aldehydes 
were high and reactions were carried out at room temperature in only 6 hours. However, 
no mechanistic experiments were conducted and the proposed mechanism was merely a 
speculation based on work by Bäckvall and co-workers81,82 regarding a similar reaction 
with a ruthenium catalyst. More information regarding this oxidation was obtained when 
Madsen and co-workers performed an experiment developed by Pàmies and Bäckvall.79 
The experiment involved racemization of a deuterated chiral alcohol to determine if a 
monohydride or a dihydride catalytic species is formed.83 The product of the reaction 
contained almost only deuterium, which is indicative of a monohydride mechanism of the 
oxidation (scheme 3).  
 
 
Scheme 3. Monohydride mechanism. 
 
At first it was believed that after oxidation of the alcohol the corresponding carbonyl 
compound was released and in solution it would react with the amine.78 Interestingly, a 
combination of recent experimental and computational studies indicates that the formed 
carbonyl compound does not leave the catalyst and imine formation is proposed to 
proceed via a hemiaminal bond to iridium in a bidentate fashion.30,79 In addition, also the 
imine has to be bound to the iridium species to be able to undergo reduction. This is 
supported by a test reaction where an imine in the presence of a hydrogen donor is not 
reduced by the catalyst.30 Furthermore, computational experiments have revealed that all 
intermediates most likely stay coordinated to iridium throughout the catalytic cycle.  
 
The precise structure the active catalytic species has been studied by computational 
experiments by Crabtree and co-workers.84 The results indicate that bidentate carbonate 
(most often added to the reaction as NaHCO3) lowers the energy barriers and is therefore 
likely to act as a ligand. In contrast, Madsen and co-workers argue that it is more likely 
that the amine starting material act as a ligand as this is present in a large excess 
compared to iridium.79 The proposed mechanistic cycle illustrated in scheme 4 is a result 
of calculations based on an amine-iridium species as the active component.79 
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Scheme 4. Proposed reaction mechanism. 
 
The catalytic cycle initiates with coordination of the alcohol to iridium. Subsequent β-
hydride elimination furnishes a carbonyl-iridium species. The amine (either internal or 
external) attacks the carbonyl to afford a hemiaminal and as a result of a proton shift the 
imine-iridium species is formed. The next step is ligand exchange from water to amine 
followed by reduction of the imine. Lastly, protonation affords the final product which is 
then released.  
 
1.4.1.2 Ruthenium 
In contrast to the iridium catalyzed reaction where [Cp*IrCl2]2 is almost exclusively 
employed as catalyst, in the ruthenium catalyzed reaction many different ligands are 
used. One of the most widely used catalytic systems is RuCl2(PPh3)3.
85 To the best of our 
knowledge no general mechanism for the ruthenium catalyzed reactions has been 
supported with solid evidence as for the iridium catalyzed reaction described above. An 
example of the importance of the nature of the ligand is the reaction of anilines (or 
heteroaromatic amines) with alcohols where the dialkylated amines are obtained with 
RuCl2(PPh3)3 and the monoalkylated amine with [Ru(cod)(cot)].
37 Interestingly, 
modification of RuCl2(PPh3)3 to the cationic species [Ru(PPh3)2(CH3CN)3]
+[BPh4]
- resulted 
in formation of only monoalkylated products.27  
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In 1984 Watanabe and co-workers proposed a mechanism based on kinetic 
measurements of the reaction of aniline and benzyl alcohol catalyzed by RuCl2(PPh3)3.
25 
The key steps of this were the same as for the iridium catalyzed reaction. However, 
coordination of intermediates to ruthenium was not investigated. The experiments also 
revealed that formation of the imine is most likely the rate-determining step. Later Brandt 
and co-workers used different ruthenium catalysts to determine if the transformation 
proceeds via a mono- or a dihydride mechanism.86 The results were to a great extend 
depending on the exact nature of the ligands. The result of reactions catalyzed by 
RuCpCl(PPh3)2 supports the mono-hydride mechanism (as for the iridium catalyzed 
reaction (scheme 3)), whereas reactions with RuCl2(PPh3) seems to occur via a dihydride-
mechanism as illustrated in scheme 5.  
 
 
Scheme 5. Dihydride mechanism. 
 
Williams and co-workers have conducted mechanistic experiments with [Ru(p-
cymene)Cl2]2 and DPEphos suggesting that the carbonyl compound can dissociate from 
ruthenium and that the imine is not necessarily formed while coordinated to ruthenium.28 
This is in contrast to the iridium catalyzed reactions where all intermediates are 
coordinated throughout the catalytic cycle.79 
 
Interestingly, when a ruthenium complex with an N-heterocyclic carbene ligand is 
employed for coupling of an alcohol and an amine none of the expected amine was 
formed. Instead, the corresponding amide was formed with extrusion of two equivalents 
of hydrogen in high yield (scheme 6).87 The mechanism of the reaction is currently being 
investigated in the Madsen group.  
 
 
Scheme 6. Amides from primary alcohols and amines catalyzed by a ruthenium-carbene complex. 
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1.5 Concluding remarks 
There is a growing awareness of the need to protect the environment in a chemical 
production. In particular there is a need for new and more environmentally benign 
synthetic pathways to produce biologically active molecules. N-alkylation of amines with 
alcohols or amines catalyzed by iridium and ruthenium is a promising method for 
achieving this goal. In this thesis synthesis of secondary amines and the privileged 
structures piperazines and indoles from amines and alcohols will be described.  
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2 Secondary amines 
Secondary amines are present in many pharmaceuticals as well as in agrochemicals and 
fine chemicals.88 To the best of our knowledge there has not been conducted any survey 
on the precise number of pharmaceuticals containing secondary amines. However, a 2004 
survey of almost 1200 orally administered pharmaceuticals revealed that almost 12% of 
these contained a (-NH-CH2-) scaffold.
89 This unit is not necessarily a secondary amine, 
but it underlines the importance of the core amine function in pharmaceuticals. In figure 
3 a few of the many pharmaceuticals containing a secondary amine function are shown.  
 
Figure 3. Secondary amine containing pharmaceuticals. 
 
 
2.1 Syntheses of secondary amines 
As C-N bond formation is one of the most crucial areas in synthetic chemistry in terms of 
producing biologically active molecules many different syntheses of amines have been 
developed during the last century. A selection of these methods will be described herein. 
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The chapter is divided into four parts. The first part describes the progress in N-alkylation 
of amines with alkyl halides. This is followed by reactions involving reductions (either 
catalytic or non-catalytic). The last two sections concern N-alkylation of primary amines 
with alcohols as well as with amines where the focus is on ruthenium and iridium 
catalysis. 
 
2.1.1 N-alkylation of primary amines with alkyl halides 
In theory, the simplest reaction for synthesis of secondary amines is N-alkylation of 
primary amines with alkyl halides. Despite the simplicity it suffers one great disadvantage, 
which is risk of overalkylation to give both tertiary amines and quaternary ammonium 
salts. A way to overcome this can be achieved by using a great excess of the primary 
amine. However, this is not a general solution to overalkylation and it generates large 
amounts of waste.88 More promising results are obtained when an excess amount of an 
inorganic base (e.g. K2CO3) is added to the reaction mixture. Hereby, formation of 
quaternary ammonium salts becomes very unfavorable.90 Unfortunately, this does not in 
all cases hamper formation of the tertiary amine as well. An example is the reaction of 
cyclohexylamine, alkyl bromide and K2CO2. The secondary amine is predominantly 
obtained with 1-bromopentane and the tertiary amine is the sole product when using the 
shorter alkyl group of 1-bromopropane.91  
 
Cesium hydroxide has proved not only to suppress quaternary amine formation but it also 
hampers overalkylation. For the less active alkyl halides (such as primary and secondary 
alkyl halides) excess cesium hydroxide is necessary, whereas for the very active halides 
(such as benzyl and tertiary alkyl halides) a catalytic amount of cesium hydroxide is 
sufficient.92  
 
With the goal to develop an environmentally benign procedure for N-alkylation of amines 
with alkyl halides Nanda and co-workers have shown that silica gel added to the reaction 
mixture results in a 5-10 fold excess of the secondary amine to the tertiary amine (in most 
cases yields are above 75%).93 This procedure completely avoids the use of excess amine 
and base as well as addition of other reagents.  
 
A different approach to hamper formation of tertiary amine is introduction of a 
protection group on nitrogen (scheme 7). Incorporation of this group will make 
quaternary amine formation impossible and in presence of base the secondary amine is 
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favored (as explained above).94,95 The disadvantage is the requirement of additional 
synthetic steps, resulting in poor atom economy. 
 
 
Scheme 7. Suppressing tertiary amine formation by introduction of N-protection group. 
 
The methods described so far are most efficient with alkyl amines. Reactions of aryl 
amines often proceed to the tertiary or quaternary amines, hence no general procedures 
using secondary alkyl and aryl amines are reported.88 Secondary aromatic amine 
formation is better achieved utilizing metal catalysis. 
 
In general N-alkylations with alkyl halides are not suitable in large scale productions as 
they are highly toxic. Furthermore, the reactions have high E-factors, which is both a 
disadvantage for the environment as well as the cost of the production. 
 
2.1.2 Reduction reactions 
2.1.2.1 Reductive amination/alkylation 
In “indirect reductive amination” the first step is reaction of a ketone or an aldehyde and 
an amine to produce an imine. This imine is subsequently reduced to the secondary 
amine by an appropriate reducing agent (e.g. by NaBH4). As illustrated in scheme 8, 
ammonia can also be used as the nitrogen source in the reaction with aldehydes and 
benzotriazoles followed by reduction with LiAlH4.
96 This method provides symmetrical 
secondary amines.  
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Scheme 8. Ammonia as the nitrogen source in a reductive amination reaction. 
 
To reduce the number of steps, “direct reductive amination” can be applied. In this 
reaction the amine and the carbonyl compound react in the presence of the reducing 
agent. Therefore the reducing agent has to be chosen wisely as it must not reduce the 
starting carbonyl compound. Several efficient reducing agents have been reported and 
one of the most commonly used agents is NaCNBH3, which was first introduced in 1971.
97 
A disadvantage of this reagent is that it is highly toxic and therefore not suitable for large 
scale synthesis. Reducing agents such as NaBH(OAc)3
98 or a combination of Ti(OiPr)4 and 
NaBH4
99 are therefore more suitable. Still, the major disadvantage of reductive amination 
is the use of a stoichiometric amount of the reducing agent.88 
 
2.1.2.2 Catalytic reductions 
Bieber and co-workers have shown that reductive alkylation of aliphatic ketones with aryl 
amines to give secondary amines can be achieved in the presence of zinc and a minute 
catalytic amount of IrBr3 (scheme 9).
100 The advantage of this reaction is the optimal 
reaction temperature and it is suitable for a broad range of amines (aryl and benzyl) and 
ketones (yields range from 75-100%). The disadvantages are the requirement of a great 
excess of acid and in most cases also excess of ketone is necessary.  
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Scheme 9. Zinc mediated reductive amination with iridium catalysis. 
 
Other catalytic reductions include: 
• Catalytic hydrogenation of imines with various metals (e.g. asymmetric 
hydrogenation catalyzed by Pd, Rh and Ir).101   
• Catalytic hydrogenation of secondary amides (e.g. by ruthenium catalysis).102,103  
• Reductive N-alkylation of nitroarenes with alcohols (e.g. by gold catalysis)104 or 
with nitriles (e.g. catalyzed by palladium on carbon, which also works for aliphatic 
nitro compounds)105,106.  
• Reductive N-alkylation of amines with nitriles (e.g. by palladium or rhodium on 
carbon under a hydrogen atmosphere).107 
Despite the fact that these reactions are catalytic and therefore minimize waste, they all 
employ starting materials which are not as readily available as amines and alcohols. 
 
2.1.3 N-alkylation of primary amines with alcohols 
As described in chapter 1, N-alkylations of amines with alcohols have received an 
increased interest during the last three decades. This section is concerned with the 
progress in this area specifically aimed at syntheses of secondary amines. Not only the 
ruthenium and iridium catalyzed reactions are described, but also a brief description of 
catalysis by other metals is included.  
 
2.1.3.1 Palladium and gold 
The metal catalyzed N-alkylations of amines have been widely studied, and here some of 
the more recent reports will be briefly discussed. In scheme 10 three different catalytic 
systems are shown (all reactions are performed in closed systems). 
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Scheme 10. N-alkylation of amines with alcohols catalyzed by palladium or gold. 
 
In reaction a), palladium supported on magnesium oxide has been employed.108 The 
reaction is extremely fast for unsaturated alkyl amines (usually less than 1 hour), whereas 
the saturated alkyl amines require a much longer reaction time. The disadvantage of the 
reaction is the necessity of a great excess of the amine. Reaction b) involves a catalytic 
system consisting of palladium supported on iron oxide.109 In this method the alcohol has 
to be added in excess. Reaction a) and b) are both environmentally unfriendly as a result 
of poor atom economy. Reaction c) uses equimolar amounts of amine and alcohol and 
the active catalyst is gold nanoparticles.110 This system is efficient for a broad range of 
amines and alcohols, though it is best suited for aromatic amines (shorter reaction time 
and higher yields). In general these heterogeneous reactions often have the advantage of 
being more practical as the catalysts are easier to recover compared to homogeneous 
catalysts.109 
 
2.1.3.2 Ruthenium 
The first publication involving ruthenium catalysis was published in 1981. Anilines and 
small primary alcohols were condensated to furnish secondary amines in the presence of 
RuCl2(PPh3)3.
18 The yields were relatively low (less than 55%) and aniline had to be used in 
excess. Interestingly, a few years later the authors published an improved method where 
equimolar amounts of anilines and alcohol were reacted in presence of the same catalyst 
to provide the secondary amines in high yields (scheme 11).25 Even methanol could be 
employed in the reaction to give N-methylanilines.26  
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Scheme 11. N-alkylation of arylamines with benzylic or aliphatic alcohols. 
 
Also RuH2(PPh3)4 is a very efficient catalyst for reaction of alkyl amines with alkyl alcohols 
to give aliphatic secondary amines (scheme 12).38 
 
 
Scheme 12. N-alkylation of alkyl amines with alkyl alcohols. 
 
More recent results show that the catalytic system consisting of [Ru(p-cymene)Cl2]2 and 
dppf is capable of catalyzing the reaction of a primary amine bearing a tert-alkyl group (as 
well as aryl groups) with primary alcohols (scheme 13).28,39 The reaction affords the 
secondary amines in high yields (60-93 %).  
 
 
Scheme 13. Employment of sterically hindered primary amines. 
 
Later, the authors published an improved method where microwave irradiation reduced 
the reaction time to 1-2 hours and the products were still obtained in the same high 
yields.29 
 
Only few methods utilize secondary alcohols as they are more difficult to oxidize. Beller 
and co-workers have employed Ru3(CO)12 and this proved to be a very efficient catalyst 
for employing secondary alcohols in the N-alkylation with aliphatic amines (scheme 14).42 
In most cases the aryl phosphine ligand is superior with yields ranging from 29-92% yield 
(the lowest yields are when secondary amines are employed). 
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Scheme 14. Employment of a secondary alcohol.  
 
2.1.3.3 Iridium 
One of the first general methods using iridium catalysis for synthesis of a broad range of 
secondary amines was published in 2003 (scheme 15).20 The reaction was most efficient 
for anilines and benzyl amines, whereas alkyl amines reacted slower and afforded lower 
yields.  
 
 
Scheme 15. Iridium catalyzed condensation of amines and alcohols. 
 
The authors later optimized the reaction conditions. Decreasing the amount of [Cp*IrCl2]2 
and additive to 1-3 mol% Ir proved to be sufficient to maintain high yields.30 In some 
cases the yields were even increased (yields ranged from 71-98 %).  
 
N-alkylation in water was initially reported by Nordstrøm and Madsen in 2007 in the 
synthesis of piperazines from diols and diamines catalyzed by [Cp*IrCl2]2 and NaHCO3 
(more details in chapter 3).111 Based on that work, Williams and co-workers published the 
corresponding results of N-alkylation of primary/secondary amines with 
primary/secondary alcohols in 2010 (scheme 16).49 Noteworthy, additive was not 
required for the transformation and still the yields were high. 
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Scheme 16. Use of water as solvent in N-alkylation of amines with alcohols. 
 
Yamaguchi and co-workers have developed a different iridium catalyst that is active in 
water and a broad range of amines and alcohols have been examined with excellent 
results (scheme 17).36 Also in this case no additive is required and additionally, the 
reaction can be performed under air.  
 
 
Scheme 17. Use of a water soluble iridium catalyst. 
 
Even carbene ligands are effective in the process. A system consisting of a [IrCl2Cp*(NHC)] 
complex  together with AgOTf is suitable for the reaction of a broad range of amines and 
alcohols (scheme 18).31 Though, in some cases also the corresponding tertiary amine is 
formed. A major disadvantage is that the alcohol has to be used in a great excess to 
obtain the moderate to high yields.  
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Scheme 18. Use of a carbene ligand for iridium catalysis. 
 
Recently, ammonium salts have been employed as the nitrogen source for the N-
alkylation reaction. NH4BF4 and a simple primary or secondary alcohol are converted in 
the presence of [Cp*IrCl2]2 to symmetric secondary amines in 50-98% yield (scheme 19).
76 
The authors have also used aqueous ammonia and this also furnishes the secondary 
amines in slightly higher yields.75 It should be noted that if ammonium acetate is 
employed the tertiary amines are obtained in equally high yields.76 
 
 
Scheme 19. Reaction between ammonium salt and primary alcohols. 
 
Kempe and co-workers have published several papers utilizing [IrCl(cod)]2 together with 
P,N-ligands to achieve secondary amines from anilines (or heteroaromatic amines) and 
primary alcohols.32-35 The most recent results are illustrated in scheme 20.35 The reaction 
affords secondary aryl amines in very high yields. Interestingly, the reaction failed to 
convert alkyl amines. The major disadvantage is that the stoichiometric amount of base is 
required. However, what it lacks in preventing waste it gains by a very low catalyst 
loading as well as a low reaction temperature, which had not been seen before. 
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Scheme 20. Reaction between arylamines and primary alcohols catalyzed by 
an irdium-P,N-ligand complex. 
 
2.1.4 N-alkylation of primary amines with amines 
Secondary amines can also be achieved by N-alkylation of amines with primary amines. 
This section describes the progress in this area specifically aimed at syntheses of 
secondary amines. Focus is on ruthenium and iridium, but also other metals are briefly 
discussed.  
 
2.1.4.1 Palladium, platinum, nickel 
The early attempts to form secondary amines from primary amines in a catalytic manner 
include alkyl group exchange of primary and secondary amines in the presence of 
palladium black as illustrated in scheme 21.112 The reaction suffers from poor atom 
economy as it also produces a primary amine in an equimolar amount relative to the 
formed secondary amine.   
 
 
Scheme 21. Use of palladium catalysis for cross-coupling of amines. 
       
Secondary amines 
26 
 
To avoid a stoichiometric amount of waste, self-condensations of primary amines are 
more efficient. It can be achieved by different catalytic systems (scheme 22). In reaction 
a) PtCl2(PPh3)2 combined with SnCl2
.H2O affords secondary amines in moderate to good 
yields in a short reaction time.113 Reaction b) involves Raney-nickel in a heterogeneous 
catalytic system which also proved to be very efficient.114 More recently water and 
microwave irradiation has been employed in the reaction. In the presence of palladium 
on carbon and aluminum powder secondary amines are acheived in an extremely short 
reaction time (reaction c).115 However, it suffers from a great variation in yields due to 
formation of the corresponding tertiary amines (for primary alkyl groups) and the 
corresponding ketones (for secondary alkyl groups).  
 
 
Scheme 22. Metal catalyzed self-condensation of primary amines. 
 
Recently, Shimizu et al reported cross-couplings of amines catalyzed by alumina-
supported palladium nanoclusters (scheme 23).116 The majority of the examined reactions 
involved condensation of a benzylic amine with morpholine (only one example with an 
aliphatic amine). The major advantage is the good to high yields obtained in a very short 
reaction time. Additionally, the catalyst has a very high turn over number (even higher 
than that of [Cp*IrCl2]2 in a similar reaction)
117. However, a disadvantage is the use of 
excess amount of the secondary amine starting material. 
 
 
Scheme 23. Cross-coupling of amines catalyzed by palladium nanoclusters. 
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2.1.4.2 Ruthenium 
One of the first reports on the use of ruthenium in N-alkylation of amines with amines 
utilized RuCl2(PPh3)3 for self-condensation of simple primary amines to afford the 
symmetric secondary amines in high yields.118 This is exemplified with reaction of 
butylamine in scheme 24. Other aliphatic amines as well as benzylamine afforded the 
products in 72-99% yield.  
 
 
Scheme 24. Ruthenium catalyzed self-condensation of a primary amine. 
  
Aryl amines react with alkyl amines in the presence of the Shvo catalyst (scheme 25).119 
The reaction is suitable for a broad range of anilines and the aliphatic amine can have 
either primary or secondary alkyl groups. Yields range from 76-99%, but unfortunately the 
aryl amine must be added in excess. As also illustrated in scheme 25 even secondary 
amines as well as tertiary amines (not shown) can be used in the reaction and still the 
desired secondary amines are obtained in high yields.120 However, the reaction requires 
addition of an even greater excess of aniline and additional waste is generated. The 
authors have also reported the condensation between two different aliphatic amines in 
the presence of the Shvo catalyst (also illustrated in scheme 25).121 One of the amines 
must bear a tertiary alkyl group. Additionally, the reaction temperature is increased and 
an excess of the tert-alkyl amine is required to obtain satisfying yields (49-94 %). To some 
extend also secondary and tertiary amines can condensate with the tert-alkyl amine to 
give the desired secondary amine.  
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Scheme 25. Use of the Shvo catalyst for cross-couplings of amines. 
 
2.1.4.3 Iridium 
Iridium has not been as thoroughly explored as a catalyst for N-alkylation of primary 
amines with amines. Though, one example utilizes an iridium-carbene complex to 
catalyze the reaction between an aryl amine and a primary amine (scheme 26).31 The 
yields are high and the temperature is moderate, but the disadvantage is that the 
arylamine has to be added in excess. 
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Scheme 26. Use of a carbene ligand for cross-coupling of amines. 
 
Similar transformations have been performed with [Cp*IrI2]2 as the catalyst and both 
primary, secondary and tertiary amines were able to react with anilines (scheme 27).117 
The bulkier the alkyl group is, the higher the yields are. The most efficient of the 
examined amines were (i-Pr)2NH with the majority of the yields being close to 
quantitative. (i-Pr)2NH was also reacted with a range of benzyl amines (and alkylamines) 
with great success. The disadvantage of all the transformations is the use of a great 
excess of alkylamine.  
 
 
 
Scheme 27. Iridium catalyzed cross coupling of amines. 
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2.1.5 Concluding remarks 
It has been illustrated that secondary amines can be synthesized by many different 
methods. The non-catalytic methods all produce large amounts of waste. Additionally, for 
N-alkylation with alkyl halides and reactions involving strong reducing agents, these are in 
particular unfriendly to the environment as these materials are highly toxic. As a result of 
this, the methods are not suitable for large scale synthesis. Many of the described 
methods (both catalytic and non-catalytic) have issues with selectivity as also the tertiary 
amine is formed. More environmentally benign results are obtained by metal catalyzed N-
alkylation of primary amines with either alcohols or amines. These methods all have 
advantages and disadvantages and there is still room for improvements. In particular 
iridium has not been studied in depth as a catalyst for N-alkylation of amines with amines.  
 
Secondary amines - Results 
 
31 
 
2.2 Aim of the project 
A green and atom economical method for synthesis of secondary amines (both 
symmetrical and unsymmetrical) is desired. In particular it was decided to aim at a simple 
and straightforward method for isolation of products.  
 
2.3 Results and discussion 
2.3.1 N-alkylation of amines with amines 
The project initially started with examination of the capability of the catalyst to form C-N 
bonds. This was tested by reacting benzylamine and styrene with a catalytic amount of 
base or acid. The system was not able to furnish the desired product(s). Interestingly, it 
was able to reduce the double bond of styrene and self-condensation of benzylamine to 
dibenzylamine was observed in trace amounts (according to GC-MS) (scheme 28). 
 
 
Scheme 28. Initial investigations. 
  
Resultantly, the self-condensation of benzylamine was further examined starting with 
screening of reaction conditions. The results are summarized in table 7. 
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Table 7. Self-condensation of benzylamine. 
 
 
Entry Solvent Additive Temp (
o
C) Time(h) Conversion (%)
a 
1 Toluene - 140 18 0 
2 Toluene TFA 140 18  <5 
3 - - 140 18 ∼ 10 
4 - TFA 140 18 ∼ 10 
5 - - 160 18 ∼ 90 
6 - - 160 30 100
b 
7 - - 170 18 100 
8 - - 180 6 ∼ 90 
 a: by GC-MS. b: in this case also unidentified compounds were 
observed. 
 
Initially, the reaction was performed in toluene at 140 oC in the absence of an additive, 
but this gave a very poor conversion (entry 1). Addition of an acid additive did not 
improve the result significantly (entry 2). In the absence of a solvent the reaction afforded 
some conversion and dibenzylamine was observed in a trace amount (entry 3). Neither in 
this case did an acidic additive improve the outcome of the reaction (entry 4). Instead, a 
higher reaction temperature (160 oC) afforded almost full conversion of benzylamine 
(entry 5). Increasing the reaction time to 30 hours resulted in complete conversion (entry 
6). Unfortunately, the prolonged reaction time increased the formation of by-products. As 
a compromise a reaction temperature of 170 oC with a reaction time of 18 hours proved 
successful (entry 7). An attempt to shorten the reaction time to 6 hours by increasing the 
temperature to 180 oC was, however, not successful as full conversion was not obtained 
(entry 8).  
 
With the optimized reaction conditions focus was then moved to substrate screening. All 
products were isolated by direct vacuum distillation from the reaction mixture. The 
results are summarized in table 8.  
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Table 8.  Self-condensation of primary amines. 
 
 
Entry Amine Product Yield (%)
a 
1 
  
70b (66) 
2 
  
75c 
3 
  
77c 
4 
NH2
F   
83 
5 
  
80 (62) 
6 
NH2
Br   
76 
7 
  
79 
8   
72d (49) 
9   
72d 
10 
  
73d (39) 
Yields in parenthesis are after 8 hours. a: isolated yield by distillation. b: 86% yield after 72 
hours. c: synthesized by former bachelor student Paw Jensen. d: after 72 hours.  
 
Dibenzylamine was isolated in 70% yield (entry 1). If the reaction time was reduced to 6 
hours a yield of 66% was obtained, whereas a reaction time of 72 hours afforded 86% 
yield. Consequently, it was decided to maintain the reaction time of 18 hours despite the 
higher yield with a prolonged reaction time. Both methyl and methoxy substituents as 
well as halogenated benzylamines afforded the dibenzylamines in good yields ranging 
from 75-80% yield (entry 2-6). The reaction of 4-chlorobenzylamine was also stopped and 
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purified after 8 hours and this afforded an isolated yield of 62% compared to 80% after 18 
hours (entry 5). It is noteworthy that even a bromo substituent is stable under the 
reaction conditions (entry 6). This serves as a great advantage as the bromo substituent 
can act in further functionalization of the molecule. The heteroaromatic compound 2-
picolylamine could also be self-condensated affording the product in 79% yield (entry 7). 
For the aliphatic amines, hexyl-, octyl- and cyclohexylamine, good yields were likewise 
obtained (72-73%, entry 8-10), but an increased reaction time of 72 hours was required. 
Isolation of the products after 8 hours gave only 49% yield in the case of dihexylamine 
and 39% yield for dicyclohexylamine.  
 
In some cases the corresponding tertiary amines were observed if the reaction time was 
prolonged. In one reaction of benzylamine at 170 oC for 72 hours tribenzylamine was 
isolated in 37% yield, but this result was unfortunately not reproducible. Another reaction 
of benzylamine for 72 hours afforded dibenzylamine in 86% yield.  
 
Other substrates tested for self-condensation were 4-cyanobenzylamine, tryptamine and 
furfurylamine (figure 4). They all decomposed under the reaction conditions.  
 
Figure 4. Failed substrates. 
 
 
2.3.1.1 Formation of unsymmetrical secondary amine 
Attempts to make unsymmetrical amines were conducted with benzylamine and 
hexylamine (scheme 29). Unfortunately, this was rather unsuccessful as N-
hexylbenzylamine was isolated by flash chromatography in only 40% yield. The remainder 
was dibenzyl- and dihexylamine (not quantified).  
 
 
Scheme 29. Cross-coupling of benzylamine and hexylamine. 
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2.3.1.2 Cyclization of diamines 
In 1981 it was shown that cyclic secondary amines could be formed by a self-
condensation reaction with a ruthenium catalyst.118 Therefore it was decided to 
investigate the cyclization of 1,4-butanediamine to give pyrrolidine. The results are 
summarized in table 9. 
 
Table 9. Cyclization of 1,4-diaminobutane. 
 
 
Entry Additive Solvent Temp (
o
C) Product (%)
a 
1 TFA Water 140 < 5 
2 NaHCO3 Water 140 < 5 
3 TFA Toluene 140 < 5 
4 NaHCO3 Toluene 140 < 5 
5 TFA - 140 < 5 
6 TFA - 160 ∼ 10 
7 TFA - 140
b < 5 
a: by GC-MS.  b: after 2 days. 
 
Initially, the reaction was performed in water, but poor conversion and only trace 
amounts of pyrrolidine was observed with either TFA or NaHCO3 as additive (entry 1 and 
2). Changing the solvent to toluene had no effect (entry 3 and 4) and neat reaction 
conditions did not improve the outcome either (entry 5). Increasing the reaction 
temperature resulted in slightly more product formation, though also dimerization of the 
starting material had occurred and still the conversion of starting material was poor 
(entry 6). Lastly, prolonging the reaction time was examined, but that had no effect on 
the conversion (entry 7). The one carbon atom longer compound 1,5-pentanediamine 
was then examined, but also this compound failed at cyclizing and absolutely no 
piperidine was observed by GC-MS.  
 
As a result of these poor outcomes it was decided that no further attempts to improve 
the cyclization reaction was conducted. It is clear that the intramolecular transformation 
is not as straightforward as intermolecular reactions of primary amines.  
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2.3.2 Mechanism 
There was not conducted any experiments in order to determine the reaction 
mechanism, but a proposal is illustrated in scheme 30. This mechanism is based on the 
postulated mechanism by Madsen and co-workers79 with all intermediates coordinated to 
iridium as described in chapter 1. 
 
 
Scheme 30. Proposed reaction mechanism for N-alkylation of amines with amines. 
 
Firstly, the primary amine coordinates to iridium and subsequent oxidation afforded the 
imine. With the imine still coordinated another primary amine coordinates to iridium and 
this is followed by attack of the amine on the imine to furnish a cyclic intermediate. A 
proton shift provides the imine and then ammonia is released from the iridium complex. 
A final protonation leads to the secondary amine product. The exact nature of the active 
iridium species has not been illustrated. As for N-alkylation of amines with alcohols it is 
speculated that the primary amine also acts as a ligand. Therefore, it is possible that 
ammonia is released as a result of ligand exchange with the primary amine due to the 
higher concentration of primary amine compared to ammonia initially in the reaction. 
Whether a mono- or dihydride mechanism is involved could potentially be determined by 
conducting a racemization experiment with a deuterated racemic amine (as described in 
the chapter 1). 
 
The work described in this chapter was published in Synthesis in 2009 simultaneously 
with the work by Williams and co-workers117 (described in section 2.1.4.3). They 
employed the same catalyst but were able synthesize unsymmetrical secondary amines, 
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in particular N-isopropylbenzylamines. Unfortunately, the reaction was not examined 
with simple linear primary amines, and the success of the reaction required a 3-fold 
excess of the alkyl amine. Additionally, the products were purified by column 
chromatography and this generates large amount of solvent waste. Synthesis of the 
unsymmetrical amine described in this thesis was obtained by direct distillation from the 
reaction mixture in only 40% yield, but it must be kept in mind that it was obtained with 
equimolar amounts of starting materials making this reaction more atom economical. 
 
2.4 Conclusion 
Symmetrical secondary amines have been synthesized in good yields by a very 
environmentally benign procedure. No solvent or additives are necessary and products 
are directly distilled from the reaction mixture. Unfortunately, the reaction conditions 
were not able to give good selectivity when two different primary amines were mixed. 
The intramolecular reaction of amines to give cyclic amines was not successful either.  
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3 Piperazines 
A survey of more than 1000 drugs revealed that the piperazine moiety is found in 
approximately 6% of the orally administered drugs.89 Due to this relatively high number, 
there is, also in this field, focus on environmentally benign syntheses. Besides the 4 of the 
20 top selling drugs listed in table 2 in chapter 1, a few other examples of piperazine 
containing pharmaceuticals are shown in figure 5. 
 
Figure 5. Piperazine containing pharmaceuticals. 
 
 
3.1 Methods for synthesis of piperazine derivatives 
Piperazine derivatives can have many different substitution patterns. It can have 
substituents on one or both of the nitrogen atoms and/or one or more substituents on 
the carbon atoms.  Catalytic as well as non-catalytic approaches to synthesize of a wide 
variety of piperazine derivatives have been published. In this chapter a selection of these 
methods will be described. 
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3.1.1 Non-catalytic methods 
3.1.1.1 From piperazine (or N-protected piperazine) 
Piperazine itself is commercially available and it is possible to synthesize derivatives 
directly, e.g. by N-alkylations.122 A very simple method is a substitution reaction with an 
appropriate leaving group (such as chloride) to generate N-substituted piperazines. 
Despite its simplicity, this method suffers major disadvantages such as risk of over 
alkylation if only monosubstituted piperazine is desired. Additionally, alkyl/benzylhalides 
are highly toxic and for this reason the method is inappropriate for large scale synthesis 
(as also explained for the synthesis of secondary amines in chapter 2). A different 
approach to N-substituted piperazines from piperazine itself is illustrated in scheme 31. 
Initially, piperazine is acylated with amino acids and then further functionalization is 
possible.123 If only mono-N-substitution is desired the reaction must start with protection 
of one of the two nitrogen atoms.  
 
 
Scheme 31. Piperazine as starting material for synthesis of N,N’-disubstituted piperazines. 
 
2-Substituted piperazines can be synthesized from Boc-protected piperazine (scheme 
32).124 The reaction proceeds through an initial α-lithiation and this is followed by 
transmetallation to copper. Subsequently, substitution with electrophilic reagents such as 
alkyl-, allyl- or benzylbromides takes place. Depending on the added electrophile further 
functionalization is possible. The procedure suffers from disadvantages such as the use of 
toxic reagents and the formation of additional waste in the form of the copper species.  
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Scheme 32. Synthesis of 2-Substituted piperazines from N,N’-diprotected piperazine. 
 
3.1.1.2 From (di)ketopiperazines 
2,6-Diketopiperazines are easily reduced to the corresponding piperazine e.g. by BH3
125 or 
LiAlH4
126 (scheme 33). The only requirement for the reduction agent is that it must not 
affect the substituents on neither carbon nor nitrogen atoms.  
 
 
Scheme 33. Reduction of diketopiperazines. 
 
Synthesis of diketopiperazines has been studied for decades. In particular syntheses 
starting from amino acids (or derivatives) have been reported.125 For that reason, most of 
the methods described in this section are based on amino acids.  
 
The Ugi reaction can be used to synthesize 2,6-diketopiperazines. As exemplified in 
scheme 34 the reaction involves a multi-component reaction (MCR) of four reactants.126 
By using N-Boc protected glycine a simple C,N-disubstituted diketopiperazine is acheived. 
If other amino acids are used a fully substituted diketopiperazine is obtained.127 The 
limitation of the Ugi reaction is the availability of the four reactants.  
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Scheme 34. Diketopiperazines via the Ugi reaction. 
 
Formation of diketopiperazines via peptide synthesis has been widely studied and with 
great success.128,129 Examples of both solution phase and solid phase syntheses are 
illustrated in scheme 35. The solution phase approach involves standard peptide synthesis 
and when the Boc-group is removed intramolecular peptide formation affords the six-
membered ring.130 The nature of the R/R’ groups are limited to those found in the amino 
acids (unless unnaturally occurring amino acids are used). More commonly solid phase 
synthesis is applied and also this follows standard procedures.131,132 
 
 
Scheme 35. Peptide syntheses of diketopiperazines. 
 
Symmetrical N-substituted diketopiperazines can be synthesized in one-pot from amines 
and chloroacetyl chloride in high yields (scheme 36).133 Despite the simplicity of the 
reaction, the major disadvantage is the use of the toxic halogenated starting materials. 
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Scheme 36. One-pot synthesis of diketopiperazines. 
 
2-Oxo-piperazines can also be reduced to piperazines by LiAlH4.
134 Donati and co-workers 
have published a method starting from a Weinreb amide (derived from an amino acid) as 
illustrated in scheme 37.135 Initially, the amide is reduced to the corresponding aldehyde, 
which then undergoes a reductive amination. The formed amine is amidated and finally 
an intramolecular substitution reaction provides the 2-oxopiperazine. If desired, an 
electrophile can be introduced via ortho-lithiation.  
 
 
Scheme 37. Synthesis of 2-oxopiperazines. 
 
C-substituted ethylenediamine in reaction with dimethyl maleate (or fumarate) is a one-
pot approach to 2-oxipiperazines (scheme 38).136 The limitation of this reaction is the 
nature of the diamine, as only small substituents are tolerated. Additionally, substitution 
on nitrogen is possible. However, if the substituent on nitrogen is large the reaction is 
only successful with carbon unsubstituted ethylenediamine. 
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Scheme 38. One-pot synthesis of 2-oxopiperazines. 
 
3.1.1.3 By other methods 
Bis-(2-chloroethyl)amine hydrochloride is reacted with aryl amines to provide N-aryl 
substituted piperazines as illustrated in scheme 39.137 The advantage of the procedure is 
the good atom economy, as HCl is the only by-product and no additives are used. 
However, the reaction is limited to non-sterically hindered aryl amines. This can be 
circumvented by the use of a more recent method involving microwave irridation 
(scheme 39).138 The drawback is the use of large excess of the base as well as a 
deprotection step (of N-Nos). In addition, the procedure suffers from poor atom 
economy. 
 
 
Scheme 39. N-arylsubstituted piperazines from bis-(2-chloroethyl)amine hydrochloride. 
 
Symmetrical N-substituted piperazines are the product of the reaction between 
ethylamine hydrobromide and benzyl bromides (scheme 40).139 The disadvantage is the 
use of excess amounts of the base as well as the use of the toxic halogenated starting 
materials.  
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Scheme 40. Synthesis of symmetrical N-substituted piperazines. 
 
An example of the synthesis of C-substituted piperazines from diimines is illustrated in 
scheme 41. It is achieved via a cyclization reaction involving intramolecular reductive 
coupling of the diimines.140-142 The drawback of this reaction is the use of excess reagents 
as well as the limited availability of the diimines.  
 
 
Scheme 41. C-substituted piperazines from diimines. 
 
Grignard reagents can be reacted with pyrazine N-oxides to generate N-
hydroxylpiperazine, which can then undergo reaction at one or both nitrogen atoms 
(scheme 42).143,144 This strategy affords therefore a good handle for further 
functionalization of the compound. The disadvantage is the use of excess Grignard 
reagent as well as a reduction step that generates additional waste.  
 
 
Scheme 42. Use of Grignard reagents and pyrazine N-oxides. 
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3.1.2 Catalytic methods 
3.1.2.1 Palladium 
Palladium is capable of catalyzing N-arylation of piperazines as illustrated in scheme 
43.145,146 The reactions require excess amounts of base and the yields vary tremendously, 
though the method using Pd(OAc)2 is generally superior.  
 
 
Scheme 43. Palladium catalyzed N-arylation of piperazines.  
 
Another approach to piperazines by palladium catalysis is the intramolecular 
carboamination reaction147 and the hydroamination reaction148 illustrated in scheme 44. 
The disadvantage for both procedures is the prior synthesis of the starting materials. 
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Scheme 44. Palladium catalyzed intramolecular formation of piperazines. 
 
Heterogeneous catalysis can also be employed for piperazine formation (scheme 45). 
When palladium is immobilized on magnesium oxide it is efficient as a catalyst for N-
alkylation of amines with alcohols.108 In addition to synthesis of piperazine itself, also 
substituted diols and diamines can be utilized in the reaction affording both C- and N-
substituted piperazines. The benefit of the reaction is that the catalyst is used in very 
small quantities (0.8 % Pd) and an additive is not required.  
 
 
Scheme 45. Use of heterogeneous palladium catalysis for piperazine formation. 
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3.1.2.2 Ruthenium 
To the best of our knowledge there have been no reports on any general ruthenium 
catalyzed methods to produce a broad range of both C- and N-substituted piperazines. 
Some of the methods described in chapter 2 (synthesis of secondary amines) have 
piperazine as an example, though they do not report synthesis of a broad range of 
derivatives. In this section some of the methods for synthesis of either C- or N-substituted 
piperazines will be described. 
 
Reaction between N-substituted diethanolamine and a primary amine in the presence of 
a ruthenium catalyst afforded N,N’-disubstituted piperazines in moderate yields (scheme 
46).55 The reaction was later examined by van Koten and co-workers with a much more 
complex ruthenium catalyst.56 However, the obtained yields were only slightly higher and 
only two examples were reported.  
 
 
Scheme 46. Ruthenium catalyzed formation of N,N’-disubstituted piperazines. 
 
Jenner and Bitsi have used the borrowing hydrogen methodology to synthesize 
piperazines from 1,2-diamines and 1,2-diols (scheme 47).57 The reaction was performed 
at a very high pressure and only very simple derivatives have been synthesized with a 
maximum of two substituents; methyl groups or a cyclohexyl group. The reactions 
afforded full conversion of amines, except for the cyclohexyl substituent where only 75-
88% conversion of amine was obtained. Selectivity towards the piperazine ranged from 
60 to 100%. Unfortunately, the yields were not reported. Nevertheless, if it is assumed 
that ethyleneglycol conversion is 100%, the yields range from 60 to 100%. 
 
 
Scheme 47. Ruthenium catalyzed N-alkylation of amines with alcohols. 
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Williams and co-workers have very briefly examined N-substitution of piperazines with a 
secondary alcohol (in two examples) and with a primary alcohol (in one example) all in 
high yields (scheme 48).28 The latter has also been examined under microwave 
conditions.29 This proved to be successful as the same high yield was obtained in a highly 
reduced reaction time. 
 
 
Scheme 48. Ruthenium catalyzed N-alkylation of piperazine with secondary alcohols. 
 
3.1.2.3 Iridium 
Methods involving iridium catalysis have not received much attention for piperazine 
synthesis. Nevertheless, a few examples are worth to be mentioned herein. Piperazine 
itself can be used as the nitrogen source for the N-alkylation of amines with alcohols as 
illustrated in scheme 49.49 Unfortunately, only one specific example has been reported, 
but the procedure should be applicable with a broad range of alcohols.  
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Scheme 49. Iridium catalyzed N-alkylation of piperazine with a primary alcohol. 
 
Yamaguchi and co-workers published in 2009 their work on synthesis of symmetrical N-
substituted piperazines from N-substituted ethanolamines (scheme 50).58 This method is 
also expected to be successful with C-substituents on the starting material.  
 
 
Scheme 50. Iridium catalyzed formation of symmetrical piperazines. 
 
Not technically a piperazine, but still an interesting approach, tetrahydroquinoxalines 
have been synthesized by an intramolecular reaction of arylamino alcohols (scheme 51).59 
The reaction tolerated a quaternary center closest to nitrogen and the corresponding 
product was isolated in high yield after reduced reaction time (1 versus 2-3 days). This is 
an interesting result as it is usually difficult to form piperazine derivatives containing a 
quaternary center.59 In general the reaction required a relatively high catalyst loading and 
the methyl substitution on nitrogen was crucial. With hydrogen or benzyl substitution on 
nitrogen the reaction afforded very low yields.  
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Scheme 51. Iridium catalyzed synthesis of quinoxalines.  
 
3.1.3 Previous work on synthesis of piperazines within the group 
In 2007 former PhD student Lars Ulrik Rubæk Nordstrøm published together with 
Professor Robert Madsen their work concerning iridium catalyzed synthesis of piperazine 
derivatives.111 The goal was to condensate 1,2-diamines with 1,2-dialcohol. Several N- and 
C-substituted piperazines were obtained in good to excellent yields as shown in table 10.   
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Table 10. Condensation of diamines and diols. 
 
 
Amine Diol Solvent Temp. (
o
C) Product Yield(%) 
 
 
1 
Water 
Toluene 
100 
110 
 
96 
94 
 
 
Water 
Toluene 
100 
110 
 
98 
87 
 
 
Water 
Toluene 
140 
140 
 
81 
79 
  
Water 
Toluene 
140 
140 
 
73 
74 
  
Water 
Toluene 
100 
110 
 
60/86 
54 
  
Water 120 
 
quant. 
 
 
Neat 160 
 
94 
 
This was the first published method where water is used as a solvent for reaction of 
amines and alcohols by the borrowing hydrogen methodology. It was a breakthrough as 
the reaction proceeds via imines which are usually unstable in water. Interestingly the 
isolated yields are generally high.  
 
It is believed that the reaction proceeds via the mechanism illustrated in scheme 52. 
Initial oxidation of the alcohol affords the aldehyde (or ketone), which is subsequently 
condensated with the diamine to form imine A. This imine can be reduced by iridium to 
give amino alcohol B and subsequently oxidized to aldehyde C. On the other hand, it is 
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also possible for the imine to undergo a Voigt reaction (isomerization of α-imino alcohols 
to α-amino ketones)149,150 to produce aldehyde C. This aldehyde undergoes an 
intramolecular condensation to provide the final product.  
 
 
Scheme 52. Proposed pathways for piperazine formation from 1,2-diols and 1,2-diamines. 
 
3.1.4 Concluding remarks 
It has been illustrated that piperazines can be synthesized by many different methods. 
The conclusion is similar to that given in chapter 2 concerning synthesis of secondary 
amines; non-catalytic procedures are not optimal due to large amounts of waste, whereas 
the catalytic methods show more promising results. The field of metal catalyzed reactions 
has not been widely explored. In particular in regards to condensation of diols and 
diamines by iridium catalysis the reaction should be further explored. 
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3.2 Aim of the project 
C-N bond formation by metal catalysis is a field that has received much attention. 
However, in terms of piperazine synthesis the number of publications is limited. The work 
described in this chapter is a continuation of the work by former PhD student Lars Ulrik 
Nordstrøm. It is desirable to expand the substrate scope to establish the limitations of the 
reaction. In particular the selectivity of the reaction when both C-substituted diols and C-
substituted diamines are condensated is of interest. Attempts to use other types of 
starting materials (ethanolamine, aromatic amines and ammonium salts) are also 
explored. As mentioned, [Cp*IrCl2]2 is relatively expensive, and it would be of great 
interest to the industry if a cheaper catalyst could perform the same transformations. 
Lastly, the mechanism has so far not been supported by any real evidence and should be 
studied in further details. 
 
3.3 Results and discussion 
3.3.1 Piperazine from ethanolamine 
As it is possible to condensate 1,2-diamines with 1,2-diols to give piperazine derivatives it 
was envisioned that ethanolamine in a self condensation reaction would afford the 
parent piperazine (scheme 53). 
  
 
Scheme 53. Piperazine from ethanolamine. 
 
The reaction was tested in a large number of experiments with variations in catalyst 
loading, temperature, solvent and reaction time; 0.01-1 mol% [Cp*IrCl2]2 and 5 mol% 
NaHCO3 at temperatures ranging from 55 to 110 
oC in THF, DME, dioxane, toluene or 
water for 5-24 hours. Unfortunately, all reactions afforded poor conversions and only 
trace amounts of piperazine were observed. In the pursuit to obtain full conversion only 
water and neat reaction conditions were further examined and the results are 
summarized in table 11.  
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Table 11. Self-condensation of ethanolamine. 
 
 
Entry mol% cat Solvent Temp (
o
C) Time Conversion (%)
a 
Products
a 
1 0.5 Water or neat 140 1 day < 10 1, 2, and 3  
2 0.25 water 140 4 days 100 2 (30%), 3 (27%) 
3 0.25 Neat 140 2 days 100 2 (23%), 3 (25%) 
4 0.25 Neat 140 6 days 100 2 (14%), 3 (20%)  
5 0.25 Neat 160 2 days 100 No products 
  Numbers in parenthesis are isolated yields. a: by GC-MS. 
 
A reaction time of 1 day at 140 oC in water or neat reaction conditions did not afford full 
conversion (entry 1). Nevertheless, several products were detected by GC-MS analysis; 
two major products as well as an intermediate. According to the mass of the intermediate 
it is likely to be N-(2-aminoethyl)ethanolamine, which is an expected intermediate in the 
formation of piperazine from ethanolamine. Unfortunately, the structure has not been 
confirmed as the compound was not isolated. Extending the reaction time afforded full 
conversions and the two major products (according to GC-MS analysis) were isolated and 
identified as 1-piperazinoethanol and 1,4-piperazinediethanol. At full conversion of 
starting material the intermediate was no longer observed by GC-MS analysis and 
interestingly still no piperazine was detected. When water was used as solvent a reaction 
time of 4 days was required to obtain full conversion and this resulted in isolated yields of 
30% and 27% respectively, of 1-piperazinoethanol and 1,4-piperazinediethanol (entry 2). 
With neat reaction conditions a reaction time of 2 days was sufficient, though the yields 
were slightly lower; 23% and 25% of 1-piperazinoethanol and 1,4-piperazinediethanol, 
respectively (entry 3). When the reaction time was further increased to 6 days (neat 
reaction conditions) the yields dropped to 14% and 20% of 1-piperazinoethanol and 1,4-
piperazinediethanol, respectively (entry 4). Reaction at 160 oC (neat conditions) resulted 
in no products according to GC-MS analysis (entry 5). This could be due to polymerization 
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or possible degradation of the starting material. In no cases were any other compounds 
isolated. It is possible that the reactions have formed higher polymers that cannot be 
isolated by column chromatography and are not detectable in GC-MS analysis.  
 
Unfortunately, the ratio between the two products cannot be controlled and the products 
have a limited possibility for functionalization. This combined with the assumed 
polymerization of starting material and/or intermediates resulted in the decision not to 
attempt any further optimization of the reaction conditions.  
 
As illustrated in scheme 54 other strategies were also examined. Attempts to synthesize a 
piperazine derivative from substituted ethanolamine were briefly investigated. Using 2-
aminopropanol instead of ethanolamine at 140 oC in either water or neat conditions 
failed completely at affording 2,5-dimethylpiperazine. A change in reactant from using 
solely ethanolamine to reacting equimolar amounts of ethanolamine and ethylene glycol 
afforded only trace amounts of morpholine.  
 
 
Scheme 54. Failed reactions with ethanolamines. 
 
It is concluded that ethanolamine (and methyl-C-substituted ethanolamine) are not 
suitable starting materials for piperazine synthesis. Interestingly, Yamaguchi and co-
workers had success with self-condensation of N-benzyl ethanolamines to furnish the 
corresponding disubstituted piperazine.58 It is possible that the presence of a substituent 
on nitrogen is crucial - at least it hampers polymerization. It should also be noted that a 
very high catalyst loading (20 mol%) was used, which might also account for the high 
yields.  
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3.3.1.1 Reactions of N-(2-aminoethyl)ethanolamine 
As already mentioned, the intermediate observed in the reaction of ethanolamine was 
not isolated, but on the basis of GC-MS analysis it is possible that it is N-(2-
aminoethyl)ethanolamine. Despite the failed attempt to synthesize piperazine from 
ethanolamine it was tested if N-(2-aminoethyl)ethanolamine could be an intermediate in 
the formation of piperazine and/or 1-piperazinoethanol and 1,4-piperazinediethanol. The 
results are summarized in table 12.  
 
Table 12. Reaction of N-(2-aminoethyl)ethanolamine. 
 
 
Entry mol% cat Solvent Temp (
o
C) Time Products
a 
1 0.25 Neat 140 1 day piperazine (14% isolated yield)
b 
2 0.25 Neat 160 1 day Piperazine (31% isolated yield)
b 
3 0.25 Neat 160 2 days Piperazine (34% GC-yield)
b,c 
4 0.5 Water 140 1 days Piperazine (70% GC-yield) 
5 0.5 Water 140 2 days Piperazine (100% GC-yield) 
6 0.25 Water 140 2 days Piperazine salt (79% isolated yield)  
a: by GC-MS. b: 1-piperazinoethanol also observed (not quantified). c: also many minor peaks 
were observed by GC-MS. 
 
After reaction for 1 day at 140 oC a mixture of starting material, piperazine and 1-
piperazinoethanol was observed, and piperazine was isolated by column chromatography 
in 14% yield (entry 1). At 160 oC the reaction afforded full conversion and piperazine was 
isolated by distillation in 31% yield (entry 2). Longer reaction time did not increase the 
yield of piperazine, though it gave rise to more by-products (entry 3). When water was 
used as the solvent the reaction afforded after 1 day a 70% GC-yield of piperazine and 
after 2 days the GC-yield of piperazine had increased to 100% (entry 4 and 5). Isolation of 
piperazine from water is rather difficult as the two form an azeotrope. Instead, piperazine 
was isolated as the hydrochloride salt in 79% yield (entry 6).  
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Hereby, it is shown that N-(2-aminoethyl)ethanolamine under the reaction conditions 
produces piperazine, but it does not by any means prove that the compound is an 
intermediate in the formation of piperazine from ethanolamine. 
 
3.3.1.2 Mechanism 
At some point in the reaction pathway an imine has to react with an amine. Otherwise, 
the observed products are not likely to be formed. From previous work on self-
condensation of primary amines (chapter 2) it is known that this is possible.151 Still, it is 
not known if amine oxidation is possible in the presence of an alcohol or if the imine is 
always formed as a result of the Voigt reaction. Williams and co-workers have reported 
that a ruthenium catalyzed reaction between a secondary amine and an amino alcohol 
afforded not only the expected amine product but also the alcohol product (scheme 55).28 
They postulate that the latter is obtained as a result of the starting amino alcohol 
undergoing the Voigt reaction.  
 
 
Scheme 55. Proposed pathway via the Voigt reaction. 
 
Many different suggestions to the mechanism of 1-piperazinoethanol and 1,4-
piperazinediethanol formation from ethanolamine can be drafted, but none are 
supported by mechanistic experiments. Two possible pathways are illustrated in scheme 
56.  
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Scheme 56. Proposed pathways for self-condensation of ethanolamine. 
 
It is possible that reaction of ethanolamine gives piperazine via N-(2-aminoethyl)-
ethanolamine (pathway A). Though, as soon as piperazine is formed it reacts with 
ethanolimine to give the two piperazine derivatives. The other suggestion proceeds via a 
diethanolamine intermediate obtained from reaction of ethanolimine with ethanolamine 
(pathway B). Unless a long polymer at some point makes a ring closing reaction with 
ethanolamine (or ethanolimine) it is liable to assume that 1,4-piperazinediethanol arises 
from reaction of 1-piperazinoethanol with ethanolamine as illustrated. 
 
More experiments should be conducted to further elucidate the mechanism. For instance, 
reaction of diethanolamine with ethanolamine might reveal if pathway B is more likely. 
Reaction of 1-piperazinoethanol with ethanolamine could clarify if 1-piperazinoethanol is 
an intermediate in the formation of 1,4-piperazinediethanol.  
 
1-Piperazinoethanol and 1,4-piperazinediethanol were tested for reactivity in reaction 
with iridium and NaHCO3. In the first case, reaction in water at 140 
oC and neat reaction 
at 160 oC afforded release of ammonia and many compounds were observed in low 
amounts by GC-MS analysis. However, the starting material is by far the dominating peak 
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in the GC-MS chromatogram, indicating a low degradation of the starting material. In the 
latter case, no other peaks than the starting material was observed by GC-MS analysis. 
Nevertheless, 20% of the starting material was consumed and this could be due to 
formation of higher polymers, which are not detectable by GC-MS analysis. This indicates 
that the two products are not completely stable under the reaction conditions. It also 
supports the relatively low yields of the two piperazine derivatives obtained from 
reaction of ethanolamine.  
 
3.3.2 Piperazine from ethylene glycol and ethylenediamine 
Piperazine derivatives have been obtained by condensation of ethylene glycol and 
ethylenediamine with at least one substituent on one of the starting materials. As a 
consequence, it was investigated if also piperazine itself could be synthesized by this 
strategy as illustrated in scheme 57.  
 
 
Scheme 57. Piperazine from 1,2-ethylenediamine and ethyleneglycol. 
 
Initially, screening of reaction conditions were analyzed solely by GC-MS. In all cases the 
only detectable product was piperazine, though isolation of this turned out to be rather 
tedious. Mainly toluene and water was used as solvents and these form azeotropes with 
piperazine. Isolation by column chromatography was unsuccessful. Instead, the product 
was isolated as the hydrochloride salt which in turn is a very simple work-up procedure. 
Unfortunately, only trace amounts of piperazine were isolated, and as a consequence an 
internal standard was introduced. The results are summarized in table 13. 
 
Table 13. Reactions between 1,2-ethylenediamine and ethyleneglycol. 
Entry Solvent Temp (
o
C) Conversion (%) products
a
  
1 Toluene 110 < 10 Trace of piperazine 
2 Toluene 140 100 Piperazine (15% GC) 
3 Water 110 < 10 Trace of piperazine 
4 Water 140 100 Piperazine (< 10%) 
5 Neat 140 100 Piperazine (< 10%), (by-products) 
a: by GC-MS 
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The reaction performed in toluene at 110 oC gave poor conversion (entry 1). Increasing 
the temperature to 140 oC afforded full conversion, but unfortunately piperazine was only 
obtained in 15% yield (entry 2). Performing the reaction in water had an almost identical 
outcome (entry 3 and 4) and using neat reaction conditions caused formation of by-
products (entry 5). With these poor results it was decided not to attempt any further 
optimizations of the reaction. Decomposition or formations of higher polymers are likely 
to have occurred.  
 
3.3.3 Piperazines from substituted ethylene glycol and substituted 
ethylenediamine 
3.3.3.1 2-Methylpiperazine 
As the reaction of ethylene glycol and ethylenediamine failed to provide piperazine it was 
envisioned that introduction of a substituent might enhance reactivity due to the Thorpe-
Ingold effect. This effect is described as a change in the tetrahedral angle by introduction 
of substituents which then enhances chemical reactivity.152 This can be achieved by 
placing the substituent on either of the two starting materials as illustrated in scheme 58. 
In both cases the reactions proceeded smoothly and the products were isolated as 
hydrochloride salts in high yields.  
 
 
 
Scheme 58. Synthesis of 2-methylpiperazine. 
 
3.3.3.2 2,5- and 2,6-dimethylpiperazine 
The regioselectivity of the reaction was then investigated. The most simple starting 
materials, 1,2-diaminopropane and 1,2-propanediol, were used and the reaction provided 
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the two possible products in combined high yields (scheme 59). Unfortunately, the 
regioselectivity of the reaction was poor. 
 
 
Scheme 59. Synthesis of 2,5- and 2,6-dimethylpiperazine. 
 
The products were also isolated as the free amines, though this afforded lower yields. 
Isolation by flash column chromatography of products obtained from the reaction in 
water resulted in 34% yield in a 1:4 ratio with 2,5-dimethylpiperazine as the major 
product. When the reaction was performed in toluene the yield was comparable (31% 
yield), though in a 1:1,5 ratio with 2,5-dimethylpiperazine being the major product. Not 
only are the yields low, but also the regioselectivity is varying. This indicates that the 
products are difficult to isolate by column chromatography (despite use of TEA as co-
eluent). When products were purified by distillation the yield increased to 60% (reaction 
performed in toluene) with a 1:1 ratio. However, in this case the toluene phase also 
contained products which might indicate azeotrope formation. Resultantly, isolation as 
the hydrochloride salts is the preferred method. 
 
3.3.3.3 2-Methyl-5-phenylpiperazine and 2-methyl-6-phenylpiperazine 
The formation of disubstituted piperazines with two different substituents was 
investigated with 1,2-diaminopropane and 1-phenyl-1,2-ethanediol (scheme 60). The 
reaction temperature had to be increased to 160 oC to afford full conversion and the 
products were isolated by vacuum distillation in good yields. The selectivity is dependent 
on the choice of solvent, with water providing a ratio of 3:1 (2,5-substitution pattern as 
major), whereas in toluene an almost equimolar ratio was obtained.   
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Scheme 60. Synthesis of 2-methyl-5-phenylpiperazine and 2-methyl-6-phenylpiperazine. 
 
3.3.4 N-Benzylpiperazine 
Preparation of N-monosubstituted piperazine was examined with N-
benzylethylenediamine in the reaction with ethylene glycol. The results are summarized 
in table 14. 
 
Table 14. Synthesis of N-benzylpiperazine. 
 
 
Entry Solvent Temp. (
o
C) Conversion (%)  Yield (%)
a 
1 Water 110-140 < 10 - 
2 Toluene 110-140 < 10 - 
3 Toluene 160 100 63 
4 None 160 100 35 
5 Mesitylene 180 100 71
b 
a: after flash column chromatography. b: GC-yield.  
 
The reactions in water and toluene afforded only minor conversion of the starting 
material at 140 oC (entry 1 and 2). Toluene as the solvent and a reaction temperature of 
160 oC proved to be the optimal conditions for full conversion and the product was 
isolated in 63% yield (entry 3). Interestingly, neat reaction conditions afforded a 
significantly lower yield of 35% (entry 5), whereas increasing the temperature only 
afforded a slightly higher yield (GC-yield) (entry 6). 
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In another attempt to make N-benzylpiperazine ethylene glycol was reacted with 
ethanolamine to give diethanolamine to which benzylamine was added (scheme 61). This 
was not successful and as described previously it is possible that ethanolamine 
polymerizes under the reaction conditions. 
  
 
Scheme 61. Failed formation of N-benzylpiperazine from ethanolamine, 
ethyleneglycol and benzylamine. 
 
As previously described N,N’-dibenzylpiperazine can be synthesized from ethylene glycol 
and benzylamine.111 It was further investigated if also 1,2-cyclohexanediol could react in a 
similar reaction as illustrated in scheme 62. 
 
 
Scheme 62. Reaction between 1,2-cyclohexanediol and benzylamine. 
 
Unfortunately, none of the desired product was observed. After reaction of one 
equivalent of benzylamine to give the secondary amine no further reaction was observed. 
The mono addition product was isolated in 54% yield and it is plausible that steric 
hindrance hampers further reaction with benzylamine.  
 
3.3.5 1,2,3,4-Tetrahydroquinoxaline 
So far, only aliphatic amines have been utilized for synthesis of piperazines. It was 
envisioned that using o-phenylenediamine together with ethylene glycol would produce 
1,2,3,4-tetrahydroquinoxaline and the results are summarized in table 15.   
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Table 15. Synthesis of 1,2,3,4-tetrahydroquinoxaline. 
 
 
Entry diol (eq) Solvent Time (h) Temp. (
o
C) Conversion of amine (%) Yield (%)
a 
1 1 Toluene 18 110 < 10 - 
2 1 Mesitylene 16 180 ∼ 80
b - 
3 2 Mesitylene 18 180 100 34 
4 1.5 Mesitylene 18 180 100 35 
a: after flash column chromatography. b: full conversion of diol. 
 
At 110 oC in toluene very little conversion of the starting materials was observed (entry 
1). Raising the temperature to 180 oC in mesitylene resulted in full conversion of ethylene 
glycol, but still some 1,2-diaminobenzene remained (entry 2). Using an excess of ethylene 
glycol (2 eq) gave complete conversion of both starting materials and the desired product 
was isolated by flash column chromatography in 34% yield (entry 3). A slightly lower 
excess (1.5 eq) of ethylene glycol proved sufficient to maintain the same yield (entry 5).  
 
As a result of the relatively low yield of the expected product, the choice of additive was 
examined. Different bases (Na2CO3, TEA) as well as an acidic additive (TFA) and lithium 
chloride were tested. A reaction in the absence of an additive was also performed. In all 
cases the outcome of the reaction was not improved (internal standard was used to 
estimate relative GC-yields) and NaHCO3 remained the choice of additive. At this stage a 
reaction in the absence of a solvent (at 180 oC) was conducted in order to perform NMR 
of a crude reaction mixture. Interestingly, this revealed the presence of an unidentified 
product, which was later identified as 2-benzimidazolemethanol (figure 6). 
 
Figure 6. 2-benzimidazolemethanol. 
 
 
 
According to NMR the ratio of this unexpected product and the desired product was 2:1. 
Lowering the reaction temperature or increasing the reaction time had no effect on this 
ratio. Isolation of 2-benzimidazolemethanol was rather tedious. Column chromatography 
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of the crude reaction mixture was unsuccessful as contamination with ethylene glycol was 
a major problem. Attempts to extract ethylene glycol into an aqueous phase were also 
unsuccessful as this to some extend also removed 2-benzimidazolemethanol. Fortunately, 
it was possible to remove the remaining ethylene glycol by vacuum distillation. 
Subsequent flash column chromatography in a two stage process (firstly pure EtOAc to 
get the desired quinoxaline-product off the column and then 10% MeOH in DCM to get 
the 2-benzimidazolemethanol off) separated the two products. By this work-up procedure 
the reaction in mesitylene at 180 oC afforded 22% of the pure product. The purification 
method also produced fractions of product contaminated with other by-products, and the 
total yield is estimated to be approximately 30%. 
 
A plausible mechanism of the reaction is illustrated in scheme 63. After oxidation of 
ethylene glycol and condensation with the diamine, an α-imino alcohol is produced. This 
can undergo the reduction-oxidation process by iridium or the Voigt reaction to furnish 
the desired product. Interestingly, the α-imino alcohol can also undergo direct 
intramolecular attack by the amine to provide the benzimidazole product.  
 
 
Scheme 63. Proposed pathways for reaction between ethyleneglycol and 1,2-diaminobenzene. 
 
The two pathways seem to be equally favored and for that reason it was decided not to 
attempt any further optimization studies. Introduction of a protection group on one of 
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the alcohols of ethylene glycol should enhance the yield of the benzimidazole product. 
The expected α-imino alcohol will not be able to isomerize; hence no 
tetrahydroquinoxaline can be formed. If successful this could be an interesting reaction as 
the benzimidazole scaffold has also been identified as a privileged structure.14 The 
methanol substituent can act in further functionalization of the product.  
 
Others have performed very similar reactions. o-Phenylenediamine and a primary alcohol 
were reacted to produce benzimidazoles in presence of a ruthenium catalyst (as 
previously described).61, 62 In one case [Cp*IrCl2]2 was tested but it failed, which may be 
due to the fact that a basic additive was not added.62  
 
3.3.6 Piperazines from reaction of ammonium ions with diols 
It has recently been reported that secondary (and tertiary) amines can be synthesized 
from alcohols and ammonium salts (ammonium tetrafluoroborate favors formation of 
secondary amines) in presence of [Cp*IrCl2]2 and NaHCO3.
75,76 Based on these results, it 
was envisioned that piperazines could be synthesized from the reaction between a diol 
and ammonium tetrafluoroborate (scheme 64). 
 
 
Scheme 64. Failed synthesis of piperazine from ammonium salt and ethylene glycol. 
 
The main challenge was isolation of the product. As the reaction is performed with an 
ammonium salt, the product is also a salt. Therefore aqueous acidic work-up is necessary 
to furnish the free amine. As already mentioned this is rather difficult as piperazine and 
water forms an azeotrope. Instead, a reaction was performed under neat reaction 
conditions and NMR of the crude reaction mixture revealed only starting material (no 
quantification). It was believed that maybe the Thorpe-Ingold effect would be beneficial 
in this case, as it also was for the condensation of diamines and diols. 2,3-Butanediol was 
reacted with ammonium tetrafluoroborate under neat reaction conditions (scheme 65). 
The outcome was analyzed by GC-MS, which revealed presence of three products; the 
desired piperazine together with pyrazine and morpholine derivatives.  
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Scheme 65. Reaction between 2,3-butanediol and ammonium tetrafluoroborate. 
 
Unfortunately, the products could not be isolated by column chromatography, and as a 
consequence the product distribution could not be determined. However, it was clear 
that it was dependant on the reaction temperature. According to GC-MS analyses the 
piperazine and morpholine derivatives were major products at 160 oC, whereas at 180 oC 
the pyrazine derivative was the major product.  
 
Instead, 1,2-cyclohexanediol was utilized as the starting material for the reaction, as the 
expected products should be easier to handle during work-up. The results are 
summarized in table 16. 
 
Table 16. Reactions between 1,2-cyclohexanediol and ammonium tetrafluoroborate. 
 
Entry diol (eq) Solvent additive Temp. (
o
C) 
Yield of dodecahydro-1H-
phenoxazine (%) 
1 1 - NaHCO3 160 - 
2 1 - NaHCO3 180 - 
3 2 - NaHCO3 180 30 
4 1
a - TFA 180 ∼ 45 
5 2 Mesitylene NaHCO3 180 ∼ 45 
6 2 Mesitylene TFA 180 63 
7 2 Mesitylene - 180 50 
a: same product distribution when 2 eq diol is used (no isolated yield). 
Piperazines - Results 
 
69 
 
A reaction temperature of 160 oC was optimal to obtain full conversion of the starting 
materials, and it was established that this required a small excess (1.2 eq) of the diol. In 
this case not only the desired tetradecahydrophenazine was formed but also 
dodecahydro-1H-phenoxazine together with 1,2,3,4,6,7,8,9-octahydrophenazine was 
produced (entry 1). When the temperature was increased to 180 oC formation of the 
phenoxazine adduct became more dominating (entry 2). Focus was therefore moved to 
optimization of the reaction to furnish solely dodecahydro-1H-phenoxazine. Increasing 
the excess of the diol to two equivalents afforded the phenoxazine derivative as the 
major product (according to GC-MS analysis) (entry 3). Purification was more difficult 
than expected and contamination with the other products could not be avoided. Merely 
30% yield of phenoxazine product was obtained. Further examination of reaction 
conditions revealed that an acidid additive was a better compared to base (entry 4). Using 
catalytic amounts of TFA increased the formation of the phenoxazine derivative and 
suppressed the formation of the piperazine derivative. Additionally, with use of TFA as 
additive the product ratio did not change when equivalent amounts of diol were used in 
the reaction. An isolated yield of 45% of the phenoxazine product was obtained when 
equimolar amounts of the starting materials were reacted in the presence of the catalyst 
and TFA. Reactions performed in a solvent (mesitylene) were examined using two 
equivalents of the diol. The use of acid or base as additive afforded in both cases almost 
solely the phenoxazine derivative according to GC-MS analysis. A reaction performed with 
NaHCO3 as the additive afforded approximately 45% yield (entry 5), whereas with TFA the 
yield increased to 63% (entry 6). A reaction in the absence of an additive lowered the 
yield to approximately 50% (entry 7). Reactions performed at a higher reaction 
temperature of 200 oC for either 6 or 28 hours did not have any effect on the product 
distribution (determined by GC-MS analysis – no quantification). 
 
In conclusion, the best results were obtained by reaction of the ammonium salt and the 
diol in a 1:2 ratio in mesitylene at 180 oC and with catalytic amounts of TFA and 
[Cp*IrCl2]2. This afforded a yield of 63% of the phenoxazine product.  
 
The suggested reaction pathways are illustrated in scheme 66. Initially, the diol is oxidized 
and reacted with the ammonium salt to generate 2-aminocyclohexanol. After oxidation of 
the alcohol it can either react with the ammonium salt or with 1,2-cyclohexanediol. In the 
first case, the reaction gives 1,2-diaminocyclohexane, which then reacts with 1,2-
cyclohexanediol to give the desired product. In the latter case, the reaction with 1,2-
cyclohexanediol furnishes a diol intermediate that upon reaction with the ammonium salt 
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affords an amino alcohol intermediate. This amino alcohol is setup for an intramolecular 
reaction to afford the desired product. Interestingly, the diol intermediate can undergo 
an intramolecular reaction between the two alcohols to furnish the morpholine derivative 
instead of reacting with the ammonium salt. This pathway is apparently more favored.  
 
 
Scheme 66. Proposed pathways for reaction between 1,2-cyclohexanediol and ammonium salt. 
 
3.3.7 Piperazines by ruthenium catalysis 
As it has already been explained, ruthenium catalysts are generally cheaper than iridium 
catalysts and in the literature there have been many examples of ruthenium catalyzed 
condensations of primary amines and alcohols (see chapter 1 and 2). Consequently, it was 
envisioned that the reaction between 1,2-diols and 1,2-diamines in the presence of a 
ruthenium catalyst would furnish piperazines. The results are summarized in table 17. 
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Table 17. Ruthenium catalyzed reactions of 1,2-diaminocyclohexane and ethyleneglycol. 
 
 
Entry Catalyst Ligand Solvent Additive Temp. (
o
C) 
1 RuCl3 PPh3 Water - 100 
2 RuCl3 PPh3 Toluene - 110 
3 RuCl3 PPh3 - - 110 
4 RuCl3 PPh3 Toluene - 140 
5 RuCl3 PPh3 Mesitylene - 180 
6 RuCl3 PPh3 - - 180 
7 RuCl3 PPh3 Mesitylene - (110)170 
8 RuCl3 PPh3 - - (110)170 
9 RuCl3 PPh3 Mesitylene NaHCO3 (110)170 
10 RuCl3 PPh3 - NaHCO3 (110)170 
11 RuCl3 PPh3 Mesitylene TFA (110)170 
12 RuCl3 PPh3 - Stoic. TFA (110)170 
13 RuCl3 Xantphos Mesitylene - (110)170 
14 RuCl3 Xantphos Mesitylene - (110)170 
15 RuCl2(PPh3)3 - Mesitylene - (110)170 
16 RuCl3 (x5) PPh3 Mesitylene - (110)170 
 
It was chosen to focus predominantly on RuCl3 and triphenylphosphine as the catalytic 
system, as it is cheap and it has been widely used in reactions of primary/secondary 
amines and alcohols with good results (see chapter 1 and 2). Initially, the optimal reaction 
temperature was examined. Unfortunately, no product was observed when performing 
the reaction at temperatures ranging from 100-180 oC in different solvents as well as 
under neat reaction conditions (entry 1-6). Former PhD student Matyas Tursky had used 
the same catalyst and ligand for indole synthesis (more details in chapter 4). He found 
that more reliable (and reproducible) results were obtained when the reaction mixture 
was initially heated to 110 oC for 1 hour (optimal temperature for generation of the active 
catalyst) and then increased to 180 oC for the remainder of the reaction time.  
Unfortunately, this had no effect in this project (entry 7+8). Neither did addition of a 
catalytic amount of base (NaHCO3) or acid (TFA) change the outcome of the reaction 
(entry 9-11). It was then tested if a fully protonated amino group would increase 
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reactivity of the starting material, and a stoichiometric amount of TFA was therefore used 
in the reaction. However, the reaction did not afford the desired product (entry 12). 
Focus was then moved to the catalytic system. Instead of the monodentate ligand 
triphenylphosphine, a bidentate ligand (xantphos) was tested for reactivity, but with no 
success (entry 13-14). Also, the preformed active catalyst RuCl2(PPh3)3 failed completely 
(entry 15). Finally, it was examined if an increased catalyst loading would increase 
reactivity and a reaction with 10 mol% ruthenium was performed, but still product 
formation did not occur (entry 16).  
 
It is possible that the diamine starting material coordinates to ruthenium and hereby 
deactivates the catalyst. Therefore, o-phenylenediamine was used instead of 1,2-
diaminocyclohexane (scheme 67). Unfortunately, reaction between the two starting 
materials did not take place. 
 
 
Scheme 67. Failed attempt to synthesise 1,2,3,4-tetrahydroquinoxaline. 
 
It should be noted that Cho and Oh in 2006 published a method for preparation of the 
fully aromatized quinoxaline as illustrated in scheme 68.71 Excess amount of diol 
increased the yield from 50% to 75%. More importantly, addition of KOH was crucial as a 
reaction in the absence of this afforded only 18% of the product. Unfortunately, they did 
not examine if a catalytic amount of KOH is sufficient.    
 
 
Scheme 68. Literature example on the use of aromatic diamines. 
 
An excess amount of base may be required for the reaction described herein and this 
could explain the poor results rather than the catalyst inactivation by coordination to the 
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diamine. Consequently, it was decided not to attempt any further optimizations of the 
reaction.  
3.3.8 Mechanism of the piperazine reaction 
Formation of piperazines from diols and diamines is believed to start with oxidation of the 
alcohol to the carbonyl compound followed by condensation with the amine to furnish an 
imine. This is supported by both mechanistic and computational experiments (formation 
of secondary amines from primary alcohols and amines) as described in details in chapter 
1. However, when diamines and diols are condensated, the corresponding imine is 
actually an α-imino alcohol. It has not been established how this further reacts. 
Obviously, it can undergo the reduction/oxidation process catalyzed by iridium to provide 
an α-amino ketone, but this can also be achieved in a Voigt reaction (scheme 69). 
  
 
Scheme 69. Mechanism via iridium reduction/oxidation sequence or via the Voigt reaction? 
 
In the pursuit to elucidate if the Voigt reaction plays a significant role in the reaction 
mechanism the reactions illustrated in scheme 70 were performed. 
 
 
Scheme 70. Mechanistic experiments.  
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The reaction of cyclohexylamine and acetoin in toluene at 60 oC (reaction 1) revealed that 
the α-aminoketone was the sole product after 1 hour. As the temperature in the 
piperazine synthesis is higher (110-180 oC) and with longer reaction times (12-24 hours) 
the result strongly indicates that the Voigt reaction is dominating. The same reaction was 
performed in presence of the iridium catalyst and this did not increase the reaction rate 
of the transformation, which also supports that iridium has a very limited effect on the 
formation of the α-amino ketone. Further examination of the reaction mechanism was 
conducted with 1,2-diaminocyclohexane (reaction 2). However, in this case the expected 
cyclic imine was not observed. Instead the cyclic diimine illustrated in figure 7 was the 
sole product after 4 hours.  
 
Figure 7. 2,3-dimethyl-5,6,7,8,9-hexahydroquinoxaline 
 
 
To the best of our knowledge the expected cyclic imine is too unstable and is oxidized 
immediately to the cyclic diimine (even at inert conditions). In this way, these results also 
support that the Voigt reaction plays a significant role in the formation of piperazines. 
With these results the complete transformation is illustrated in scheme 71. 
 
 
Scheme 71. Proposed pathway for synthesis of piperazines from 1,2-diols and 1,2-diamines. 
 
Interestingly, this implies that iridium is only involved in the first and the last step of the 
pathway; initially oxidation to the aldehyde (or ketone) and the final reduction of the 
imine to the secondary amine.  It must be noted that it has not been established if the 
intermediates are coordinated to iridium throughout the process. 
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3.4 Conclusion 
The work described in this chapter will be combined with the published results of 
Nordstrøm and Madsen111 for a full paper on piperazine synthesis from amines and 
alcohols and the manuscript is currently in preparation. 
 
Ethanolamine was not suitable as a starting material for the synthesis of piperazine as it 
formed N-mono- and di-N-substituted ethylalcohol piperazines in almost 60% combined 
yield. It is assumed that ethanolamine also undergo polymerization, which could account 
for the moderate yields of isolated products.  
 
It was established that the Thorpe-Ingold effect plays a significant role in the reaction as 
unsubstituted diols and diamines failed to produce piperazine. With just one methyl 
substituent (on the diol or the diamine) the corresponding product was obtained in high 
yields (69-92%). Substituents on both starting materials (methyl or phenyl) also furnished 
the products in high yields (60-90%). In general, the 2,5-disubstituted product was 
favored, but in some cases the 2,6-disubstituted piperazine was formed in equal 
amounts.  
 
N-benzylpiperazine was obtained in 71% yield from ethylene glycol and N-
benzylethylenediamine, whereas reaction of 1,2-cyclohexanediol and benzylamine failed 
to provide 5,10-dibenzyltetradecohydrophenazine. Instead, 2-(benzylamino)cyclohexanol 
was formed in 54% yield as a result of only monoaddition of benzylamine to the diol. 
Steric hindrance is believed to be the reason for no further reaction with benzylamine.  
 
Use of o-phenylenediamine turned out to be more difficult than anticipated as there is a 
competing reaction to form 2-benzimidazolemethanol. The expected quinoxaline product 
and the benzimidazole product were formed in almost equimolar amounts in a total yield 
of 65%.   
 
Ammonium salts were examined as the source of nitrogen in the reaction with diols to 
furnish piperazines. Substituents on the diol proved to be crucial and with 1,2-
cyclohexanediol and ammonium tetrafluoroborate not only the piperazine derivative was 
formed, but also the corresponding morpholine derivatives. Optimized reaction 
conditions furnished the morpholine product in 63% yield. 
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Unfortunately, piperazine synthesis from 1,2-diaminocyclohexane and ethylene glycol by 
ruthenium catalysis failed completely. It is plausible that the reaction requires excess 
amount of base as this has been reported in the literature for a similar reaction. However, 
it was not attempted as this would result in poor atom economy. 
 
The mechanistic experiments revealed that the Voigt reaction plays an important role in 
the formation of the piperazine ring. Additionally, it also supports the results obtained 
from the reactions of ethanolamine. 
Indoles 
 
77 
 
4 Indoles 
Indoles are widely used in products ranging from dyes and plastics to flavor enhancers, 
perfumes and pharmaceuticals.153 As already explained in chapter 1 the indole scaffold 
has been identified as a privileged structure. In figure 8 a few of the many indole 
containing pharmaceuticals are illustrated.  
 
Figure 8. Indole containing pharmaceuticals.  
 
 
4.1 Indole syntheses 
Syntheses of indoles have been investigated for more than a century and due to its 
importance in the pharmaceutical industry many methods have been developed. 
Interestingly, the field still receives great attention with new publications every week. 
Herein, some of the classical routes to indoles as well as more recent methods will be 
briefly described. As a consequence of the almost immeasurable number of procedures 
focus will predominantly be on one-pot syntheses that tolerate a wide variety of 
substitution patterns. Additionally, the described methods will not include those where 
the benzene moiety is formed as a part of the indole synthesis.  
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4.1.1 From arylhydrazines or arylhydrazones 
One of the most widely used methods for indole synthesis is the Fischer indole synthesis 
developed in 1883.154-156 It involves reaction between an arylhydrazine and a ketone or 
aldehyde to furnish the indole skeleton via an arylhydrazone (scheme 72). The reaction is 
still undergoing constant modification and optimization157-159. Nevertheless, the reaction 
in its original form is used in many large scale syntheses and herein it is exemplified with 
the kilogram production of MDL 103371, a potential candidate for treatment of stroke 
(scheme 72).154 The major drawback from an environmental perspective is the toxicity of 
the arylhydrazines. 
 
 
Scheme 72. Fischer indole syntheses. 
 
A commonly used modification of the Fischer indole synthesis is the Japp-Klingemann 
procedure, involving the reaction of an aryldiazonium salt with a β-keto ester (or acid) 
(scheme 73).160 The formed indole always contains an ester moiety in the 3-position, 
which can either be further functionalized or undergo decarboxylation.161 This method is 
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also used on a kilogram scale and is exemplified in scheme 73 with the synthesis of 
Melatonin.162  
 
 
Scheme 73. Japp-Klingemann modification of the Fisher indole synthesis. 
 
Aryldiazonium salts can also be converted into 2,3-disubstituted indoles when reacted 
with alkyl zinc reagents (scheme 74).163 
 
 
Scheme 74. Use of aryldiazonium salts. 
 
Other modifications of the Fischer indole synthesis include the reaction between an 
arylhydrazine and an alkyne catalyzed by gold164 and the reaction between an 
arylhydrazine and a terminal alkene catalyzed by rhodium165 (scheme 75). These methods 
furnish 2,3-disubsituted and 3-substituted indoles, respectively.  
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Scheme 75. Catalytic modifications of the Fisher indole synthesis.  
 
4.1.2 From anilines or ortho-haloaniline 
Synthesis of indoles from anilines and α-haloketones is today known as the Bischler 
indole synthesis (scheme 76).166,167 It was developed in the late 1900’s, but has since 
received little attention.  Nevertheless, a few improved examples have been reported, 
e.g. use of microwave irridation168 and addition of additives169. In the original Bischler 
indole synthesis the substituent always ends up in the 2-position, though with the more 
recent optimization also selectivity towards the 3-position has been reported (e.g. when 
additives are used).169 Despite the limited use of this procedure the reaction is still 
interesting from a mechanistic point of view (more details in section 4.3.3).  
 
 
Scheme 76. Bischler indole synthesis. 
 
The Larock indole synthesis from 1991 involves reaction between an ortho-iodoaniline 
and an alkyne catalyzed by palladium.170 This procedure is widely used on a large 
scale154,156 and an example is illustrated in scheme 77.171 
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Scheme 77. Larock indole synthesis. 
 
Senanayake and co-workers have optimized the Larock indole synthesis, which makes it 
possible to use the much cheaper and more readily available chloro- and bromoanilines 
(scheme 78).172 
 
 
Scheme 78. Optimized Larock indole synthesis. 
 
Utilization of a titanium catalyst in the Larock indole synthesis (scheme 79) changes the 
selectivity of the reaction and the smallest substituent ends up in the 2-position and the 
largest subsitutent in the 3-position.173 
 
 
Scheme 79. Reversing the selectivity of the Larock indole synthesis. 
 
Ortho-haloanilines react with terminal alkynes to give 2-substituted indoles in a two-step 
process; firstly, a Sonogashira coupling catalyzed by palladium or copper, which is 
followed by a cyclization reaction often mediated by base. Many examples of this type of 
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reaction have been reported154,156, and herein it is exemplified with the multi-kilogram 
synthesis of the indole shown in scheme 80.174 
 
 
Scheme 80. Indoles from ortho-haloanilines and terminal alkynes via a Sonogashira coupling. 
 
If a Sonogashira coupling product is reacted with IPy2BF4 this will lead to incorporation of 
an iodine in the 3-position.175 This can serve as a handle for further functionalization of 
the compound (scheme 81).  
 
 
Scheme 81. Use of a Sonogashira coupling product for indole formation. 
 
The Castro indole synthesis was developed in the 1960’s and was the first reported use of 
copper for preparation of indoles.176 It involves reaction of either iodoanilines with 
cuprous acetylides or ortho-alkynylanilines with copper(I) salts (scheme 82).177-179 The 
reaction is also exemplified in scheme 82 as a large scale synthesis with slightly modified 
reaction conditions.180 The major disadvantages are the use of excess acidic additive and 
a relatively high use of copper iodide for the ring closing reaction. 
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Scheme 82. Castro indole syntheses. 
 
4.1.3 From nitroarenes 
Use of nitroarenes and vinylmagnesium bromide for the synthesis of 7-substituted indoles 
is best known as the Bartoli indole synthesis from 1989.181 It is crucial for the reaction 
that the nitroarene has a substituent in the ortho-position. Later, it was found that the 
reaction also tolerates substituents on vinylmagnesium bromide furnishing 2,3,7-
substituted indoles (scheme 83).182 
 
 
Scheme 83. Bartoli indole synthesis. 
 
Several modifications of the procedure have been published avoiding the requirement of 
a substituent in the ortho-position of the nitroarene. One example is the Dobbs 
modification, which involves use of ortho-bromonitrobenzenes in reaction with the 
vinylmagnesium halides.183 This affords an indole with a bromide in the 7-position (as well 
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as substituents in the 2- and 3-position) and is removed in a radical reaction with AIBN 
and Bu3SnH. Another modification is reaction of nitroarenes with alkynes in the presence 
of a ruthenium catalyst as illustrated in scheme 84.184 
 
 
Scheme 84. Modified Bartoli synthesis. 
 
Buchwald and co-workers have used ortho-halonitrobenzenes in the reaction with 
ketones to give the corresponding ortho-nirobenzenyl ketone (scheme 85).185 Without 
purification this is treated with a great excess of TiCl3 to provide the 2-subsituted indole. 
The ortho-nitrobenzenyl ketone can also be reacted with an electrophile to provide an 
additional substitution in the 3-position. A major disadvantage, besides the poor atom 
economy due to at 16-fold excess of titanium(III) chloride, is the toxicity of nitroarenes.  
 
 
Scheme 85. Reaction between ortho-halonitrobenzenes and ketones. 
  
4.1.4 From ortho-dihaloarenes 
Indoles can also be achieved from ortho-dihaloareanes in the reaction with imines in the 
presence of a palladium catalyst (scheme 86).186,187 The intermediate undergoes a 
Buchwald-Hartwig amination to furnish the indole, which is either 2,3- or 2-substituted 
depending on the nature of the iminie. As also illustrated in scheme 86 the imine can be 
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generated in situ and therefore the indole is obtained in a one-pot synthesis from an 
ortho-dihaloarene, an arylamine and a terminal alkene.186 
 
 
Scheme 86. Synthesis of indoles from ortho-dihaloarenes. 
 
Ortho-dihaloarenes reacts with internal alkenes in the presence of a palladium catalyst 
(scheme 87).188 The first step is N-arylation, which is followed by an intramolecular Heck-
coupling to furnish the indole skeleton.  
 
 
Scheme 87. Use of internal alkenes in reaction with ortho-dihaloarenes. 
 
Ackerman investigated the Sonogashira coupling of terminal alkynes with ortho-
dihaloarenes and found a catalytic system that provides the indoles in a one-pot 
procedure as illustrated in scheme 88.189 The reaction was further optimized in a manner 
that tolerate more sterically hindered N-substituents190 and also utilization of a much 
cheaper nickel catalytic system has been reported.191 
 
Indoles 
86 
 
 
Scheme 88. Reaction between ortho-dihaloarenes and terminal alkynes. 
 
4.1.5 By N-alkylation of amines with alcohols by Ru- or Ir-catalysis 
One of the first reports concerning synthesis of indoles by the hydrogen transfer 
methodology was published in 1986 by Watanabe and co-workers.65 Anilines were 
reacted with diols in the presence of a ruthenium catalyst affording the indoles in 
moderate to high yields (scheme 89).  
 
 
Scheme 89. Ruthenium catalyzed reaction between anilines and 1,2-diols. 
 
The reaction proved to be difficult if ethylene glycol itself was utilized and therefore the 
authors examined an intramolecular reaction between an alcohol and an amine to 
provide 2,3-unsubstituted indoles (scheme 90).67,68 Yamaguchi and co-workers have 
shown that also an iridium catalyst ([Cp*IrCl2]2) is capable of catalyzing the same 
transformation under very similar reaction conditions (scheme 90).60 
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Scheme 90. Metal catalyzed intramolecular reaction between amine and alcohol. 
 
Keep and co-workers have used [Cp*IrCl2]2 in the two-component syntheses illustrated in 
scheme 91 providing either 3-substituted or 2,3-disubstituted indoles.69 The major 
drawbacks of this procedure are the great excess of the primary alcohol as well as excess 
amount of basic additive.  
 
 
Scheme 91. Two component synthesis catalyzed by [Cp*IrCl2]2. 
 
An iridium-BINAP catalytic system can be used for the reaction of naphtylamines with 
diols to give benzoindoles in good to high yields (scheme 92).192 
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Scheme 92. Use of an iridium-BINAP catalytic system. 
 
4.1.6 Concluding remarks 
The total number of approaches to indole synthesis is enormous and there is not one 
specific method that stands out. The classic methods, some dating back more than a 
century, are still widely used on an industrial scale. However, these methods do not 
necessarily represent the most environmentally benign procedures. Many of the 
described methods suffer from disadvantages such as use of toxic starting materials, poor 
atom economy and poor E-factors. Recently, a growing interest in catalytic procedures 
has been seen. Environmentally benign syntheses of indoles from readily available 
starting materials with a broad range of substitution patterns have still not been fully 
explored. 
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4.2 Aim of the project 
Despite the many known procedures for indole syntheses there is still room for 
improvements in an environmentally benign fashion. In particular, indoles synthesized 
from anilines and diols are of great interest. 
 
4.3 Results and discussion 
It was speculated that iridium and ruthenium would be able to catalyze both the C-N 
formation and the C-C formation when anilines and 1,2-substituted vicinal diols are 
condensated to 2,3-disubstituted indoles (scheme 93).  
 
 
Scheme 93. Indoles from anilines and vicinal diols. 
 
4.3.1 Previous work within the group 
The project was started by former PhD student Matyas Tursky and bachelor student Lasse 
B. Olsen.  
 
Initially, Matyas Tursky investigated the reaction of aniline and 2,3-butanediol with 1 
mol% [Cp*IrCl2]2 at 170 
oC. Screening of additives revealed that a catalytic amount of acid 
was required and 5 mol% of methanesulfonic acid afforded the highest yield. Neither 
base nor the absence of an additive was able to co-catalyze the formation of the desired 
product. The optimal reaction time was established to be 48 hours. As ruthenium 
catalysts are generally much cheaper than [Cp*IrCl2]2 focus was moved to examination of 
these. As a consequence of previous work within the Madsen group regarding C-C bond 
formation catalyzed by RuCl3 and PPh3 (alkylation of the 3-position of oxindoles with 
alcohols)193 focus was merely on RuCl3 and different phosphine ligands. Matyas Tursky 
quickly established that the addition of acid was not necessary as the absence of this 
provided the indole in 60% yield compared to less than 50% yield in the presence of an 
acid. The best results were obtained with the monodentate ligand triphenylphosphine 
and the bidentate ligand xantphos. Interestingly, inconsistent yields of repeated reactions 
were observed during the screening of ligands. It was speculated that it is due to the 
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difference in size of the RuCl3 crystals as the preformed catalyst RuCl2(PPh)3 did not give 
inconsistent results. A solution to the problem was heating of the reaction mixture to 110 
oC for one hour and then increasing the temperature to 170 oC for the remainder of the 
reaction time. At 110 oC the active catalyst can be generated and the temperature is not 
high enough to allow for reaction between amine and alcohol. The ruthenium catalyzed 
reactions required a reaction time of only 24 hours compared to 48 hours for the iridium 
catalyzed reactions.  
 
A substrate scope was explored for both the iridium and the ruthenium catalyzed 
condensations and the results are summarized in table 18.  
 
Table 18. Previous results of reaction between anilines and 2,3-butanediol. 
 
 
 
Entry Aniline Indole 
[Cp*IrCl2]2  
 Yield (%)
a,b
 
RuCl3/PPh3 
Yield (%)
a,c 
RuCl3/xantphos 
Yield (%)
a,c
 
1 
 
 
76 60 71 
2 
 
 
61 48 50 
3 
 
 
59 56 53 
4 
 
 
66 57 69 
5 
 
 
46 45 52 
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Entry Aniline Indole 
[Cp*IrCl2]2  
 Yield (%)
a,b
 
RuCl3/PPh3 
Yield (%)
a,c 
RuCl3/xantphos 
Yield (%)
a,c
 
6 
 
 
34 49 51 
7 
 
 
64 48 58 
8 
 
 
47d 57e 69e 
9 
 
 
47 48 52 
10 
  
65 72 87 
11 
  
41 X X 
12 
  
65 X X 
13 
  
76 X X 
a: after column column chromatography. b: performed by Matyas Tursky; c: performed by 
bachelor student Lasse B. Olsen. d: isolated as a 4:1 mixture of the 6-chloro and 4-chloro isomer. e: 
isolated as a 6:1 mixture of the 6-chloro and 4-chloro isomer. X: see section 4.3.2.1. 
 
The tolerated substituents on anilines were methyl, methoxy, chloro and fluoro (entry 2-
11). In general the yields were moderate to good, but problems occurred with chloro and 
fluoro substituents in the ortho position of aniline where less than 25% yield of the 
corresponding indoles were isolated. In addition also naphtylamines were tolerated 
(entry 12-13). Unfortunately, bromo, boronic esters, carboxylic acids, methyl esters, 
cyano, dimethylamino, acetamido, nitro or trifluoromethyl substituents did not afford the 
desired product as they were either unstable or reacted poorly. 
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The iridium catalyzed condensation was also examined with unsymmetrical diols in the 
reaction with aniline by Matyas Tursky and the results are summarized in table 19. The 
reactions were all highly selective towards the indole with the largest substituent in the 2-
position and in general the highest yields were obtained when the substituents on the 
diol were small.  
 
Table 19. Previous results of reaction between aniline and vicinal diols. 
 
 
Entry diol Indole A Indole B Ratio A:B Yield (%)
a 
1 
 
  
5:1 80
b 
2 
 
  
7:1 65
b 
3 
   
1:0 58 
4 
  
 
1:0 31
b 
5 
  
- - 29 
6 
 
 
- - 53 
a: after column chromatography. b: aniline:diol ratio 2:3. 
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4.3.2 Continuation of the project 
When Matyas Tursky and Lasse B. Olsen left the Madsen group the reaction was not 
explored in depth in particular in regards to the ruthenium catalyzed condensation of 
anilines and vicinal diols. Additionally, the mechanism was not fully understood. 
4.3.2.1 Reaction of substituted anilines with 2,3-butanediol 
The remaining starting materials for the substrate scope studies with 2,3-butanediols and 
substituted anilines were ortho-anisidine as well as 1- and 2-naphtylamine. The results 
are summarized in table 20.  
 
Table 20. Results of reactions between anilines and 2,3-butanediol. 
 
 
Entry Aniline Indole 
RuCl3/PPh3 
Yield (%)
a 
RuCl3/xantphos 
Yield (%)
a 
1 
  
41 34 
2 
  
60 72
b 
3 
  
58b 63a 
a: after column chromatography. a: after 2 days. 
 
Ortho-anisidine was successfully used in the reaction and the corresponding indoles were 
isolated in 41% and 34% yield with triphenylphosphine and xantphos, respectively (entry 
1). These yields are comparable with those of the iridium catalyzed reaction. 1-
Naphtylamine afforded the desired indoles in good yields (entry 2). Interestingly, in the 
reaction employing xantphos as the ligand, full conversion was not obtained after 24 
hours, thus the reaction time was increased to 48 hours. 2-naphtylamine afforded the 
products in good yields and also in these cases an increased reaction time of 48 hours was 
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necessary to obtain full conversion of starting materials. The selectivity of the reaction 
was high as none of the corresponding 2,3-dimethyl-1H-benzo[f]indole was observed. 
 
These results combined with those provided by Matyas Tursky and Lasse B. Olsen 
demonstrate that both [Cp*IrCl2]2 and RuCl3 in combination with either PPh3 or xantphos 
provides indoles from anilines and diols in comparable yields. The smallest difference in 
yield for a given substrate is 5 percentage points and the highest is 22 percentage points. 
There is no clear trend in which of the catalytic systems that are superior.  
 
4.3.2.2 Reaction of aniline with unsymmetrical vicinal diols 
The unsymmetrical vicinal diols were also tested in the ruthenium catalyzed 
condensations and the results are summarized in table 21.  
 
Table 21. Results of reactions between aniline and vicinal diols. 
 
 
Entry diol Indole A Indole B 
PPh3 
Yield (%)
a
  
Xantphos 
Yield (%)
a 
1 
 
  
49 (1:0)b 57 (1:0)b 
2 
 
  
54 (7:1)b 61 (1:0)b 
3 
   
32 (1:0)c - 
4 
  
 
27 (1:0)d 28 (1:0)d 
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5 
  
- - - 
6 
 
 
- 50
e 52e 
Numbers in parenthesis indicate A:B ratio a: after column chromatography.  b: aniline:diol 
ratio is 2:3. c:  after 3 days. d: performed by Lasse B. Olsen. e: with 5% MsOH. 
 
For 2,3-pentanediol the reactions afforded almost solely the indoles with the ethyl 
substituent in the 2-position in 49% and 57% yield with triphenylphosphine and xantphos, 
respectively (entry 1). When a longer alkyne chain on the diol was employed (2,3-
heptanediol, entry 2) the reaction also provided a small amount of the 3-substituted 
products. Triphenylphosphine resulted in a total yield of 54% in a 7:1 ratio of 2- and 3-
substituted products, respectively. Interestingly, when xantphos was used only the 2-
substituted product was observed and this was isolated in 61% yield. Both 2,3-pentane- 
and 2,3-heptanediol in a slight excess was required in order for the reactions to go to 
completion. When 4-methyl-2,3-pentanediol was utilized a reaction time of 3 days was 
necessary to obtain full conversion. Interestingly, only with triphenylphosphine was the 
reaction successful and the indole with the isopropyl group in the 2-position was isolated 
in 32% yield (entry 3). Lasse B. Olsen synthesized 2-phenyl-3-methylindole with both 
triphenylphosphine and xantphos in 27% and 28% yield, respectively (entry 4). 
Employment of two phenyl substituents was unsuccessful for both triphenylphosphine 
and xantphos (entry 5). GC-MS analysis revealed the presence of many by-products in 
large quantities and isolation was therefore not attempted. Similar results were seen for 
1,2-cyclohexanediol (entry 6). GC-MS analysis indicated that not only was by-product 
formation a concern, but also intermediates were observed. However, addition of 5% 
methanesulfonic acid afforded a clean reaction without the presence of intermediates or 
by-products and the product was isolated in 50% and 52% yield with triphenylphosphine 
and xantphos, respectively.     
 
With a few exceptions the yields obtained from ruthenium catalyzed condensation of 
anilines with unsymmetrical vicinal diols are comparable with those obtained by iridium 
catalysis.  Use of 2,3-pentanediol afforded significantly lower yields, though the selectivity 
was better and only one product was obtained. Iridium catalysis was to a great extend 
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superior when an isopropyl substituent as well as the diphenyl substituents were utilized. 
An explanation for this difference has not been established.  
 
4.3.3 Mechanism 
The proposed mechanism is illustrated in scheme 94. The first step is oxidation of the 
alcohol to the ketone. This is followed by reaction with the amine that upon removal of 
water affords an α-hydroxyimine. This imine can then undergo either a Voigt reaction to 
give α-amino ketone (A) or catalytic reduction to give the α-amino alcohol (B). Either A or 
B could possibly furnish the indole directly, or A could be reduced to B by the catalyst. 
 
 
Scheme 94. Possible pathways for indole formation from anilines and vicinal diols. 
 
Mechanistic experiments for both iridium and ruthenium catalyzed reactions were 
conducted to provide more information about the reaction. The reactions performed with 
the iridium catalyst were conducted by Matyas Tursky who also synthesized α-amino 
alcohol B. This was reacted under the iridium or ruthenium reaction conditions (scheme 
95). With iridium catalysis the result was a complex reaction mixture with only little 
formation of the indole. The ruthenium-triphenylphosphine catalytic system allowed the 
formation of the product but still after 24 hours a substantial amount of starting material 
remained. This concludes that α-amino alcohol B is not a likely intermediate in the indole 
formation from anilines and diols.  
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Scheme 95. Mechanistic experiments for route B. 
 
As it was found that methanesulfonic acid improved the reaction outcome in one case for 
a ruthenium catalyzed reaction, an experiment of α-amino alcohol B with ruthenium and 
triphenylphosphine and 5% of the acid was performed (scheme 96). After only 3 hours 
the product was the major peak in the GC-MS chromatogram. This indicates that the 
acidid additive has an influence on the reaction (at least with the more difficult 
substrates).  
 
 
Scheme 96. Influence of MsOH in the ruthenium catalyzed reaction. 
 
Also α-amino ketone A was prepared and reacted under both iridium and ruthenium 
reaction conditions (scheme 97). This resulted in full conversion to the indole in 15 min 
and 2 hours with iridium and ruthenium, respectively. This clearly supports the postulate 
that α-amino ketone A is an intermediate in the reaction; hence the Voigt reaction plays 
an important role in the formation of the indoles from anilines and vicinal diols. 
   
Indoles - Results 
98 
 
 
Scheme 97. Mechanistic experiments for route A. 
 
In this work there has not been conducted any mechanistic experiments to establish the 
explanation for the high selectivity towards the indole with the largest substituent in the 
2-position (scheme 98). It is merely speculated that an isomerization similar to that seen 
in the Bischler indole synthesis168,194,195 is the underlying cause (scheme 99).  
 
 
Scheme 98. Selectivity of the reaction with unsymmetrical diols. 
 
 
Scheme 99. Bischler mechanism of indole formation. 
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It should be noted that with the mechanistic results reported herein it is not clear if the 
iridium and the ruthenium catalyzed reactions proceed via the exact same pathway. The 
mechanistic evidence for the iridium catalyzed reactions is to some extend stronger 
towards the pathway via α-amino ketone A, whereas the results for the ruthenium 
catalyzed reactions could indicate an alternative pathway. 
 
4.4 Conclusion 
Indoles have been synthesized from anilines and vicinal diols by RuCl3 and 
triphenylphosphine or xantphos catalysis in good yields. The procedure is highly atom 
economical as neither solvent nor additives are required and water and dihydrogen are 
the only by-products. When unsymmetrical diols are employed the corresponding indole 
is favoured with the largest substituent in the 2-position and it is believed to follow the 
Bischler mechanism. The reaction is best suited for diols with small substituents. When 
larger substituents such as cyclohexyl, isopropyl and phenyl are employed yields drop 
radically and longer reaction times are in some cases required. However, it was briefly 
explored that methanesulfonic acid increases reaction rate and hampers by-product 
formation. Unfortunately, due to time restraints it was not possible to test that for all the 
different substrates. Mechanistic experiments strongly supports that for the ruthenium 
catalyzed reactions the Voigt reaction plays an important role.  
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5 Protein folding 
This part of the thesis describes research conducted at The Scripps Research Institute, La 
Jolla, California, USA as a part of the PhD programme. The project was supervised by 
Professor Philip E. Dawson and concerns a better understanding of protein folding.  
 
5.1 Background 
Protein folding is a very complex procedure, and it is one of the most perplexing problems 
in molecular biology. It can be divided into two parts;196 1) how is it possible to predict 
the three-dimensional structure of the biologically active compound from the amino acid 
sequence? and 2) how does the protein reach this three-dimensional structure? In 1969 
Levinthal pointed out, that even if a small protein would have to go through all possible 
conformations to reach the active structure it would take longer than the age of the 
universe.197 Consequently, proteins must be programmed for efficient folding.  
 
5.1.1 Folding mechanisms 
Protein folding can be compared to a chemical reaction; a starting material (the unfolded, 
denatured protein), transition states (maybe also intermediates) and then the product 
(the folded, native protein). The reaction of protein folding does not involve breaking and 
forming new chemical bonds. Instead, it involves breaking and formation of non-covalent 
interactions, most often hydrogen bonding. Each individual interaction is very small, but 
due to the very large number of interactions the total energy is large. Interestingly, the 
folded protein is only slightly more stable compared to the denatured state (generally by 
5-15 kcal/mol).198 
  
The fundamental description of protein stability is the difference in free energy, ∆G, 
between the unfolded and folded states, which is defined as:199 
 
STHG ∆⋅−∆=∆       (eq. 1) 
 
where ∆H is the enthalpy difference, T the temperature and ∆S the entropy difference. A 
positive value of ∆G implies that the folded state is favoured.  
 
In the denatured state the protein has some configurational preferences and is therefore 
never fully unfolded. As a consequence of this, it is rather termed the denatured state 
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instead of unfolded state in order to minimize confusion. In the denatured state many of 
the side groups can rotate and therefore the configurational entropy of this state is high. 
However, in the folded stated the structure is more locked and the side groups have 
limited ability to rotate resulting in low configurational entropy. In order for the folding 
reaction to favour the folded state the decrease in entropy has to be balanced by a gain in 
enthalpy.198 
 
Recently, protein folding has gained an increased attention as a result of the growing 
interest in diseases resulting from protein misfolding and aggregation.196 The mechanism 
of protein folding is not fully understood and in particular the role of local interactions 
during the process is in focus. Initially, it was believed that backbone hydrogen bonding 
was the driving force of folding.200 This was replaced by the theory that the hydrophobic 
effects initiate folding201, which resulted in numerous studies concerning side-chain 
interactions.202-204 However, there is currently an ongoing debate concerning which 
factors contribute the most to protein folding. This has lead to many different theories, 
e.g.:  
 
• Jigsaw model – where a large number of parallel folding pathways are present.205  
• Framework model – where the secondary structures are initially formed followed 
by docking of these to furnish the folded structure.206-209  
• Hydrophobic collapse model – where hydrophobic effects allow the protein to 
collapse followed by formation of the secondary structures.201,210-212  
• Diffusion-collision model – where formation of subdomains that adopts native 
conformations initiates the process followed by a collision to afford the folded 
structure.213-215  
 
Examinations of several well-known proteins have ruled out these models one by 
one.216,217 As described above a protein is never fully unfolded and there is to some 
extent a residual structure, which might not be native-like, but something that guides 
folding. As a consequence of this, it is now believed that the mechanism of folding lies 
somewhere between the framework and hydrophobic collapse models. This is called the 
nucleation-condensation (or nucleation-collapse) model, where secondary and tertiary 
structures are formed more or less simultaneously (figure 9).217 
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Figure 9. Nucleation-condensation model.217 
 
 
 
It is possible to view the framework and hydrophobic collapse models as extremes of the 
nucleation-condensation model.217 
 
5.1.2 The protein engineering method for transition state analysis 
As a result of the complexity of protein folding it is essential that theoretical and 
experimental studies are combined to obtain a better understanding of the procedure. 
One approach is to combine theoretical molecular dynamics, NMR and experimental 
transition state analysis.196 Herein, the latter will be described. 
 
The protein engineering method developed by Fersht and co-workers is used to study the 
transition states of protein folding.218 It involves thermodynamic and kinetic 
measurements of folding and unfolding of mutants in comparison with the wild type 
protein. The method is also called Φ-value analysis or transition state analysis, and it is 
the only method for transition state analysis at an almost atomic level.217 Figure 10 
illustrates two different pathways of folding of the denatured protein (D) to the native 
structure (N) and the associated free energie diagrams. Residue A represent the site of 
mutation (mutant is denoted by ‘) and if this is a part of the α-helix in the folded structure 
transition state analysis will reveal if the helix is or is not formed (or partially formed) in 
the tranisition state. 
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Figure 10. Free energy diagrams for protein folding.198 
 
The thermodynamic measurements provide values for the change in stability of the 
protein upon mutation, ∆∆GN-D, and the kinetic measurements provide values for the 
change in stability of the transition state upon mutation, ∆∆G‡-D. Identical values 
represent that the region where the mutation site is located is equally folded in the 
transition state and in the folded structure. If  ∆∆G‡-D is zero it means that the region is 
equally unfolded in the transition state and in the denatured state. The relationship 
between ∆∆GN-D and ∆∆G‡-D is described as the Φ-value:219 
 
 
 D-N
 ‡-D
D-ND-N
‡-D‡-D
'
'
G
G
GG
GG
∆∆
∆∆
∆−∆
∆−∆
=Φ        (eq. 2) 
 
In other words, if Φ = 0 it implies that the site of mutation is completely denatured in the 
transition state and therefore the mutation does not affect the folding rate. In terms of 
energy it means that the interaction the residue makes in the native state is lost in the 
transition state. If    Φ = 1 the site of mutation is completely folded in the transition state 
and the transition state loses as much energy as the folded state. It also indicates that the 
interaction, which the residue makes, is retained in the transition state. Fractional or 
intermediate values of Φ are more difficult to interpret as there are no linear relationship 
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between the value and formation of structure. There are several different reasons for 
fractional values of Φ depending on the exact nature of the protein, e.g. parallel folding 
pathways, access of water to the mutation site.218 Fortunately, for the protein selected 
for this project fractional values arrise from weakened interactions.198 For example a Φ-
value of 0.6 indicates that 60% of the interactions that are present in the folded state are 
formed in the transition state, e.g. if it concerns is an α-helix, this is partially formed in the 
transition state.198 If Φ > 1 it could imply that the side chain makes more interaction in the 
transition state compared to the native state.216  
 
It should be noted that figure 10 could give the impression that there is no energy 
difference between the denatured states of wild type protein and the mutant. This is of 
course not always the case. However, the difference in energy for the denatured states 
cancels out in the equations since all energy differences are relative to the denatured 
state.198   
 
More detailed description on how ∆∆GN-D and ∆∆G‡-D are calculated from the results of 
the thermodynamic and kinetic experiments are provided in section 5.3.  
 
5.2 Chymotrypsin inhibitor (CI2) 
One of the most well known proteins in terms of transition state analysis is chymotrypsin 
inhibitor (CI2). It is a very unique protein because it folds via very simple two-state 
kinetics without accumulation of stable intermediates.196 It is found in the albumin 
fraction of seeds from the Hiproly strain of barley and is a member of the potato inhibitor 
I family of serine protease inhibitors.220 The sequence and 3D structure are show in figure 
11.  
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Figure 11. Amino acid sequence and 3D structure of CI2.
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Figure 12. Simulations of unfolding of CI2 in reverse time.217 
 
 
As previously mentioned CI2 folds via a two-state model, where only the denatured 
structure, transition state and native structure occupy free energy minima. It should be 
noted that it does not mean that intermediates are not present only that they are not 
significantly present.218 Molecular dynamic simulations have identified one intermediate, 
which facilitates folding, but unfortunately it is has not been supported by any 
experiments.196 Consequently, this proposed intermediate is ignored in the studies of CI2 
folding. 
 
The first step of the nucleation-condensation mechanism for CI2 reported by Fersht and 
co-workers218 is the formation of the nucleus (the α-helix), and subsequently the overall 
structures condense around the nucleus. The protein must be “programmed” via a rapid 
random search of conformations under conditions that favour folding to first shape the α-
helix. However, it is not fully formed and the interactions are only weak. This structure is 
the transition state and can be termed as a “native-like” structure. The rest of the protein 
condenses around the helix via secondary and tertiary interactions. A well established 
characteristic of this model is that the nucleation site does not necessarily have to be well 
established in the denatured state as it might be in the process of being formed in the 
transition state.218,223 Additionally, long range interactions are more important than the 
more local interactions. In other words the α-helix and β-sheets cannot be formed 
without long range interactions.218 
 
Another factor to take into consideration is that despite the low levels of residual 
structure in the denatured state, there are still some conformational preferences. 
Consequently, not all conformations exist in the denatured state. As previously described 
the protein does not go through all possible conformations to reach the active structure. 
There is a loose retention of native topology that together with a great deal of variation 
of secondary structure and side-chain interactions makes the protein obtaining the 
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confirmation of the transition state.196 The denatured state of CI2 is no exception. It is 
highly expanded and as previously described almost a random coil with some residual 
structure. Simulations of the denatured states are illustrated in figure 13 and it is clear 
that the α-helix is partially formed together with a small amount of hydrophobic 
clustering.224 
 
Figure 13. Simulations of the denatured states of CI2.224 
 
 
 
The advantage of studying a protein with a simple folding mechanism is that the single 
rate-determining transition state can be studied in either of the directions of folding and 
unfolding.218 The nucleation-condensation model has since also been used to study other 
systems as it has proved to be a quite common mechanism.196  
 
5.2.2 Transition state analysis of CI2 
It has been demonstrated that the nucleus consists of those residues that have the 
highest Φ-values.198 The most extensive study on CI2 mutants has been conducted by 
Fersht and co-workers with a total of 99 mutants.218 The results supports that the α-helix 
is to some extent formed in the transition state. The study revealed that only two 
residues in the core of the protein resulted in Φ-values above 0.5; residue 16 (alanine) 
and 49 (leucine). These two residues together with the surrounding residues represent 
the nucleus and when the interactions are made the rest of the protein condenses around 
it. The crystal structure of native CI2 and the simulations of the transition state are 
illustrated in figure 14.219 
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Figure 14. Crystal structure of CI2 (Xtal) and simultations of transition states of folding (TS1-4).219 
 
 
Φ-values of the remainder of the residues in the α-helical region were 0.5 for residues 12-
18 and for residues 19-24 the values ranged from -0.4 to 0.2. Negative Φ-values were 
predominantly obtained when residues were mutated to alanine. Alanine increases the 
preference to form the α-helix as it has the highest α-helical propensity out of the 20 
naturally occurring amino acids. It results in stabilization of the transition state and 
destabilization the less helical denatured state and overall this affords negative Φ-values. 
 
The authors concluded that only the N-terminal part of the helix is formed in the 
transition state. Interestingly, the data is in disagreement with NMR studies and 
molecular dynamics that implies that it is rather the C-terminus that initiates folding of 
the α-helix.224 It could be reasoned that the side-chain mutations applied by Fersht and 
co-workers are not suitable due to the fact that the C-terminus residues do not make 
contacts with the core of the protein. It is also possible that the α-helix in the transition 
state is more folded than it is in the native state. This is supported by the crystal structure 
and NMR studies of CI2 that revealed a bending of the helix and long hydrogen bonds on 
the solvent exposed phase.224 
 
Previous work performed in the Dawson group has demonstrated that backbone 
hydrogen bonding is not a requirement for protein folding.225 CI2 mutants with some of 
the amide bonds replaced with ester bonds were prepared. This produced protein was 
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still able to fold, however the protein was not as stable as the all amide wild type CI2. In 
more details the mutations led to Φ-values of 0.6 and 0.7 for residue 19 and 22, 
respectively, suggesting that backbone hydrogen bonds at the C-terminus are formed to a 
significant degree in the transition state (unpublished results in the Dawson group). This 
is in agreement with the NMR and molecular dynamic studies224 mentioned above and do 
not agree with the results obtained from Φ-value analysis by Fersht and co-workers.218  
 
5.3 Calculation of Φ-values 
In this section it is described how to calculate the Φ-values. As previously mentioned Φ is 
defined as:  
 D-N
 ‡-D
G
G
∆∆
∆∆
=Φ
         
(eq. 2) 
 
The Gibbs free energies are calculated from thermodynamic and kinetic measurements of 
folding and unfolding.  
 
5.3.1 Guanidine hydrochloride denaturation monitored by fluorescence 
Guanidine hydrochloride denaturation experiments226 can be used to calculate the 
difference in stability of a protein upon mutation, ∆∆GN-D, as well as the difference in 
stability of the transition state upon mutation, ∆∆G‡-D. The chosen technique to analyse 
guanidine denaturation is measurement of the fluorescence emission. Other techniques 
include UV difference spectroscopy, circular dichroism, optical rotation and NMR.226 CI2 is 
very simple to analyse by guanidine hydrochloride denaturation due to a great change in 
the physical properties of the protein as it unfolds. Additionally, this procedure requires 
less amount of protein compared to the other techniques.226 In a fluorescence 
experiment the molecule is excited at a given wavelength and after relaxation it emits 
light at a different wavelength. The preferred residue for excitation is tryptophan, which 
fortunately there is one of in CI2. The emission by tryptophan is in some proteins highly 
quenched in the native state and as the protein unfolds a large increase in the 
fluorescence intensity is detected.227 For other proteins like CI2 it is the opposite. The 
nearby lysine residue of tryptophan in CI2 quenches the emission in the folded state. 
Other requirements for Guanidine denaturation experiments include:226  
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• A minimum of 10-15 data points are required to be able to get reliable data from 
the measurements.  
• It is crucial that equilibrium have been reached before the measurement is made. 
For some proteins it can take days to reach equilibrium. 
• It is important to know if the unfolding process is reversible. Irreversible folding is 
most common for proteins containing free sulfhydryl groups because these form 
stable disulfide bonds.  
• Aggregation must be avoided.  
 
It has been shown by Fersht that the guanidine denaturation of CI2 is completely 
reversible and equilibrium is reached within one hour.220  
 
5.3.2 Thermodynamic experiments 
The data obtained from thermodynamic measurements of guanidine hydrochloride 
denaturation are fluorescence versus the guanidine hydrochloride concentration. A 
typical denaturation curve is shown in figure 15. 
 
Figure 15. Guanidine hydrochloride denaturation curves for CI2.198 
 
 
These curves are the basis for calculations of the free energies of the unfolding 
reactions.216,218,220 The free energy at a particular denaturant, guanidine hydrochloride, 
concentration [GdnHCl] is defined as: 
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[ ]
N-DND ln KRTG
GdnHCl
−=∆
−     (eq. 3)
 
 
where R is the gas constant, T is the temperature and KD-N is the equilibrium constant for 
the unfolding reaction. In a two-state model only the denatured and native structures are 
populated: 
 
1DN =+ fracfrac       (eq. 4) 
 
where fracN and fracD is the fraction of protein folded and unfolded, respectively. The 
observed fluorescence, F, is given by: 
 
uDNf fracFfracFF +⋅=      (eq. 5) 
 
where FN and FD are the fluorescence of the folded and unfolded protein, respectively. 
Combining equation 4 and 5 gives: 
 
DN
N
D FF
FFfrac
−
−
=
      
(eq. 6) 
 
The equilibrium constant for folding is defined as: 
 
 
D
N
N
D
D
D
ND
-1 FF
FF
frac
frac
frac
frac
K
−
−
===
−
       (eq. 7) 
 
It is assumed that FN and FD are linearly dependent on guanidine hydrochloride 
concentration: 
 
[ ]GdnHClNNN ⋅+= βαF        (eq. 8) 
 
[ ]GdnHClDDD ⋅+= βαF        (eq. 9) 
 
Consequently, the observed fluorescence is derived from a combination of equation 7, 8 
and 9: 
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(eq. 10) 
 
where [ ]GdnHClN-DG∆  is the free energy of unfolding at a particular denaturant concentration. 
Additionally, it is assumed that there is a linear relationship between the free energy of 
unfolding in the presence of guanidine hydrochloride and the concentration of 
denaturant. The free energy of unfolding is therefore: 
 
 
[ ]GdnHClN-DOH N-DGdnHClN-D 2 mGG −∆=∆       (eq. 11) 
 
where OH N-D 2G∆ is the free energy of unfolding in water (zero molar guanidine 
hydrochloride) and  mD-N is a constant that is proportional to the increase in the degree of 
exposure of the protein on denaturation. The observed fluorescence is derived by 
combining equation 10 and 11: 
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(eq. 12) 
 
Values of the observed fluorescence and the related guanidine hydrochloride 
concentration are fitted into this equation. Hereby the values of OH N-D 2G∆  and mD-N with 
standard errors are obtained. From equation 11 it obvious that at the point where 50% of 
the protein is denatured the free energy is given by: 
 
[ ] %50N-DOH N-D GdnHCl2 ⋅=∆ mG         (eq. 13) 
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At the point where the reaction is at equilibrium the free energy is zero, [ ]GdnHClN-DG∆  = 0. 
Resultantly, [GdnHCl]50% is given by: 
 
[ ]
N-D
OH
N-D
%50
2
GdnHCl
m
G∆
=
        
(eq. 14) 
 
At any given guanidine hydrochloride concentration the free energy is given by inserting 
equation 11 into equation 13: 
 
[ ] [ ]( )GdnHClGdnHCl %50N-DGdnHClN-D −⋅=∆ mG       (eq. 15) 
 
Calculation of the difference in the free energy upon mutation can be done in three 
different ways:218 
 
1. [ ] [ ] %50NDGdnHClND GdnHCl%50 ∆⋅=∆∆ −− mG      (eq. 16) 
 
where ND−m is the average value of m for wild-type and mutant. 
 
2. When an average value of mD-N is neglect ∆∆GD-N  can also be calculated by 
 
OH
ND
OH
ND
OH
ND
222
'
−−−
∆−∆=∆∆ GGG       (eq. 17) 
 
 
where OH ND 2−∆G and 
OH
ND
2
'
−
∆G  are the free energies of unfolding in water for wild 
type and mutant, respectively.  
 
3. Furthermore, it can be calculated at any given guanidine hydrochloride 
concentration by 
[ ] [ ] [ ]( ) [ ] [ ]( )'GdnHCl'GdnHCl'GdnHClGdnHCl %50ND%50NDGdnHClND −⋅−−⋅=∆∆ −−− mmG      
 
(eq.18) 
 
where [GdnHCl]’ and m’ represents values for the mutant and [GdnHCl] and m 
values for the wild type protein. 
 
Fersht and co-workers have examined the three methods and found that the method 3) 
has the smallest error.216 Their results of repeating experiments afforded values of 
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[GdnHCl]50% which was reproducible within 0.02 M However, the values of m and 
therefore also OH ND 2−∆G  were significantly larger. Even a small error in m leads to a large 
error in OH ND 2−∆G because of the long extrapolation from the transition region 
(approximately 4-5 M guanidine hydrochloride) to zero molar guanidine hydrochloride. 
The values of [ ] %50GdnHClND −∆∆G were reproducible within 0.1 kcal/mol versus the values of 
OH
ND
2
−
∆∆ G that were only reproducible within 0.5 kcal/mol.  
 
The calculated values of [ ] %50GdnHClND −∆∆G  can be used for calculating the Φ-values because
[ ] [ ] %50%50 GdnHCl
ND
GdnHCl
ND −− ∆∆−=∆∆ GG  
 
5.3.3 Kinetic experiments 
Kinetic measurements of guanidine hydrochloride denaturation involve a stop-flow 
fluorescence spectrofluorometer. It mixes the protein-buffer solution with the guanidine 
hydrochloride solution very rapidly and has a very small “dead time” before 
measurements are made. This small dead time is crucial as α-helices form within a few 
hundred nanoseconds, β-strands within a few microseconds and short loops within 10-6 
seconds.198 The data obtained by the stopped-flow experiments are fluorescence versus 
time, which follows exponential curves. The equations of these exponential curves and 
the related rate constants are obtained by computational data fitting. The rate constants 
versus guanidine hydrochloride concentration are plotted in a so called chevron plot as 
illustrated in figure 16. 
 
Figure 16. Chevron plot for wild type CI2.198 
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The right side of the chevron plot arises from unfolding experiments and the left side of 
the plot from refolding experiments. For unfolding experiments the protein is kept in a 
buffer solutions and each data point is a result of mixing the protein-buffer solution with 
a solution containing a given guanidine hydrochloride concentration. For refolding 
experiments the protein is kept in a solution with a high guanidine hydrochloride 
concentration and is then mixed in different ratios with a buffer solution to provide each 
data point on the curve. The chevron plots are the basis for further computational data 
fitting.216,218,220 
  
Fitting the unfolding and folding kinetics cannot be obtained using the same equations as 
for the thermodynamic experiments. Proline-isomerization has to be taken into account. 
Despite the fact that proline in the trans conformation is highly favoured there is still 2-
20% of the cis conformation in the denatured state. In native CI2 all prolines are trans and 
the conversion from cis to trans is relatively slow and thereby also the folding phase is 
slow. In the kinetics this accounts for approximately 20-30% of the amplitude.198  
 
The unfolding data is fitted to a single-exponential equation as the unfolding in 
monophasic: 
 
( ) CtmeAtF tk D +⋅−−⋅= ⋅−1)( 0       (eq. 19) 
 
where F(t) is the fluorescence at time t, A0 is the amplitude, kD is the rate constant, m is 
the slope of the drift and C is an offset. The folding kinetics is fitted into a multiple-
exponential equation due to proline-isomerization giving a triphasic refolding reaction:  
 ( ) ( ) CtmeAeAtF tktk +⋅−⋅+⋅= ⋅−⋅− 21 21)(      (eq. 20) 
 
where A1 and A2 are the amplitudes. Plots of the natural logarithm of the rate constant 
versus the guanidine hydrochloride concentration (before the transition state is reached) 
are linear: 
 
[ ]GdnHCllnln DOHDD 2 ⋅+= kmkk       (eq. 21) 
 
where kD is the rate constant of unfolding at a given guanidine hydrochloride 
concentration and OHD
2k is the rate constant of unfolding in water and mKD is the slope. 
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Similarly, the plots of the natural logarithm of the rate constant against the guanidine 
hydrochloride concentration (after the transition state is reached) are also linear:  
 
[ ]GdnHCllnln NOHNN 2 ⋅+= Kmkk       (eq. 22) 
 
where kN is the rate constant of folding at a given guanidine hydrochloride concentration 
and OHN
2k is the rate constant of folding in water and mKN is the slope. The complete 
kinetics used for data fitting is: 
 
[ ]( ) [ ]( )( )GdnHClexpGdnHClexplnlnlnln NOHNDOHD 22 ⋅+⋅⋅=+= KkND mkmkkkk    
       
(eq. 23) 
 
In addition, [GdnHCl]50% can also be determined: 
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As previously described the free energy at a particular denaturant concentration is 
defined as [ ] N-D
GdnHCl
ND ln KRTG −=∆ −  and therefore the difference in energy of the 
transition state of the unfolding relative to the folded state between wild-type and 
mutant, ‡-NG∆∆ , is defined as: 
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where kD and k’D are the rate constants for the wild-type and the mutant, respectively. 
Similar the difference in energy of the transition state of the folding relative to the folded 
state between wild-type and mutant, ‡-DG∆∆ , is calculated: 
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where kN and k’N are the rate constants for the wild type protein and the mutant, 
respectively. This is used for calculation of Φ. The most accurate value of ‡-DG∆∆  is that 
calculated at [GdnHCl]50% as this minimizes errors due to limited extrapolation.  
 
5.4 Concluding remarks 
Recently, there has been an increased interest in a better understanding of protein 
folding due to the focus on diseases arising from protein misfolding. Since the 1950’s 
several different folding mechanisms have been proposed. However, no complete 
understanding has yet been reached, and the research within this field is ongoing. The 
protein engineering method is one way of studying protein folding. It involves mutation of 
a well-known protein with a simple folding mechanism (e.g. CI2). The difference in 
stability upon mutation and the difference in energy of the transition state upon mutation 
are measured by guanidine hydrochloride denaturation. Different methods can be utilized 
to monitor the denaturation, e.g. by fluorescence. An extensive study on several CI2 
mutants has been conducted, but there is still gaps to fill out. In particular there is a need 
to mutate residues within the α-helical region to form more stable mutants. This would 
make it clearer if formation of the α-helix initiates the folding of CI2.  
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5.5 Aim of the project 
Despite the extensive experiments performed with CI2 there are still many unsolved 
issues in terms of how to interpret the observed folding rates upon mutation. 
 
This project is a continuation of the investigation on how a change in the backbone of CI2 
will affect the ability of the protein to fold. Fersht and co-workers have made almost 100 
mutants of CI2, however not all mutants afforded the expected results.218 In a few cases it 
was not possible to calculate Φ-values, namely mutations of residue 18 and 22. 
Interestingly, the mutations of these residues to alanine resulted in no change in stability 
of the protein. The results were unexpected and therefore a different choice of mutant 
should be examined in order to form more stable proteins. Furthermore, most of the 
mutants made by Fersht and co-workers destabilized the protein. It would also be of 
great interest to make mutations of other residues, which would increase stability of the 
protein. Hopefully, it will complement the ester study previously performed in the 
group228 (and also unpublished results). Stabilization of the protein is attempted by 
introducing a helical inducing amino acid. What is of particular interest for this project is 
the evaluation of the source of several negative Φ-value towards the C-terminus of the α-
helix. This will complement the work by Fersht and co-workers, where the predictions of 
the computational work could not be tested well enough by side-chain mutations.218 
 
5.6 Results and discussion 
5.6.1 Mutation choice 
The choice of mutation site and the nature of the mutant are of great importance. It must 
not produce new interactions or structural rearrangements to the folded protein since 
that can alter the folding pathway. However, at the same time it must change the stability 
of the protein in order for Φ-values to be determined.198,216  
 
The chosen amino acid to, hopefully, increase the stability of CI2 is α-aminoisobutyric 
acid, Aib (figure 17).  
 
Figure 17. Structure of Aib. 
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Aib is a natural non-protein amino acid found in membrane-channel-forming peptides of 
microbial origin.229 It possesses high α–helical propensity, even higher than that of 
alanine, which has already been mentioned as being the most α-helical favouring amino 
acid among the 20 protein amino acids. Aib should decrease the chain entropy of the 
unfolded state due to the presence of an additional methyl group. This will reduce the 
allowed conformational space and the torsion angles of the backbone will be more 
restricted. Aib does not affect either the secondary or the tertiary structure when it 
replaces alanine.229   
 
Besides mutation with Aib of residues 18 and 22 also residues 15 and 16 is examined. In 
wild type CI2 residues 15 and 16 are alanine, and in the native state they already posses 
some helical structure. It is expected that mutation to Aib will result in high Φ-values.  
 
5.6.2 Protein synthesis 
The CI2 mutants are made by chemical synthesis using standard procedures. If each 
protein consisting of 64 amino acids were to be synthesised in one linear peptide 
synthesis, the overall yield would most likely be low due to the many coupling reactions. 
Even if each coupling yield is high, e.g. in 99.5% yield this will result in overall yield of only 
72.6%. If the each coupling is just slightly lower, e.g. in 99.0% yield the overall yield drops 
to 52.5%. An overall yield of merely 3.8% is achieved if each coupling is in 95.0% yield. 
Therefore, it is crucial to get each coupling in the highest possible yield. However, even if 
all couplings are quantitative there is a big risk of aggregation due to the large size of the 
peptide/protein.  
 
5.6.3 Chemical ligation 
Due to the problems concerning coupling yields and aggregation it is practically not 
possible to synthesise peptides larger than 50 amino acids. Therefore chemical ligations 
of peptide fragments have been widely studied. One of the most commonly used 
methods is native chemical ligation developed by Dawson et al in 1994.230,231 It involves 
the solution phase reaction between two unprotected peptides in a guanidine 
hydrochloride buffer. One peptide contains a C-terminal thioester and the other a N-
terminal cysteine residue. This reaction affords a natural peptide backbone structure as 
illustrated in scheme 100.  
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Scheme 100. Native chemical ligation. 
 
Interestingly, the requirement of the N-terminal cysteine is not always necessary. If the 
two segments can fold to bring the C- and N-termini in close proximity then the ligation of 
the two pieces is via a regular peptide coupling. This can be performed with any given 
amino acid residue and it does not require the usual strong coupling reagents. It is 
performed in an aqueous buffer, which induces folding. This technology is termed 
conformationally or folding assisted ligation. An illustrative description of both native 
chemical and folding assisted ligations is provided in figure 18.232  
 
Figure 18. A) Native chemical ligation and B) folding assisted ligation.232 
 
 
It has been shown that fragments corresponding to CI2(1-40) and CI2(41-64) can self-
associate to form a stable protein with a crystal and solution structure very close to that 
of intact CI2.233 Therefore, it was envisioned that two fragments of CI2 would be able to 
ligate by folding assisted ligation. In the Dawson group fragments of CI2, namely CI2(1-39) 
and CI2(40-64), have previously been examined with mutation of residue 39 from 
threonine to aspartic acid. It was found that folding assisted ligation enhanced the 
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reaction rate of the ligation from 48 hours (by native chemical ligation) to only 30 minutes 
by folding assisted ligation.232 The mutation of residue 39 to aspartic acid does not affect 
the folding/unfolding reaction.218 Therefore, it was chosen for this project to synthesize 
similar segments; CI2(1-39) as the C-terminal thioesters and CI2(40-64) as C-terminal 
acids. 
 
5.6.4 Solid phase peptide synthesis 
The two CI2 segments, CI2(1-39)COSR and CI2(40-64)COOH, can be made by solid phase 
peptide synthesis (SPPS), which was developed by R. B. Merrifield in 1963.234 
 
SPPS can be performed by two strategies, which involve different temporary protection 
groups, tert-butyloxycarbonyl (Boc) or 9-fluorenylmethoxycarbonyl (Fmoc). Boc is acid 
labile, whereas Fmoc is base labile. As a consequence of this, the two strategies involve 
entirely different reagents for removal of the temporary protection group as well as the 
permanent protection groups. Additionally, different methods are employed when the 
peptide is cleaved from the solid support. In general, the Fmoc-strategy is more 
commonly used compared to the Boc-strategy due to the fact that Boc-strategy requires 
liquid HF for cleaving of peptide from the solid support. This is a potential hazard and is 
preferably avoided. However, Fmoc-strategy is generally incompatible with peptide 
thioesters, as the base required for deprotection of temporary protection groups also 
cleaves the thioester. Due to the great importance of ligations, particularly native 
chemical ligation, Fmoc compatible methods for synthesis of peptide thioesters has 
recently been reported. 235-238 Nevertheless, in the Dawson group peptide thioesters 
made by the Boc-strategy is well established and was the chosen procedure for this 
project. Instead, CI2(40-64)COOH is easily be made by the Fmoc-strategy. 
 
5.6.4.1 CI2(1-40)COSR by Boc-strategy 
CI2(1-39) were made as C-terminal thioesters on the TAMPAL resin using manual Boc-
strategy as shown in scheme 101. It involves standard SPPS conditions; Removal of 
temporary protection groups with a TFA (the trityl-group on the TAMPAL resin was 
initially removed by a TFA-cocktail with 2.5% TIS and 2.5% water), pre-activation of amino 
acids with HCTU and DIEA and DMF as solvent. After the final Boc-deprotection TFA the 
peptide was cleaved from the resin (as well as deprotection of permanent protection 
groups) by treatment with anhydrous liquid HF. 
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Scheme 101. Boc-strategy 
 
Amino acids were used in excess (5.5-fold) to allow couplings to go faster (10-15 minutes) 
and thereby also limiting unwanted side reactions. However, the first coupling is the most 
difficult and a coupling time of 40 minutes was employed. HCTU is not able to couple the 
sterically hindered amino acid Aib. Therefore the stronger (and more expensive) coupling 
reagent HATU was used with a 10-fold excess of the amino acid and a coupling time of 30 
minutes as well as a deprotection time of 2 minutes.  
 
5.6.4.2 CI2(41-64)COOR by Fmoc-strategy 
CI2(40-64) was made as C-terminal acids on Wang resin using automated Fmoc strategy. 
The Wang resin with glycine precoupled is commercially available and the coupling 
scheme for Fmoc SPPS of the peptide building block is shown in scheme 102. As for the 
Boc-strategy, this Fmoc-strategy also involves standard reaction conditions; firstly, 
deprotection of the temporary protection group by piperidine in DMF, then the amino 
acid was coupled in presence of HCTU, HOBt and DIPEA. Removal from resin was achieved 
by treatment of a suitable TFA-cocktail (5% DCM, 2.5% TIS and 2.5% water).  
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Scheme 102. Fmoc-strategy. 
 
HOBt is an additive that prevents side reactions and racemisation.239 It is acidic enough to 
provide some competition in the removal of the proton from the carbon of the activated 
species. Though, it is not acidic enough to deprotonate a free amine. The first amino acid 
was coupled manually as it requires pre-activation with DIC and DMAP. Amino acids were 
used in a 10-fold excess with coupling and deprotection times of 20 minutes each.  
 
5.6.5 Folding studies 
The CI2 mutants synthesised and analysed by both thermodynamic and kinetic 
experiments are: 
 
• CI2-A15Aib 
• CI2-A16Aib 
• CI2-K18Aib 
• CI2-K18A 
• CI2-Q22Aib 
• CI2-Q22A 
• CI2-wt 
 
CI2-K18A and CI2-Q22A are used as control experiments. Results of these should be 
identical to those reported by Fersht and co-workers.218  
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5.6.5.1 Thermodynamics 
The results of the guanidine hydrochloride denaturation experiments monitored by 
fluorescence are summarized in figure 19. 
 
Figure 19. Guanidine hydrochloride denaturation (unfitted data) of CI2 mutants and wild type. 
 
 
 
Computational data fitting of the obtained fluorescence versus guanidine hydrochloride 
results was conducted by Associate Professor Evan Powers and is summarized in figure 20 
and table 22. 
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Figure 20. Fitted data from guanidine hydrochloride denaturation of CI2 mutants and wild type. 
 
 
 
Table 22. Calculated values from thermodynamic guanidine hydrochloride denaturation 
Protein [GdnHCl]50% [GdnHCl]50% 
Reported  
m m 
Reported 
[ ]GdnHCl
N-DG∆  
[ ]GdnHCl
N-DG∆  
Reported 
[ ] %50GdnHCl
N-DG∆  
CI2-wt 4.48 4.00 2.24 1.90 10.06 7.60 - 
CI2-
K18A 
4.52 4.11 2.08 1.61 9.38 6.61 -0.06 
CI2-
K18Aib 
4.70 - 1.80 - 8.45 - -0.41 
CI2-
Q22A 
4.47 3.99 2.29 1.77 10.23 7.06 0.03 
CI2-
Q22Aib 
4.12 - 2.24 - 9.24 - 0.70 
CI2-
A15Aib 
4.46 - 1.79 - 7.97 - 0.04 
CI2-
A16Aib 
3.81 - 2.18 - 8.31 - 1.30 
 (<m>) = 2.09, which in the literature is 1.94.
218 
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Unfortunately, the results are not in accordance with literature values. As seen in the 
table the three known proteins (CI2-wt, K18A and Q22A) all afforded significantly higher 
values of [GdnHCl]50% and 
[ ]GdnHCl
N-DG∆ , which implies that the synthesized proteins are 
significantly more stable compared to the proteins made by Fersht and co-workers. This is 
not possible as they are identical proteins and an error in the measurements must have 
taken place.  
 
5.6.5.2 Kinetics 
The kinetic measurement of guanidine hydrochloride denaturation shows fluorescence 
versus time.  The obtained data was fitted by computational methods by Associate 
Professor Evan Powers. Two examples of folding of CI2-A15Aib at approximately 3.2 M 
guanidine hydrochloride are provided in figure 21 and 22. It is clear from figure 22 that 
the procedure is very sensitive and data fitting can become very complicated and often 
result in unusable data.  
 
Figure 21. An example of folding of CI2 suitable for data analysis. 
 
 
Figure 22. An example the influence of proline-isomerization in folding of CI2. 
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Results of unfolding of the CI2-A15Aib are illustrated in figure 23 and 24, with the latter 
affording best results of data fitting.   
 
Figure 23. An example of unfolding of CI2 not suitable for data analysis. 
 
 
 
Figure 24. An example of unfolding of CI2 suitable for data analysis. 
 
 
 
Interestingly, sometimes unexpected results were obtained as illustrated in figure 25 
(folding of CI2-K18A at approximately 3.0 M guanidine hydrochloride). Despite the good 
fit, the reaction constant is off, and results are not usable for calculation of the Gibbs free 
energy. 
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Figure 25. Unexpected results of unfolding of CI2. 
 
 
 
For each mutant the same experiment is repeated five times as the technique is very 
sensitive and the smallest air bobble in the solutions can affect the results tremendously. 
Each experiment affords a curve as those above and the rate constants are calculated and 
plotted versus guanidine hydrochloride concentration in the chevron plot. This is 
exemplified with CI2-A15Aib in figure 26, which clearly emphasizes the need for repeated 
experiments as some rate constants are far off. It also makes data analysis rather tedious 
as the poor results has to be manually removed.   
 
Figure 26. Chevron plot for CI2-A15Aib. 
 
 
 
Combinations of all chevron plots of the synthesized proteins are provided in figure 27.  
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Figure 27. All chevron plots. 
 
 
The curves in the chevron plots 
Different slopes imply different folding mechanisms, which
mutants. The curves to the ri
left more stable proteins. Interestingly
are placed higher in the diagram (have higher rate constants).  Data of rate constants and
m-values are listed in table 23
 
Table 23. Calculated values of ln 
Entry Protein ln
1 CI2-wt 3.14 ± 0.16
2 CI2-K18A 2.72 ± 0.10
3 CI2-K18Aib 2.23 ± 0.10
4 CI2-Q22A 3.34 ± 0.14
5 CI2-Q22Aib 3.05 ± 0.14
6 CI2-A15Aib 2.26 ± 0.14
7 CI2-A16Aib 3.49 ± 0.28
ln k 
 
were expected to have the same slope for all CI2 mutants. 
 is not the case for
ght of wild type CI2 indicate less stable protein
, all mutants fold faster than wild type CI2 as they 
 and the literature values are listed in table 24
k and m. 
OH
N
2k  mN 
OH
D
2ln k  
 -1.30 ± 0.06 -7.03 ± 0.51 
 -1.02 ± 0.04 -6.81 ± 0.50 
 -0.59 ± 0.04 -9.16 ± 1.28 
 -1.17 ± 0.05 -9.39 ± 0.68 
 -1.29 ± 0.06 -6.11 ± 0.35 
 -1.04 ± 0.07 -6.89 ± 0.65 
 -1.12 ± 0.13 -7.81 ± 1.62 
[D] 
 
 CI2 
s and to the 
 
. 
mD 
1.11 ± 0.08 
1.10 ± 0.08 
1.40 ± 0.19 
1.48 ± 0.11 
1.15 ± 0.06 
1.05 ± 0.10 
1.90 ± 0.35 
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Table 24. Literature values of ln k and m. 
Entry Protein 
OH
N
2ln k  mN 
OH
D
2ln k  mD 
1 CI2-wt 4.03 ± 0.04 -1.82 ± 0.12 -9.04 ± 0.07 1.31 ± 0.01 
2 CI2-K18A 3.90 ± 0.01 -1.77 ± 0.03 -8.89 ± 0.13 1.31 ± 0.02 
4 CI2-Q22A 4.24 ± 0.02 -2.15 ± 0.05 -8.98 ± 0.68 1.32 ± 0.01 
 
Unfortunately, also the kinetic results are not in accordance with the literature values. 
The errors are significantly larger than those for the literature values. This indicates that 
there is an error in the spetrofluorometer. Air bobbles was a recurrent problem during 
the experiments, which might be held accountable.  
 
In table 25 the [GdnHCl]50%-values for both kinetic and thermodynamic experiments as 
well as the literature values are listed. Not only are the results not agreeing with 
literature values, they are also in disagreement with each other.  
 
Table 25. Values of [GdnHCl]50% 
Entry Protein [GdnHCl]50% 
kinetics 
[GdnHCl]50% 
thermodynamics 
[GdnHCl]50% 
literature 
1 CI2-wt 4.22 4.48 4.00 
2 CI2-K18A 4.50 4.52 4.11 
3 CI2-K18Aib 5.72 4.70 - 
4 CI2-Q22A 4.80 4.47 3.99 
5 CI2-Q22Aib 3.75 4.12 - 
6 CI2-A15Aib 4.38 4.46 - 
7 CI2-A16Aib 3.74 3.81 - 
 
Values of the change in stability of the transition state upon mutation, ‡-DG∆∆ , from the 
kinetic experiments as well as literature values are listed in table 26. Also values of 
change in stability of the protein upon mutation are provided. Obviously, neither terms of 
stability are in agreement with literature values as a consequence of the difference in 
[GdnHCl]50%-values.   
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Table 26. Gibbs free energies. 
Entry Protein 
[ ] %50GdnHCll
ND −∆∆G  
kinetics
 
[ ] %50GdnHCll
ND−∆∆G  
thermodynamics 
 
[ ] %50GdnHCll
ND−∆∆G  
literature
 
‡-DG∆∆  
kinetics 
‡-DG∆∆  
literature 
1 CI2-wt 1.38 -  - -  
2 CI2-
K18A 
1.10 -0.06  -0.15 -0.25 0.08 
3 CI2-
K18Aib 
0.68 -0.41  - -0.54 - 
4 CI2-
Q22A 
1.35 0.03  -0.11 0.12 -0.12 
5 CI2-
Q22Aib 
1.06 0.70  - -0.05 - 
6 CI2-
A15Aib 
1.36 0.04  - -0.52 - 
7 CI2-
A16Aib 
0.41 1.30  - 0.21 - 
 
As a consequence of the inaccuracy of the obtained results from both thermodynamic 
and kinetic experiments it will not make any sense to calculate the Φ-values. Once that 
spectrofluorometers are repaired new measurements can be conducted.  
 
Despite the unreliable denaturation results, it seems that the majority of the mutants are 
less stable compared to wild type. Therefore, also mutation of residue 14, 15, 16, 18 and 
22 into 1-aminocyclopropanecarboxylic acid (Acpc, figure 28) was examined as a α-helical 
inducing residue. However, due to time restraints only CI2(1-39)Acpc-mutation thioesters 
still on resin were prepared. These need to be cleaved from the resin and ligated with 
CI2(40-64) before used for guanidine denaturation experiments.  
 
Figure 28. 1-aminocyclopropanecarboxylic acid. 
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5.7 Conclusion 
Several CI2 mutants have successfully been prepared by folding assisted ligation of 
peptide segments prepared by solid phase peptide synthesis. The mutations sites are all 
within the α-helical region. Residues were mutated into alanine and Aib, which both 
posses a highly α-helical propensity. The mutants were prepared by folding assisted 
ligation of two segments, CI2(1-40)thioesters and CI2(41-64). The peptides have been 
synthesized by either Boc- or Fmoc-strategies. The proteins were used for transition state 
analysis. Guanidine hydrochloride denaturation was monitored by fluorescence both in 
terms of thermodynamics and kinetics. Unfortunately, the obtained results of reference 
compounds revealed errors in the apparatus as the values were not in accordance with 
the literature. Nevertheless, there is an indication of the majority of the mutants being 
less stable compared to the wild type protein. Therefore, also thioester segments with 
mutations into 1-aminocyclopropanecarboxylic acid were prepared. The cyclopropyl 
group might enhance the rate of formation of the α-helix and form more stable proteins. 
Due to time restraints the full proteins were not prepared and analysed. 
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6 Summary 
Many biologically active molecules contain nitrogen either as primary/secondary/tertiary 
amines or as part of a heterocycle (aromatic or non-aromatic). Resultantly, the field of C-
N bond formation receives great attention, and herein three different projects in this area 
have been carried out. All are concerned with C-N formation by the borrowing hydrogen 
methodology, i.e. N-alkylation of amines with alcohols or amines catalyzed by iridium or 
ruthenium. The theme was “green chemistry” in terms of developing new and more 
environmentally benign reactions for the use in pharmaceutical research. Focus has been 
on employment of catalysis, reducing the amount of waste (hence increasing the E-
factor), pursue high atom economy and avoid the use of toxic/hazardous reagents. 
 
The first project was based on the serendipitous discovery that a primary amine in the 
presence of the commercially available [Cp*IrCl2]2 catalyst afforded a secondary amine. 
Primary alifatic and benzylic amines were tolerated in the reaction, and the products 
were obtained in good to high yields. The method did not require use of a solvent or an 
additive and isolation of the products were achieved by simple distillations directly from 
the reaction mixtures. Unfortunately, the procedure afforded significantly lower yields if 
two different amines were reacted to afford unsymmetrical secondary amines. 
Additionally, intramolecular cyclization of primary amines failed completely. 
 
The second project dealt with the synthesis of piperazines primarily from diamines and 
diols catalyzed by [Cp*IrCl2]2. Generally, it was difficult to prepare piperazine itself as the 
reaction required at least one substituent on one of the starting materials. C- and N-
substituted piperazines were obtained in high yields. The simplest starting material for 
synthesis of piperazine is ethanolamine, though this led to disappointing results due to 
polymerization. Also, aryl amines were not suitable as starting materials as by-products 
were obtained in large quantities. The use of ruthenium catalysis (RuCl3 in combination 
with either PPh3 or xantphos) in the same reaction did not reveal any product formation. 
It was investigated if other sources of nitrogen could be employed. Interestingly, 
ammonium tetrafluoroborate was efficient, however, a morpholine derivative was 
formed as the major product instead of the expected piperazine.  
 
The third project involved formation of indoles from anilines and vicinal diols. Ruthenium-
phosphine catalytic systems (RuCl3 in combination with either PPh3 or xantphos) were 
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employed and the products were obtained in good yields. The reactions were performed 
under neat conditions and addition of additives was avoided.  
 
The fourth project was conducted as a part of an external stay at the Scripps Research 
Institute, San Diego, California, USA. It focused on protein folding of a well-known 
protein, CI2. The goal was to synthesize more stable mutants compared to the wild type 
protein and to measure the difference in energy of the transition state upon mutation. 
This was performed by guanidine denaturation monitored by fluorescence. These results 
would be a part of a larger study on how to understand protein folding better. 
Unfortunately, due to errors in the spectrofluorometer the obtained results were 
unreliable.  
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7 Experimental work performed at DTU 
7.1 Materials and methods 
All chemicals were purchased from commercial sources and used without further 
purification. Solvents as well as starting materials were used without distillation or further 
removal of water. Solvents used for chromatography were of HPLC grade. Thin layer 
chromatography was performed on aluminum plates coated with silica gel 60. 
Visualization was done by UV or by dipping in a solution of cerium(IV)sulfate (2.5 g) and 
ammonium molybdate (6.25 g) in 10% sulfuric acid (250 mL) or ninhydrin (10g) in ethanol 
(300mL)  followed by charring with a heatgun. Column chromatography was performed 
on silica gel (220-440 mesh). GC were conducted on a Shimadzu GC2010 instrument 
equipped with an Equity™ 1 column (15 m × 0.1 mm, 0.1 µm film). GC-MS was performed 
on a Shimadzu GCMS-QP5000 instrument equipped with Equity-1 capillary column (30 m 
× 0.25 mm, 0.25 µm film) or Shimadzu GCMS-QP2010S instrument equipped with an 
Equity-5 column (30 m x 0.25 mm x 0.25 µm film). GC-yields were obtained using m-
xylene as internal standard. High resolution mass spectra were recorded at the 
Department of Physics and Chemistry, University of Southern Denmark or at the 
Department of Systems Biology, Technical University of Denmark. 1H and 13C NMR spectra 
were obtained on a Varian Mercury 300 instrument at 300 MHz and 75 MHz, respectively. 
The chemical shifts are reported in ppm relative to the residual deuterated solvent.240 
Melting points are uncorrected.  
 
7.2 Secondary amines 
General methods for the synthesis of secondary amines:  
A primary amine (16 mmol) and [Cp*IrCl2]2 (0.08 mmol) were added to a 5-mL screw-top 
heavy-walled vial. The vial was flushed with argon, sealed and placed in an aluminum 
block and heated to 170 °C for 18 hours (unless otherwise stated). After cooling to room 
temperature DCM (2 mL) was added and the resulting solution was transferred to a round 
bottomed flask and DCM was removed on a rotary evaporator. The desired product was 
isolated by distillation in vacuo. 
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Dibenzylamine 
 
Yield = 70% 
Bp: 143–145 °C/10 mbar (Lit.241 113–114 °C/0.13 mbar). 
1H NMR (CDCl3): δ 7.25–7.35 (m, 10 H), 3.78 (s, 4 H), 1.56 (s, 1 H). 
13C NMR (CDCl3): δ 140.3, 128.3, 128.1, 126.8, 53.1. 
NMR data is in accordance with literature values.96 
MS (EI, 70 eV): m/z = 197 [M]. 
 
Bis(4-fluorobenzyl)amine 
 
Yield = 83% 
Bp: 130–132 °C/3 mbar. 
1H NMR (CDCl3): δ 7.30–6.97 (m, 8 H), 3.74 (s, 4 H). 
13C NMR (CDCl3): δ 161.9 (d, J = 245 Hz), 135.9 (d, J = 3.2 Hz), 129.6 (d, J = 7.8 Hz), 115.1 
(d, J = 21 Hz), 52.3. 
NMR data is in accordance with literature values.242  
MS (EI, 70 eV): m/z = 233 [M]. 
 
Bis(4-chlorobenzyl)amine 
 
Yield = 80% 
Bp: 177–181 °C/3 mbar (Lit.243 230 °C/20 mbar). 
1H NMR (CDCl3): δ 7.30–7.26 (m, 8 H), 3.73 (s, 4 H),1.56 (s, 1 H). 
13C NMR (CDCl3): δ 138.5, 132.6, 129.4, 128.4, 52.2. 
NMR data is in accordance with literature values.96  
MS (EI, 70 eV): m/z = 266 [M]. 
 
Bis(4-bromobenzyl)amine 
 
Yield = 76% 
Mp: 46–48 °C (Lit.244 48–49 °C);  
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Bp 145–147 °C/0.04 mbar. 
1H NMR (CDCl3): δ 7.44 (d, J = 8.2 Hz, 4 H), 7.20 (d, J = 8.2 Hz, 4 H), 3.72 (s, 4 H). 
13C NMR (CDCl3): δ 139.1, 131.4, 129.8, 120.7, 52.3. 
NMR data is in accordance with literature values.244  
MS (EI, 70 eV): m/z = 355 [M]. 
 
Bis[(2-pyridyl)methyl]amine 
 
Yield = 79% 
Bp: 107–110 °C/0.09 mbar (Lit.245 130–135 °C/0.13 mbar). 
1H NMR (CDCl3): δ 8.50–8.48 (m, 2 H), 7.56 (td, J = 1.7 and 7.7 Hz, 2 H), 7.28 (d, J = 7.8 Hz, 
2 H), 7.10–7.06 (m, 2H), 3.91 (s, 4 H), 2.52 (s, 1 H). 
13C NMR (CDCl3): δ 159.5, 149.1, 136.3, 122.1, 121.8, 54.6. 
NMR data is in accordance with literature values.245  
MS (EI, 70 eV): m/z = 200 [M + H]. 
 
Dihexylamine 
 
Yield = 72% (72 h reaction time) 
Bp: 85–86 °C/3 mbar (Lit.246 75 °C/1.3 mbar). 
1H NMR (CDCl3): δ 2.59 (t, J = 7.6 Hz, 4 H), 1.48 (m,4 H), 1.29 (m, 12 H), 0.89 (t, J = 6.5 Hz, 
6 H). 
13C NMR (CDCl3): δ 50.1, 31.7, 30.1, 27.0, 22.5, 13.9. 
NMR data is in accordance with literature values.247  
MS (EI, 70 eV): m/z = 185 [M]. 
 
Dioctylamine 
 
Yield = 72% (72 h reaction time) 
Bp: 139–141 °C/3 mbar (Lit.248 145–155 °C/4 mbar). 
1H NMR (CDCl3): δ 2.50 (t, J = 7.3 Hz, 4 H), 1.39 (m,4 H), 1.20 (br s, 20 H), 0.79 (t, J = 6.7 Hz, 
6 H). 
13C NMR (CDCl3): δ 50.1, 31.7, 30.1, 29.4, 29.2, 27.3, 22.5, 13.9. 
NMR data is in accordance with literature values.247  
MS (EI, 70 eV): m/z = 241 [M]. 
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Dicyclohexylamine 
 
Yield = 73% (68 h reaction time) 
Bp: 93–95 °C/5 mbar (Lit.114 79–81 °C/0.5 mbar). 
1H NMR (CDCl3): δ 2.55 (m, 2 H), 1.91–1.81 (m, 4 H), 1.76–1.67 (m, 4 H), 1.65–1.56 (m, 2 
H), 1.32–0.95 (m, 10 H). 
13C NMR (CDCl3): δ 52.9, 34.2, 26.1, 25.2. 
NMR data is in accordance with literature values.76  
MS (EI, 70 eV): m/z = 181 [M]. 
 
Tribenzylamine 
 
Yield = max. 37% (72h reaction time, not reproducible) 
1H NMR (CDCl3): δ 7.43-7.20 (m, 15 H), 3.56 (s, 6H). 
13C NMR (CDCl3): δ 139.6, 128.7, 128.2, 126.8, 57.9. 
NMR data is in accordance with literature values.36  
 
N-hexylbenzylamine 
 
 
Hexylamine (1.9 mmol), benzylamine (1.9 mmol) and [Cp*IrCl2]2 (0.019 mmol) were 
added to a 5-mL screw-top heavy-walled vial. The vial was flushed with argon, sealed and 
placed in an aluminum block and heated to 170 °C for 18h. After cooling to room 
temperature CH2Cl2 (2 mL) the reaction mixture was purified by flash column 
chromatography (EtOAc:heptane 4:1). 
Yield = 40% 
1H NMR (CDCl3): δ. 7.32-7.22 (m, 5H), 3.78 (s, 2H), 2.62 (t, 2H), 1.55-1.46 (m, 2H), 1.36-
1.25 (m, 7H), 0.88 (t, 2H).  
13C NMR (CDCl3): δ 140.8, 128.6, 128.3, 127.1, 54.3, 49.8, 32.0, 30.3, 27.3, 22.9, 14.3. 
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NMR data is in accordance with literature values.249  
 
7.3 Piperazines 
General procedure for iridium catalyzed reactions:  
To a 5 mL screw-top vial were added all reactants and catalyst, additive and solvent 
(when mentioned). The vial was flushed with argon, sealed, placed in an aluminum block 
and heated to the indicated temperature for overnight reaction (unless otherwise stated). 
After cooling to room temperature the reaction mixture was transferred to a round 
bottom flask and the solvent was removed in vacuo. The residue was further purified by 
column chromatography (heptane/EtOAc or MeOH/CH2Cl2 mixtures) unless otherwise 
stated.  
 
1-(2-Hydroxyethyl)piperazine 
 
Ethanolamine (8.3 mmol), [Cp*IrCl2]2 (2 x 10
-5 mmol) and NaHCO3 (0.1 mmol) at 140 
oC. 
Yield = 30% (water as solvent, 4 days reaction time). 
Yield = 23% (neat, 2 days reaction time). 
Yield = 14% (neat, 6 days reaction time).  
1H NMR (CD3OD): 3.68 (t, 2H), 2.92 (t, 4H), 2.56-2.51 (m, 6H).  
13C NMR (CD3OD): 61.7, 59.7, 54.4, 45.8.  
NMR data is identical to that of compound purchased from Sigma-Aldrich. 
MS: m/z 130 [M+]. 
 
1,4-Bis(2-hydroxyethyl)piperazine 
 
Ethanolamine (8.3 mmol), [Cp*IrCl2]2 (2 x 10
-5 mmol) and NaHCO3 (0.1 mmol) at 140 
oC. 
Yield = 27% (water as solvent, 4 days reaction time).  
Yield = 25% (neat, 2 days reaction time).  
Yield = 20% (neat, 6 days reaction time).  
1H NMR (CD3OD): 3.70 (t, 4H, J = 5.9 Hz), 2.73 (bs, 8H), 2.65 (t, 4H, J = 5.9 Hz). 
13C NMR (CD3OD): 60.9, 59.4, 53.6;  
NMR data is identical to that of compound purchased from Sigma-Aldrich. 
HRMS calcd for C8H19N2O2 [M+H]
+ 
m/z 174.1447, found m/z 175.1448. 
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Piperazine 
 
2-(2-Aminoethylamino)ethanol (5.0 mmol), [Cp*IrCl2]2 (0.0125 mmol), NaHCO3 (0.1 mmol) 
and water (3 mL) at 140 oC. After cooling to room temperature the reaction mixture was 
transferred to a distillation unit and solvent and product were distilled off together. To 
this was added 6M HCl and solvent removed in vacuo affording the product as a 
hydrochloride salt. 
Yield = 79% yield.  
1H NMR (CDCl3): 2.78 (s, 8H, CH2). 
13C NMR (CDCl3): 47.2. 
NMR data is in accordance with literature values.250 
MS: m/z 86 [M+]. 
 
(±)-2-methylpiperazine  
 
Diamine (4 mmol), diol (4 mmol), [Cp*IrCl2]2, (0.02 mmol), NaHCO3 (0.02 mmol) and 
solvent (1 mL) at 140 oC. After cooling to room temperature the reaction mixture was 
transferred to a distillation unit and solvent and product were distilled off together. To 
this was added 6M HCl and solvent removed in vacuo affording the product as a 
hydrochloride salt. 
From 1,2-diaminopropane and ethyleneglycol: 
Yield = 69% (water as solvent)  
Yield = 69% (toluene as solvent)  
From ethylenediamine and 1,2-propanediol: 
Yield = 92% (water as solvent) 
Yield = 72% (tolene as solvent) 
1H NMR (D2O): 2.71-2.62 (m, 3H), 2.55-2.33 (m, 3H), 2.10-2.02 (dd, 1H, J = 10.5, 12.5 Hz, 
CHH), 0.78 (d, 3H, J = 6.4 Hz, CH3). 
13C NMR (D2O): 51.4, 50.2, 45.0, 44.0, 18.5.  
NMR data is in accordance with literature values.251 
MS: m/z 100 [M+]. 
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(±)-trans-2,5- and (±)-cis-2,6-Dimethylpiperazine  
 
1,2-Diaminopropane (4 mmol), 1,2-propanediol (4 mmol), [Cp*IrCl2]2, (0.02 mmol), 
NaHCO3 (0.02 mmol) and solvent (1 mL) at 140 
oC. After cooling to room temperature the 
reaction mixture was transferred to a distillation unit and solvent and product were 
distilled off together. To this was added 6M HCl and solvent removed in vacuo affording 
the products as a hydrochloride salts. 
Yield = 90% (water as solvent), 1.5:1 ratio.  
Yield = 73% (toluene as solvent), 1:1 ratio.  
1H NMR (CDCl3): 2.87-2.82 (dd, 2H, J=11.8, 2.8 Hz, HNCHeqHax), 2.65-2.56 (m, 2H, CHaxCH3), 
2.35-2.28 (major) (dd, 1H, J = 10.3, 11.7 Hz, HNCHeqHax), 2.21-2.14 (minor) (m, 1H, J = 
10.3, 12.2 Hz, HNCHeqHax), 0.94-0.92 (minor) (d, 3H, J = 6.3 Hz, CH3), 0.93-0.91 (major) (d, 
3H, J = 6.3 Hz, CH3).  
13C NMR (CDCl3): 54.0 (major), 52.8 (minor), 51.9 (minor), 50.8 (major), 19.7 (minor), 19.5 
(major). 
NMR data is identical to that of compound purchased from Sigma-Aldrich. 
MS: m/z 114 [M+]. 
 
(±)-trans-1-phenyl-5-methylpiperazine and (±)-cis-1-phenyl-6-methylpiperazine 
 
1,2-Diaminopropane (4 mmol), 1-phenyl-1,2-ethanediol (4 mmol), [Cp*IrCl2]2, (0.02 
mmol), NaHCO3 (0.02 mmol) and solvent (1 mL) at 160 
oC. After cooling to room 
temperature the reaction mixture was transferred to a distillation unit and products were 
isolated under high vacuum. 
Yield = 60% (water as solvent), 3:1 ratio.  
Yield = 70% (toluene as solvent), 5:4 ratio.  
1 NMR (CDCl3): 7.22-7.41 (m, 5H, Ar-H), 3.80 (minor) (dd, 1H, J = 2.9, 10.4 Hz), 3.72 (major) 
(dd, 1H, J = 2.9, 10.4 Hz), 3.08 (major) (2xdd, 2H, PhCHCHeq and CH3CHCHeq), 2.98 (minor) 
(2xdd, 2H, PhCHCHeq and CH3CHCHeq), 2.89 (m, 1H, CH3CH), 2.78 (major) (dd, 1H, J = 10.3, 
11.9 Hz, PHCHCHax), 2.62 (minor) (dd, 1H, J = 10.3, 12.0 Hz, PHCHCHax), 2.55 (major) (dd, 
1H, J = 10.4, 11.1 Hz, CH3CHCHax), 2.42 (minor) (dd, 1H, J = 10.5, 12.3 Hz, CH3CHCHax), 1.01 
(d, 3H, J = 6.2 Hz, CH3). 
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13C NMR (CDCl3): 142.6 (minor), 142.4 (major), 128.3 (major and minor), 127.3 (major), 
127.3 (minor), 126.9 (minor), 126.6 (major), 61.2 (major), 54.7 (major), 54.4 (major), 52.4 
(minor), 53.5 (minor), 53.0 (minor), 52.6 (minor), 50.7 (major), 20.0 (minor), 19.8 (major). 
HRMS calcd. for C11H17N2 [M+H]
+ m/z 177.1386, found m/z 177.1407 
 
N-Benzylpiperazine 
 
N-benzylethylenediamine (2 mmol), ethyleneglycol (2 mmol), [Cp*IrCl2]2, (0.01 mmol), 
NaHCO3 (0.1 mmol) and toluene (1 mL) at 160
oC. 
Yield = 63% yield 
1H NMR (CDCl3): 7.32-7.31 (m, 5H, Ar-H), 3.49 (s, 2H, Ph-CH2), 2.89 (t, 4H J = 4.5 Hz), 2.42 
(br s, 4H), 2.33 (s, NH). 
13C NMR (CDCl3): 137.9, 129.2, 128.1, 126.9, 63.6, 54.3, 45.9. 
NMR data is in accordance with literature values.252 
MS: m/z 176 [M+]. 
 
2-(Benzylamino)cyclohexanol 
 
Benzylamine (2.2 mmol), 1,2-cyclohexanediol (2 mmol), [Cp*IrCl2]2, (0.01 mmol), NaHCO3 
(0.1 mmol) and toluene (1 mL) at 110 oC.  
Yield = 54%. 
1H NMR (CDCl3): 7.30-7.32 (m, 4H, Ar-H), 7.22-7.28 (m, 1H, Ar-H), 3.93 (d, 1H, J = 12.9 Hz, 
PhCH), 3.67 (d, 1H JA, J = 12.9 Hz, PhCH), 3.14-3.22 (m, 1H, HOCH), 2.28 (ddd, 1H,  J = 2.2, 
7.1, 9.2 Hz, HOCHCHNH), 1.96-2.02 (m, 1H), 2.10-2.18 (m, 1H), 1.68-1.72 (m, 2H), 1.14-
1.29 (m, 4H, 3xCH, NH), 0.91-1.04 (m, 1H). 
13C NMR (CDCl3): 140.4, 128.3, 128.0, 126.9, 73.6, 63.0, 50.7, 33.3, 30.4, 25.0, 24.3. 
NMR data is in accordance with literature values.253 
MS: m/z 205 [M+].  
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1,2,3,4-Tetrahydroquinoxaline 
 
1,2-Diaminobenzene (2 mmol), ethyleneglycol (3 mmol), [Cp*IrCl2]2 (0.01 mmol), NaHCO3 
(0.1 mmol)  and mesitylene (1 mL) at 180 oC. 
Yield = 34%. 
1H NMR (CDCl3): 6.61-6.56 (m, 2H), 6.53-6.48 (m, 2H) 3.42 (s, 4H). 
13C NMR (CDCl3): 133.6, 118.7, 114.7, 41.3. 
NMR data is in accordance with literature values.254 
MS: m/z 134 [M+]. 
 
2-benzimidazolemethanol 
 
1,2-Diaminobenzene (2 mmol), ethyleneglycol (3 mmol), [Cp*IrCl2]2 (0.01 mmol), NaHCO3 
(0.1 mmol)  and mesitylene (1 mL) at 180 oC.  
Yield = aprox. 30% (trace of impurities present). 
1H NMR (CD3OD): 7.56-7.50 (m, 2H, Ar-H), 7.23-7.17 (m, 2H, Ar-H), 4.89 (s, NH), 4.83 (s, 
2H, HOCH2). 
13C NMR (CD3OD): 156.2, 123.4, 59.0. 
NMR data is in accordance with literature values.255 
MS: m/z 148 [M+]. 
 
Dodecahydro-1H-phenoxazine 
 
1,2-Cyclohexanediol (2.0 mmol) and NH4BF4 (1.0 mmol), [Cp*IrCl2]2 (0.025 mmol), TFA (0.1 
mmol) and mesitylene (1mL) at 180 oC.  
Yield = 63%.  
1H NMR (CDCl3): 3.19-3.11 (m, 2H), 2.63 (s, NH), 2.54-2.47 (m, 2H), 1.90-1.83 (m, 2H), 
1.74-1.66 (m, 6H), 1.35-1.23 (m, 8H); δC (75 MHz, CDCl3). 
13C NMR (CDCl3): 80.9, 60.7, 31.0, 30.8, 24.5, 24.5. 
HRMS calcd. for C12H22NO [M+H]
+ m/z 196.1696, found m/z 196.1698. 
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3-(Cyclohexylamine)butan-2-one 
  
Acetoin (1 mmol), cyclohexylamine (1mmol) and toluene (1 mL) at 60 oC for 1 hour. Yield 
was not determined as the compound was only used for mechanistic purposes. 
1H NMR (C6D5CD3): 3.12 (q, 1H, J = 6.9 Hz, CH3CHNH), 2.25-2.17 (m, 1H, NHCHCH2), 1.80 
(s, 3H, COCH3), 1.69-1.53 (m, 6H), 1.12-1.00 (m, 4H), 0.93 (d, 3H, J = 6.9 Hz, NHCHCH3). 
13C NMR (C6D5CD3): 210.2, 60.6, 55.4, 34.3, 33.9, 26.5, 25.7, 25.2, 25.1, 18.7.  
HRMS calcd. for C10H20NO [M+H]
+ m/z 170.1539, found m/z 170.1539. 
 
2,3-Dimethyl-5,6,7,8,9,10-hexahydroquinoxaline 
 
Acetoin (1 mmol), 1,2-diaminocyclohexane (1 mmol) and toluene-d8 (1 mL) at 60 
oC for 4 
hours. Compound not purified. 
13C NMR (CD3C6D5): 158.0, 59.2, 33.8, 25.7, 22.3. 
NMR data is in accordance with literature values.256 
MS: m/z 164 [M+]. 
 
General procedure for ruthenium catalyzed reactions:  
To a 5 mL screw-top vial were added RuCl3
.xH2O, (0.02 mmol), PPh3 (0.06 mmol) or 
xantphos (0.03 mmol), diamine (2 mmol), diol (2 mmol) and solvent (1 mL). The vial was 
flushed with argon, sealed and placed in an aluminum block and heated to the indicated 
temperature for overnight reaction. After cooling to room temperature samples were 
taken for GC-MS analysis. No work-up. 
 
7.4 Indoles 
To a 5 mL screw-top vial were added the aniline (2 mmol), the diol (2 mmol), RuCl3•xH2O 
(0.02 mmol) and triphenylphosphine (0.06 mmol) or xantphos (0.03 mmol). The vial was 
flushed with argon, sealed and placed in an aluminum block and heated to 110 °C for 1 
hour and then heated to 170 °C for 24 hours (unless otherwise stated). After cooling to 
room temperature the reaction mixture was transferred to a round bottom flask and 
solvent was removed in vacuo. The residue was further purified by column 
chromatography (heptane/EtOAc, DCM/MeOH or DCM/heptanes mixtures). 
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7-Methoxy-2,3-dimethylindole 
 
Yield = 41% (PPh3).  
Yield = 34% (xantphos). 
1H NMR (CDCl3): 2.20 (s, 3H), 2.33 (s, 3H), 3.93 (s, 3H), 6.58 (d, 1H, J = 7.5 Hz), 6.99 (t, 1H, J 
= 7.8 Hz), 7.90 (d, 1H, J = 7.8 Hz), 7.90 (br s, 1H).  
13C NMR (CDCl3): 8.7, 11.5, 55.3, 101.2, 107.5, 111.0, 119.3, 125.2, 130.2, 130.7, 145.3.  
HRMS: m/z: calcd for C11H12NO: 174.0924 [M-H]
-; found: 174.0928. 
 
2,3-Dimethyl-1H-benzo[g]indole 
 
Yield = 60% (PPh3),  
Yield = 72% (xantphos, 2 days reaction time) 
Mp: 149 °C (lit.257 m.p. 153-155 °C).  
1H NMR (CDCl3): 2.29 (s, 3H), 2.45 (s, 3H), 7.36 (ddd, 1H, J = 7.8, 6.9, 1.2 Hz), 7.45 (ddd, 
1H, J = 8.2, 6.9, 1.2 Hz), 7.47 (d, 1H, J = 8.2 Hz), 7.61 (d, 1H, J = 8.4 Hz), 7.87-7.95 (m, 2H), 
8.40 (br s, 1H). 
13C NMR (CDCl3): 8.6, 11.6, 118.6, 119.0, 119.7, 121.2, 123.0, 125.1, 128.8, 129.9.  
NMR data is in accordance with literature values.258  
MS: m/z 195 [M]. 
 
1,2-Dimethyl-3H-benzo[e]indole  
 
Yield = 58% (PPh3,2 days reaction time).  
Yield = 63% (xantphos,2 days reaction time). 
Mp: 118-121 °C (lit.259 m.p. 131 °C).  
1H NMR (CDCl3): 2.39 (s, 3H), 2.61 (s, 3H), 7.37 (d, 1H, J = 8.7 Hz), 7.37 (ddd, 1H, J = 8.4, 
6.9, 1.5 Hz), 7.50(d, 1H, J = 8.7 Hz), 7.51 (ddd, 1H, J = 8.4, 6.9, 1.5 Hz), 7.90 (d, 1H, J = 8.8 
Hz), 7.94 (br s, 1H), 8.49 (d, 1H, J = 8.4 Hz).  
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13C NMR (CDCl3): 11.5, 12.4, 109.7 (2C), 112.2, 121.8, 122.5, 131.1, 125.2, 128.6, 128.9, 
129.1, 129.6, 131.3. 
MS: m/z 195 [M].  
 
2-Ethyl-3-methylindole  
 
Ratio aniline:diol = 2:3 
Yield = 49 % (PPh3).  
Yield = 57% (xantphos). 
1H NMR (CDCl3): 1.26 (t, 3H, J = 7.8 Hz), 2.23 (s, 3H), 2.74 (q, 2H, J = 7.5 Hz), 7.04-7.14 (m, 
4H), 7.22-7.28 (m, 2H), 7.46-7.54 (m, 2H), 7.68 (br s, 2H). 
13C NMR (CDCl3): 8.3, 14.0, 19.4, 106.2, 110.1, 118.0, 119.0, 120.9, 129.4, 135.0, 136.4. 
NMR data is in accordance with literature values.260  
MS: m/z: 159 [M].  
 
2-Butyl-3-methylindole 
 
Ratio aniline:diol = 2:3 
Yield = 54% (PPh3).  
Yield = 61% (xantphos). 
1H NMR (CDCl3): 0.92 (t, 3H, J = 7.3 Hz), 1.35 (sextet, 2H, J = 7.3 Hz), 1.57 (p, 2H, J = 7.2 
Hz), 2.22 (s, 3H), 2.66 (t, 3H, J = 7.3 Hz), 7.09 (m, 2H), 7.20 (d, 1H, J = 7.1 Hz), 7.50 (d, 1H, J 
= 7.5 Hz), 7.55 (br s, 1H). 
13C NMR (CDCl3): 8.4, 13.9, 22.4, 25.8, 31.8, 106.7, 110.1, 118.0, 118.9, 120.8, 129.3, 
135.0, 135.3. 
NMR data is in accordance with literature values.261  
MS: m/z 187 [M]. 
 
2-Isopropyl-3-methylindole 
 
Yield = 32% (PPh3, 3 days reaction time),  
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Yield = 0% (xantphos, 3 days reaction time) 
1H NMR (CDCl3): 1.31 (d, 6H, J = 7.0 Hz), 2.25 (s, 3H), 3.25 (septet, 1H, J = 7.0 Hz), 7.04-
7.14 (m, 2H), 7.26-7.30 (m, 1H), 7.47-7.50 (m, 1H), 7.72 (br s, NH). 
13C NMR (CDCl3): 8.4, 22.3, 25.6, 105.2, 110.2, 118.0, 119.0, 120.8, 129.4, 134.8, 140.2. 
NMR data is in accordance with literature values.262  
MS: m/z 173 [M]. 
 
1,2,3,4-Tetrahydrocarbazole  
 
MsOH (5.0 mol%) used as additive in the reaction. 
Yield = 50% (PPh3).  
Yield = 52 %(xantphos). 
mp 111–113 oC (lit.257 114 oC, lit.263  116–118 oC).  
1H NMR (CDCl3): 1.80–1.94 (m, 4H), 2.64–2.74 (m, 4H), 7.02–7.14 (m, 2H), 7.20–7.26 (m, 
1H), 7.42–7.48 (m, 1H), 7.52–7.66 (br s, 1H). 
13C NMR (CDCl3): 21.4, 23.7, 23.8, 110.6, 110.8, 118.2, 119.5, 121.4, 128.3, 134.5, 136.1.  
NMR data is in accordance with literature values.264-266  
MS: m/z 171 [M].  
 
2,3-dimethylindole 
 
The yield was not determined as the compound was only used for mechanistic purposes. 
1H NMR (CDCl3): 2.22 (s, 3H), 2.35 (s, 3H), 7.05–7.14 (m, 2H), 7.22–7.27 (m, 1H), 7.44–7.49 
(m, 1H), 7.60–7.75 (br s, 1H). 
13C NMR (CDCl3): 8.4, 11.5, 107.0, 110.0, 117.9, 118.9, 120.8, 129.3, 130.6, 135.1.  
NMR data is in accordance with literature values.265, 266  
MS: m/z 145 [M].  
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8 Experimental work performed at TSRI 
8.1 Materials and methods 
All chemicals were purchased from commercial sources. Automated synthesis was carried 
out on a C. S. Bio CS336X peptide synthesizer. Electrospray ionization mass spectrometry 
(ESI-MS) was performed on a SCIEX API-I single quadruple mass spectrometer. UV-vis was 
measured on a GenesysTM 6 spectrophotometer (Thermo Electron Corporation). 
Reverse-phase HPLC analysis and purification: HPLC buffer A is 99.9% water, 0.1% TFA and 
buffer B is 90% ACN, 9.9% water, 0.1% TFA. Analytical HPLCs were run on a HP1050 
instrument using a Phenomenex Jupiter 4 µ Proteo 90 Å column at 0–67% B over 30 min 
(for peptides) or a Phenomenex Jupiter 5 μ C18 300 Å column at 20–60% B over 30 min 
(for ligation products). Preparative scale HPLC was run on a Waters Delta Prep 4000 
instrument using a Phenomenex Jupitor 10 μ Proteo 90 Å (250 x 21.20 mm) at 25-40% or 
30-55% B (for peptides) and a Phenomenex Prodigy C18 10 µ 300 Å (250 x 10.0 mm) 
column at 25-60% B over 60  minutes (for ligation products). Denaturation experiments 
were conducted on an AVIV ATF 105 automated titrating spectrofluorometer using an 
equilibrium time of 5 minutes for every addition, using samples of 0 M guanidine 
hydrochloride and 8 M guanidine hydrochloride in 0.1 M phosphate buffer at pH 6.3. 
 
8.2 Peptide synthesis 
Side-chain protection groups 
Fmoc-strategy Boc-strategy 
Pbf for R O-cyclohexyl for D and E 
Trt for N and Q Xan for Q 
OtBu for D and E Clz for K 
Boc for K Bn for S and T 
tBu for Y  
 
Automated Fmoc-SPPS of H-MEYRIDRVRLFVDKLDNIAQVPRVG-OH, CI2(40-64) 
PAC-PEG-PS resin (0.21 mmol Fmoc/(g resin), 476 mg, 0.1 mmol) was allowed to swell in 
DMF in a 100 mL round bottom flask for 30 minutes. Meanwhile, Fmoc-Gly-OH (297 mg, 
1.0 mmol) was dissolved in DCM with a few drops of DMF and cooled to 0 oC. DIC (63 mg, 
0.5 mmol) was added and the solution was stirred for 20 minutes after which the mixture 
was warmed to room temperature. The mixture was filtrated and solvents removed in 
vacuo and then redissoveld in DMF. DMAP (1.2 mg, 0.01 mmol) was added and the 
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mixture was added to the resin and left at room temperature with occasional swirling for 
1 hour. The activated amino acid in DCM was added and the mixture was left overnight at 
room temperature. Decantation of solvent and addition of a new batch of activated 
amino acid from Fmoc-Gly-OH (297 mg, 1.0 mmol), DIC (63 mg, 0.5 mmol) and DMAP (1.2 
mg, 0.01 mmol). After sitting at room temperature overnight 20 mg of resin was removed 
and washed with DMF, dried and transferred to a 10 mL graduated flask. 2% DBU in DMF 
(2 mL) was added and the mixture was gently stirred for 30 minutes. The solution was 
diluted to 10 mL with acetonitrile and 2 mL of this solution was taken out and diluted to 
25 mL with acetonitrile. In similar way a blank sample was made without resin. 
Absorbance difference at 304 nm = 0.134, which correspond to (0.134 x 16.4)/18.2 = 0.12 
mmol Fmoc/(g resin) remained. Therefore, the yield of the couplings were in a total of 
0.12/0.21 = 60%. The rest of the resin was washed with DMF, dried and transferred to an 
automated Fmoc synthesizer. The remaining Fmoc-protected amino acids were coupled 
in a cycle consisting of 0.4 M HOBt and HCTU in DMF (2.5 mL) for coupling and 1M DIEA in 
DMF (1 mL) for deprotection. After coupling of the last amino acid (methionine) 
deprotection of Fmoc was performed manually in 20% piperidine in DMF for 20 minutes. 
The peptide was cleaved from the resin by treatment a TFA-cocktail (19 mL) consisting of 
90% TFA, 5% DCM, 2.5% TIS and 2.5% water for 2½ hours. Solvents were removed in 
vacuo and the remaining oil was poured over ice-cold diethyl ether. After precipitation 
the solvent was decanted away. Mass of 3003.5 confirmed by ESI-MS. Purification by RP-
HPLC. 
 
Manual SPPS by Boc-strategy of Boc-DKPEAQIIVLPVGTIVD-thioester on resin (CI2(24-
40)thioester on resin) 
TAMPAL resin (800 mg, 0.4 mmol) was allowed to swell in DMF for 20 minutes and was 
then treated with 2.5% TIS and 2.5% water in TFA (3 x 1 minute or until clear solution is 
observed). Then the resin was washed with DMF three times. The amino acid (2.2 mmol) 
was pre-activated with 0.5 M HCTU in DMF (4 mL) and DIEA (1 mL) in DMF and shaken for 
1 minute before added to the resin. After standing for 40 minutes the resin was washed 
twice with DMF and then treated with TFA (2 x 1 minute). The cycle was repeated starting 
with three times DMF wash and the next amino acids were coupled in only 20 minutes. To 
test if coupling was successful a Kaiser test was performed. 2-5 mg of resin was removed 
and added to small funnel and washed with DMF and then 1:1 DCM/MeOH. Resin was 
dried completely and transferred to a test tube. Two drops of a phenol/ethanol mixture, 
two drops of a KCN/pyridine mixture and one drop of a ninhydrin/ethanol mixture was 
added and diluted to 3 mL with 60% EtOH/water. The tube was heated to 100 oC for 4-5 
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minutes. If a blue color is observed it implies that free amine is present and therefore 
coupling has not been successful and must be repeated. After the final amino acid 
coupling the resin was washed with DMF followed by MeOH:DCM (1:1) and keept in a 
desiccator. Used for parallel synthesis of CI2(1-40) thioester mutants. 
 
Manual Boc-SPPS of CI2(1-40)thioesters 
Boc-DKPEAQIIVLPVGTIVD-thioester on resin (288 mg, 0.08 mmol) was allowed to swell in 
DMF and coupling of amino acids follow the procedure described above with 0.44 mmol 
amino acid, 0.5 M HCTU in DMF (0.9 mL) and DIEA (0.2 mL) in 20 minutes coupling times. 
However, coupling of Aib was achieved with (0.8 mmol) with HATU (1 mmol) in DMF (0.9 
mL) and DIEA (15 μL) and required a coupling time of 30 minutes. After removal of the 
final Boc-group with TFA the resin was washed with DMF followed by MeOH:DCM. 
Cleaving the peptide from the resin was acheived by treatment with anhydrous liquid HF. 
In a typical HF cleavage reaction, 300 mg of resin was stirred in a vessel containing 1 mL 
of scavenger (anisole or p-cresol) in 10 mL of HF. The reaction was allowed to proceed at 
0 oC for 1 h, and then the HF was distilled off under vacuum. The peptide-resin mixture 
was washed three times with ice-cold diethyl ether and filtered. The peptide was then 
dissolved in a buffer (27% acetonitrile, 73% water and 0.1% TFA) and lyophilized. 
Purification by RP-HPLC. Mass confirmed by ESI-MS. 
 
• CI2(1-39)COSR (34 mg), M =4413.3  
LKTEWPELVGKSVAAAKKVILQDKPEAQIIVLPVGTIVD-thioester  
• CI2(1-39)K18AibCOSR (38mg), M = 4370.2 
LKTEWPELVGKSVAAAKAibVILQDKPEAQIIVLPVGTIVD-thioester 
• CI2(1-39)K18ACOSR (41 mg), M = 4356.2  
LKTEWPELVGKSVAAAKAVILQDKPEAQIIVLPVGTIVD-thioester  
• CI2(1-39)Q22ACOSR (30 mg), M = 4356.2  
LKTEWPELVGKSVAAAKKVILADKPEAQIIVLPVGTIVD-thioester  
• CI2(1-39)Q22AibCOSR (51 mg), M =4370.2  
LKTEWPELVGKSVAAAKKVILAibDKPEAQIIVLPVGTIVD-thioester  
• CI2(1-39)A15AibCOSR*   
LKTEWPELVGKSVAAibAKKVILQDKPEAQIIVLPVGTIVD-thioester  
• CI2(1-39)A16AibCOSR:*  
LKTEWPELVGKSVAAAibKKVILQDKPEAQIIVLPVGTIVD-thioester  
* made by Juan Bautista Blanco-Canosa  
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• CI2(1-39)Q22CycCOSR 
LKTEWPELVGKSVAAAKKVILAcpcDKPEAQIIVLPVGTIVD-thioester on resin 
• CI2(1-39)K18CycCOSR 
LKTEWPELVGKSVAAAKAcpcVILQDKPEAQIIVLPVGTIVD-thioester on resin  
• CI2(1-39)A16CycCOSR 
LKTEWPELVGKSVAAAcpcKKVILQDKPEAQIIVLPVGTIVD-thioester on resin 
• CI2(1-39)A15CycCOSR 
LKTEWPELVGKSVAAcpcAKKVILQDKPEAQIIVLPVGTIVD-thioester on resin  
• CI2(1-39)A14CycCOSR 
LKTEWPELVGKSVAcpcAAKKVILQDKPEAQIIVLPVGTIVD-thioester on resin  
 
8.3 Folding assisted ligation 
CI2(1-39)COSR (8.9 mg), CI2(40-64) (8.0 mg) and thiphendol (45 μL) were dissolved in 0.1 
M sodium phosphate buffer (2.205 mL) at pH 6.3. The mixture was vortexed and 
sonicated and placed on a rotating table overnight. Ice-cold ether was added and the vial 
was shaken and placed in a centrifuge. Ether decanted away and the reming oil was 
purified by RP-HPLC affording 4.6 mg of CI2-wt. Mass confirmed by ESI-MS. 
LKTEWPELVGKSVAAAKKVILQDKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
 
CI2(1-39)K18ACOSR (12 mg) and CI2(40-64) (11 mg) to give CI2-K18A (7.0 mg),   
LKTEWPELVGKSVAAAKAVILQDKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
 
CI2(1-39)K18AibCOSR (13.6 mg) and CI2(40-64) (12.2 mg) to give CI2-K18Aib (7.3 mg),   
LKTEWPELVGKSVAAAKAibVILQDKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
 
CI2(1-39)Q22ACOSR (11.6 mg) and CI2(40-64) (10.1 mg) to give CI2-Q22A (7.3 mg),   
LKTEWPELVGKSVAAAKKVILADKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
 
CI2(1-39)Q22AibCOSR (18 mg) and CI2(40-64) (15 mg) to give CI2-Q22A (∼10 mg),   
LKTEWPELVGKSVAAAKKVILAibDKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
CI2(1-39)A15AibCOSR (16 mg) and CI2(40-64) (14 mg) to give CI2-A15Aib (mass not 
measured),   
LKTEWPELVGKSVAAibAKKVILQDKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
 
CI2(1-39)A16AibCOSR (7.1 mg) and CI2(40-64) (6.5 mg) to give CI2-A16Aib (2.8 mg),   
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LKTEWPELVGKSVAAAibKKVILQDKPEAQIIVLPVGTIVDMEYRIDRVRLFVDKLDNIAQVPRVG 
 
8.4 Guanidine denaturation experiments (thermodynamic and kinetic) 
The protein (1 mg) was dissolved in 0.1 M phosphate buffer (0.5 mL) at pH 6.3. Equimolar 
protein was dissolved in 8 M guanidine hydrochloride in 0.1 M sodium phosphate at pH 
6.3 and in 0.1 M sodium phosphate also at pH 6.3. The experiments were carried out 
using automated titration. Data was collected after 5 minutes equilibration time under 
constant stirring after each addition. Excitation wavelength was 280 nm and emission 
wavelength was 356 nm. All experiments were conducted at room temperature.  
 
Thermodynamic experiments: 
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Kinetic experiments: 
• CI2-wt 
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• CI2-K18A 
 
 
 
 
• CI2-K18Aib 
 
 
 
 
• CI2-Q22A 
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• CI2-Q22Aib 
 
 
 
 
• CI2-A15Aib 
 
 
 
 
• CI2-A16Aib 
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Abstract: Symmetric secondary amines are readily obtained by
heating a neat primary amine with 0.5 mol% of bis(dichloro[h5-pen-
tamethylcyclopentadienyl]iridium). The products are isolated by di-
rect distillation in good yields.
Key words: amines, dimerizations, homogeneous catalysis, hydro-
gen transfer, iridium
Secondary amines are an important class of molecules in
chemistry and biology, and are used as intermediates in
the production of pharmaceuticals, agrochemicals, dyes,
and fine chemicals.1 The most familiar methods for the
synthesis of secondary amines are the N-alkylation of pri-
mary amines with alkyl halides2 and the reduction (or
alkylation) of imines.3 The former method often suffers
from problems of overalkylation, which can be solved by
introducing a protecting group.4 The latter method can be
carried out by direct reductive amination, but is still a
rather difficult procedure and can also lead to overalkyla-
tion. Other methods for the synthesis of secondary amines
include metal-catalyzed arylation with aryl halides,5 re-
ductive alkylation with nitriles,6 and reduction of second-
ary amides.7
Some procedures that are more environmentally friendly
have recently been introduced, in which primary amines
or ammonium salts are alkylated with alcohols in the pres-
ence of a ruthenium or an iridium catalyst.8 The mecha-
nism involves dehydrogenation of the alcohol to the
carbonyl compound, imine formation, and reduction. 
Secondary amines have also been prepared by ruthenium-
or iridium-catalyzed coupling of two primary amines;9 in
this case, one of the reactants is either an aryl amine or a
tertiary-alkyl amine, which allows selective coupling to
occur. Self-condensation of primary amines into symmet-
ric secondary amines in the presence of various metal cat-
alysts has also been reported.10 The proposed mechanism
for this reaction involves dehydrogenation of the primary
amine to the corresponding imine, aminal formation,
elimination of ammonia, and reduction (Scheme 1). An
electrocatalytic system has recently been described for the
synthesis of secondary amines from primary amines; this
reaction also proceeds by the mechanism shown in
Scheme 1.11 
During our work on the iridium-catalyzed alkylation of
amines with alcohols,12 we sometimes observed the
dimerization of the amines as a side reaction, particularly
under neat conditions and with less-reactive alcohols.
Here we describe a convenient method for the synthesis of
secondary amines from primary amines in the presence of
bis(dichloro[h5-pentamethylcyclopentadienyl]iridium)
([Cp*IrCl2]2) as a catalyst.
Scheme 1 Mechanism for the dimerization of amines
Our initial experiments were performed with benzylamine
and 0.5 mol% of [Cp*IrCl2]2 in the absence of a solvent.
When this mixture was heated overnight at 140 °C, signif-
icant amounts of dibenzylamine were formed, but the
dimerization did not go to completion. The addition of
acidic or basic additives did not accelerate the reaction.
However, increasing the temperature to 170 °C resulted in
a clean conversion into dibenzylamine after 18 hours. The
secondary amine was isolated in 70% yield by direct dis-
tillation of the reaction mixture (Table 1, entry 1). This
procedure appeared to be very convenient for the synthe-
sis of symmetric secondary amines, so a number of other
substrates were also investigated. Benzylamines contain-
ing methyl, methoxy, fluoro, chloro, or bromo substitu-
ents at the para-position underwent self-coupling in a
similar manner to benzylamine, giving the corresponding
dibenzylamines in 75–83% yield (entries 2–6). Note that
the bromo substituent is stable under these reaction condi-
tions, as this can serve as a handle for further functional-
ization reactions. 1-(2-Pyridyl)methanamine was
converted into the corresponding secondary amine in 79%
yield, and the reaction was not hampered by the additional
heterocyclic amine group (entry 7). On the other hand,
more-reactive aromatic amines, such as furfurylamine or
tryptamine, decomposed under the reaction conditions.
Aliphatic amines reacted significantly more slowly than
did benzylic amines, presumably because of the slower
initial dehydrogenation to the imine. After 18 hours, only
54% of hexylamine was converted into dihexylamine;
R NH
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however, after about 70 hours, hexyl-, octyl-, and cyclo-
hexylamine were each converted into the corresponding
secondary amine in 72–73% isolated yield (entries 8–10).
An attempt to perform a selective coupling between ben-
zylamine and hexylamine was only moderately success-
ful. Heating an equimolar mixture of the two amines with
the iridium catalyst gave no more than a 40% isolated
yield of N-benzylhexan-1-amine after flash chromatogra-
phy; the remainder of the product mixture consisted of
equal amounts of the two symmetric secondary amines. In
all the cases shown in Table 1, only trace amounts of the
corresponding tertiary amines were observed.
In summary, we have developed a practical procedure for
preparation of symmetric secondary amines from a vari-
ety of primary amines. The neat reaction conditions allow
the straightforward isolation of the product by direct dis-
tillation. We believe that the method is a very attractive
procedure for the synthesis of dialkylamines because of its
simplicity and convenience.
1H NMR and 13C NMR spectra were recorded on a Varian Mercury
300 spectrometer. The chemical shifts are reported in ppm relative
to the residual deuterated solvent. Mass spectra were obtained on a
Shimadzu QP5000 GC-MS instrument equipped with an Equity-1
capillary column (30 m × 0.25 mm, 0.25 mm film).
Secondary Amines; General Procedure
A primary amine (16 mmol) and [Cp*IrCl2]2 (64 mg, 0.08 mmol)
were added to a 5-mL screw-top vial that was sealed and heated to
170 °C for the time shown in Table 1, then cooled to r.t. CH2Cl2 (2
mL) was added, and the resulting soln was transferred to a round-
bottomed flask. The CH2Cl2 was removed on a rotary evaporator,
and the desired product was isolated by distillation in vacuo. 
Dibenzylamine13
Bp 143–145 °C/10 mbar (Lit.14 113–114 °C/0.13 mbar).
1H NMR (300 MHz, CDCl3): d = 7.25–7.35 (m, 10 H), 3.78 (s, 4 H),
1.56 (s, 1 H).
13C NMR (75 MHz, CDCl3): d = 140.3, 128.3, 128.1, 126.8, 53.1.
MS (EI, 70 eV): m/z = 197 [M].
Bis(4-methylbenzyl)amine15
Bp 157–160 °C/3 mbar (Lit.14 135–137 °C/0.13 mbar).
1H NMR (300 MHz, CDCl3): d = 7.31–7.20 (m, 8 H), 3.83 (s, 4 H),
2.41 (s, 6 H).
13C NMR (75 MHz, CDCl3): d = 137.2, 136.3, 129.0, 128.0, 52.7,
21.0.
MS (EI, 70 eV): m/z = 225 [M].
Bis(4-methoxybenzyl)amine16
Bp 183–185 °C/3 mbar (Lit.14 161–163 °C/0.13 mbar).
1H NMR (300 MHz, CDCl3): d = 7.32–6.91 (m, 8 H), 3.84 (s, 6 H),
3.78 (s, 4 H).
13C NMR (75 MHz, CDCl3): d = 158.5, 132.4, 129.2, 113.6, 55.1,
52.3.
MS (EI, 70 eV): m/z = 257 [M].
Bis(4-fluorobenzyl)amine15
Bp 130–132 °C/3 mbar.
1H NMR (300 MHz, CDCl3): d = 7.30–6.97 (m, 8 H), 3.74 (s, 4 H).
13C NMR (75 MHz, CDCl3): d = 161.9 (d, J = 245 Hz), 135.9 (d,
J = 3.2 Hz), 129.6 (d, J = 7.8 Hz), 115.1 (d, J = 21 Hz), 52.3.
MS (EI, 70 eV): m/z = 233 [M].
Bis(4-chlorobenzyl)amine13
Bp 177–181 °C/3 mbar (Lit.17 230 °C/20 mbar).
1H NMR (300 MHz, CDCl3): d = 7.30–7.26 (m, 8 H), 3.73 (s, 4 H),
1.56 (s, 1 H).
13C NMR (75 MHz, CDCl3): d = 138.5, 132.6, 129.4, 128.4, 52.2.
MS (EI, 70 eV): m/z = 266 [M].
Bis(4-bromobenzyl)amine16
Mp 46–48 °C (Lit.16 48–49 °C); bp 145–147 °C/0.04 mbar.
1H NMR (300 MHz, CDCl3): d = 7.44 (d, J = 8.2 Hz, 4 H), 7.20 (d,
J = 8.2 Hz, 4 H), 3.72 (s, 4 H).
13C NMR (75 MHz, CDCl3): d = 139.1, 131.4, 129.8, 120.7, 52.3.
MS (EI, 70 eV): m/z = 355 [M].
Bis[(2-pyridyl)methyl]amine18
Bp 107–110 °C/0.09 mbar (Lit.18 130–135 °C/0.13 mbar).
1H NMR (300 MHz, CDCl3): d = 8.50–8.48 (m, 2 H), 7.56 (td,
J = 1.7 and 7.7 Hz, 2 H), 7.28 (d, J = 7.8 Hz, 2 H), 7.10–7.06 (m, 2
H), 3.91 (s, 4 H), 2.52 (s, 1 H).
13C NMR (75 MHz, CDCl3): d = 159.5, 149.1, 136.3, 122.1, 121.8,
54.6.
MS (EI, 70 eV): m/z = 200 [M + H].
Dihexylamine19
Bp 85–86 °C/3 mbar (Lit.20 75 °C/1.3 mbar).
1H NMR (300 MHz, CDCl3): d = 2.59 (t, J = 7.6 Hz, 4 H), 1.48 (m,
4 H), 1.29 (m, 12 H), 0.89 (t, J = 6.5 Hz, 6 H).
13C NMR (75 MHz, CDCl3): d = 50.1, 31.7, 30.1, 27.0, 22.5, 13.9.
MS (EI, 70 eV): m/z = 185 [M].
Table 1 Synthesis of Secondary Amines from Primary Amines
Entry R Time (h) Yield (%)a
1 Bn 18 70
2 4-MeC6H4CH2 18 75
3 4-MeOC6H4CH2 18 77
4 4-FC6H4CH2 18 83
5 4-ClC6H4CH2 18 80
6 4-BrC6H4CH2 18 76
7 (2-pyridyl)methyl 18 79
8 (CH2)5Me 72 72
9 (CH2)7Me 72 72
10 Cy 68 73
a
 Yield of isolated product after distillation.
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Dioctylamine19
Bp 139–141 °C/3 mbar (Lit.21 145–155 °C/4 mbar).
1H NMR (300 MHz, CDCl3): d = 2.50 (t, J = 7.3 Hz, 4 H), 1.39 (m,
4 H), 1.20 (br s, 20 H), 0.79 (t, J = 6.7 Hz, 6 H).
13C NMR (75 MHz, CDCl3): d = 50.1, 31.7, 30.1, 29.4, 29.2, 27.3,
22.5, 13.9. 
MS (EI, 70 eV): m/z = 241 [M].
Dicyclohexylamine8d
Bp 93–95 °C/5 mbar (Lit.10e 79–81 °C/0.5 mbar).
1H NMR (300 MHz, CDCl3): d = 2.55 (m, 2 H), 1.91–1.81 (m, 4 H),
1.76–1.67 (m, 4 H), 1.65–1.56 (m, 2 H), 1.32–0.95 (m, 10 H). 
13C NMR (75 MHz, CDCl3): d = 52.9, 34.2, 26.1, 25.2.
MS (EI, 70 eV): m/z = 181 [M].
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Iridium- and ruthenium-catalysed synthesis of 2,3-disubstituted indoles from
anilines and vicinal diols†
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A straightforward and atom-economical method is described for the synthesis of 2,3-disubstituted
indoles. Anilines and 1,2-diols are condensed under neat conditions with catalytic amounts of either
[Cp*IrCl2]2/MsOH or RuCl3·xH2O/phosphine (phosphine = PPh3 or xantphos). The reaction does not
require any stoichiometric additives and only produces water and dihydrogen as byproducts. Anilines
containing methyl, methoxy, chloro and ﬂuoro substituents can participate in the cyclocondensation.
Meta-substituted anilines give good regioselectivity for 6-substituted indoles, while unsymmetrical diols
afford excellent regioselectivity for the indole isomer with an aryl or large alkyl group in the 2-position.
The mechanism for the cyclocondensation presumably involves initial formation of the
a-hydroxyketone from the diol. The ketone subsequently reacts with aniline to generate the
a-hydroxyimine which rearranges to the corresponding a-aminoketone. Acid- or metal-catalysed
electrophilic ring-closure with the release of water then furnishes the indole product.
Introduction
The indole skeleton is one of the most important heterocyclic
ring systems which is found in many natural products1 and
biologically active molecules.2 Substituted indoles are capable of
binding to a number of receptors with high afﬁnity and the indole
substructure is found in a variety of different drugs.3 This has
stimulated intense research into the chemical synthesis of indoles
for more than a century.4 The Fischer indole synthesis from 18835
is still a widely applied method where aryl hydrazines are reacted
with enolisable aldehydes/ketones to afford the heterocycle after
a sigmatropic rearrangement of the corresponding hydrazone.6
Another classical but less commonly used procedure is the Bischler
indole synthesis from 18927 where anilines are alkylated with a-
haloketones and the resultinga-anilinoketones then cyclised to the
target molecule.8 More recently, a variety of new procedures have
been developed for assembling the indole ring system particularly
by the use of various palladium-catalysed cyclisations.9 How-
ever, the starting materials are often 1,2-disubstituted aromatic
compounds such as 2-haloanilines, which may not be widely
available, but have to be prepared in separate steps. A more
straightforward protocol with simple starting materials involve
condensation of anilines with 1,2-diols to afford indoles after
liberating two molecules of water and one molecule of dihydrogen
(Scheme 1). This procedure is also a very environmentally friendly
and atom-economical method for synthesis of the heterocycle.10
The reaction has previously been achieved with anilines and
RuCl2(PPh3)3 in dioxane at 180 ◦C11 or with 1-naphthylamine
and IrCl3·3H2O/BINAP in mesitylene at 169 ◦C under air.12
However, in both cases a signiﬁcant excess of the arylamine is
employed. A related indole synthesis has been described with
Department of Chemistry, Building 201, Technical University of Denmark,
2800 Kgs. Lyngby, Denmark. E-mail: rm@kemi.dtu.dk; Fax: +45 4593
3968; Tel: +45 4525 2151
† Electronic supplementary information (ESI) available: NMR spectra for
all products. See DOI: 10.1039/c0ob00106f
Scheme 1 Indole synthesis from anilines and 1,2-diols.
anilines, alkanolammonium chlorides and RuH2(PPh3)4, but in
this case an additional stoichiometric amount of SnCl2·2H2O is
required.13
Recently, we have shown that piperazines can be formed
by cyclocondensation of primary amines with 1,2-diols in the
presence of the iridium catalyst [Cp*IrCl2]2.14 The C–N bond
is generated by dehydrogenation of the alcohol to the carbonyl
compound followed by imine formation and hydrogenation to
the product amine with the liberated dihydrogen from the ﬁrst
step.15,16 We have also shown that oxindoles can be alkylated
in the 3-position with alcohols in the presence of RuCl3·xH2O
and PPh3.17 We speculated that with anilines the iridium or the
ruthenium catalyst would mediate both the C–N and the C–C
bond formation to furnish the indole skeleton. Herein, we describe
an expedient procedure for synthesis of substituted indoles by
cyclocondensation of anilines with 1,2-diols in the presence of
either [Cp*IrCl2]2 or RuCl3·xH2O/phosphine.
Results and discussion
The initial experiments were carried out with aniline, butane-2,3-
diol and 1% [Cp*IrCl2]2 in a toluene solution. In the absence of any
other additives very little conversion was observed at 110 ◦C while
increasing the temperature to 170 ◦C led to a very complexmixture.
With 5% K2CO3, which is known to co-catalyse the C–N bond
formation,15 a complex mixture of products was still obtained
with no visible cyclisation to the indole. Our previous work had
shown that the C–N bond formation could also be mediated by
an acidic co-catalyst.14 We reasoned that the acid would also
5576 | Org. Biomol. Chem., 2010, 8, 5576–5582 This journal is © The Royal Society of Chemistry 2010
D
ow
nl
oa
de
d 
by
 D
TU
 L
ib
ra
ry
 o
n 
17
 O
ct
ob
er
 2
01
1
Pu
bl
ish
ed
 o
n 
20
 O
ct
ob
er
 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
OB
001
06F
View Online
Table 1 Synthesis of 2,3-dimethylindole with different acid co-catalystsa
Entry Acid Reaction time Yieldb
1 H2SO4c 1 d 48%
2 H2SO4c 4 d 59%
3 none 2 d 16%
4 conc. HCl 5 d 53%
5 conc. HBr 5 d 53%
6 ZnI2 1 d 18%
7 MgBr2 2 d 53%
8 AlCl3 3 d 58%
9 TMSOTf 2 d 52%
10 BF3·OEt2 2 d 70%
11 MsOH 2 d 76%
12 conc. H3PO4 3 d 75%
13 AcOH 2 d 20%
14 CF3CO2H 2 d 46%
15 CF3SO3H 2 d 59%
a Performedwith aniline (90 mL, 1mmol), butane-2,3-diol (90 mL, 1mmol),
[Cp*IrCl2]2 (8 mg, 0.01 mmol) and acid (0.05 mmol) in a closed vial at
170 ◦C. b Isolated yield. c With 2.5% H2SO4.
facilitate the C–C bond formation to the indole. Indeed, when
the substrates were reacted in toluene at 170 ◦C with 5% sulfuric
acid, 2,3-dimethylindole was obtained as the main product. The
reaction was rather slow and only gave 34% yield after 2 days. The
main problem seems to be precipitation of the ammonium salt
between aniline and the acid. Under neat conditions, however, a
homogeneous mixture was obtained and a faster conversion was
observed giving rise to the indole in 48–59% isolated yield (Table 1,
entries 1 and 2). The reaction was performed in a closed vial with
equimolar amounts of aniline and butane-2,3-diol and catalytic
amounts of the additives. Although, dihydrogen is released and
the pressure increases, no reduction to 2,3-dimethylindoline was
observed. Not surprisingly, the reaction did not proceed in the
absence of the iridium catalyst.
Even though sulfuric acid is a very convenient co-catalyst,
the reaction was still rather slow and gave rise to a few minor
byproducts. Therefore, a number of experiments were performed
with different acids in order to identify the optimum co-catalyst.
The acid was necessary since the reaction otherwise gave a
complex mixture from which the indole could only be isolated
in a low yield (entry 3). Concentrated hydrochloric acid and
hydrobromic acid led to essentially the same result as sulfuric
acid while several Lewis acids gave faster conversion, but without
signiﬁcantly improving the yield (entries 4–10). The best result
was obtained with methanesulfonic acid which gave very clean
conversion into the indole with no visible byproducts or starting
material remaining according to GC (entry 11). Concentrated
phosphoric acid also afforded a good yield, but the reaction was
slower while other Brønsted acids were less effective (entries 12–
15). As a result the favoured catalyst system consisted of 1%
[Cp*IrCl2]2 and 5% methanesulfonic acid.
Since ruthenium is signiﬁcantly cheaper than iridium it was
decided also to investigate the cyclocondensation in the presence
Table 2 Synthesis of 2,3-dimethylindole with ruthenium trichloride and
different phosphinesa
Entry Phosphine Yieldb
1 PPh3 65% (60%)
2 PCy3 27% (20%)
3 P(OEt)3 11%
4 P(2-furyl)3 9%
5 (4-MeOC6H4)3P 64%
6 (4-FC6H4)3P 70%
7 DPEphosc 60%
8 BINAPc 35%
9 dppec 38%
10 dpppc 70%
11 dppbc 73% (66%)
12 dpppentanec 62%
13 dppfc 53%
14 xantphosc 76% (71%)
a Performedwith aniline (90 mL, 1mmol), butane-2,3-diol (90 mL, 1mmol),
RuCl3·xH2O (2.3 mg, 0.01 mmol) and phosphine (0.03 mmol) in a closed
vial at 170 ◦C. b GC yields (isolated yields in parenthesis). c 1.5% bidentate
phosphine.
of various ruthenium catalysts. Based on our previous experi-
ence with alkylation of oxindole17 we focused our attention on
ruthenium trichloride and various phosphines in the absence of a
solvent. The ﬁrst experiment was performed with aniline, butane-
2,3-diol, RuCl3·xH2O (1%), PPh3 (3%) and methanesulfonic acid
(5%). After heating the mixture to 170 ◦C for 1 day, 2,3-
dimethylindole was isolated in ~50% yield. When the experiment
was repeated in the absence of the sulfonic acid the indole was
obtained in 60% yield (Table 2, entry 1). Contrary to the iridium
experiment the acid is not necessary in this case to promote the
cyclisation. A number of phosphines were then investigated to
identify the optimum ligand for the reaction (entries 2–14).
The best results were achieved with the two bidentate ligands
dppb and xantphos which gave 66 and 71% isolated yield,
respectively. The ratio between ruthenium and phosphorus was
further investigated with PPh3 and dppb, but in both cases the
1 : 3 ratio was found to give the highest yield. However, when
repeating the same experiment several times we did in some cases
observe a variation in the yield. This appears to be caused by
differences in the size of the ruthenium trichloride crystals. The
active catalyst is presumably a ruthenium(II) complex generated
in situ by reduction of ruthenium trichloride with the phosphine.
Thus it seems that this process may vary slightly from one
experiment to another depending on the ruthenium trichloride
batch. When the cyclocondensation was performed with the more
soluble RuCl2(PPh3)3 complex, consistent yields around 50% were
obtained. Due to the convenience of the in situ generated catalyst
we opted for a solution where this could be generated in a more
reproducible way. It turned out that if the reaction mixture was
stirred at 110 ◦C for 1 h and then heated to 170 ◦C more consistent
results were obtained. At 110 ◦C the cyclocondensation does not
proceed, but ruthenium trichloride reacts with the phosphine and
the active catalyst is generated. Subsequent heating to the reaction
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 5576–5582 | 5577
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Table 3 Synthesis of indoles from substituted anilines and butane-2,3-diola
Entry Aniline X Indole Yieldb [Cp*IrCl2]2 Yieldb RuCl3/PPh3 Yieldb RuCl3/xantphos
1 Me 61% 48% 50%
2 OMe 59% 56% 53%
3 Cl 66% 57% 69%
4 F 46% 45% 52%
5 Me 34% 49% 51%
6 OMe 64% 48% 58%
7 Cl 47%c 57%d 69%d
8 F 47%e 48% 52%
9 Me 65% 72% 87%
10 OMe 41% 41% 34%
11 — 65% 60% 72%f
12 — 76% 58% 63%f
a See experimental section for reaction procedures. b Isolated yield. c Isolated as a 4 : 1 mixture of the 6-chloro and the 4-chloro isomer. d Isolated as a 6 : 1
mixture of the 6-chloro and the 4-chloro isomer. e Minor amounts of the corresponding 4-ﬂuoroindole was observed, but not isolated. f Reaction time
2 days.
temperature furnishes a more reproducible yield of the indole
product .
With these optimised conditions in place the stage was now set
to explore the substrate scope and limitation of the cycloconden-
sation method. For each substrate the reaction was performed
with both the iridium catalyst ([Cp*IrCl2]2/MsOH) and with
the ruthenium catalyst (RuCl3/PPh3 and RuCl3/xantphos). First,
regioselectivity and functional groups in the aniline were investi-
gated by reacting various substituted anilines with butane-2,3-diol
(Table 3). Methyl and methoxy substituents were compatible with
the reaction conditions and yielded the corresponding indoles
without any major byproducts (entries 1, 2, 5, 6, 9 and 10).
Chloro and ﬂuoro substituents were allowed in the para and
the meta positions (entries 3, 4, 7 and 8) while o-chloro- and o-
ﬂuoroaniline reacted sluggishly and gave less than 25% yield of the
corresponding indole (results not shown). With the chloroanilines
small amounts of 2,3-dimethylindolewas observed as a byproduct,
but not isolated. Bromo and boronic ester substituents, on the
other hand, were completely reduced off with both the iridium
and the ruthenium catalyst and carboxylic acids underwent
decarboxylation. Methyl ester groups were partially cleaved off
while anilines with cyano, dimethylamino, acetamido, nitro or
triﬂuoromethyl substituents either decomposed or reacted very
poorly. Meta-substituted anilines gave a good regioselectivity in
the cyclisation to the para position (entries 5–8). The same regios-
electivity is observed for the sigmatropic rearrangement in the
Fischer indole synthesis when the directing group is ortho-
para directing.6 The two naphthyl amines gave good yields of
the corresponding benzindoles (entries 11 and 12) while 2-
aminopyridine gave a complex mixture and 4-aminopyridine
did not react. In all cases, the three different catalysts gave
comparable yields of the indole product. However, the reac-
tions with the ruthenium catalysts were performed in a shorter
time and with a lower catalyst loading than with the irid-
ium catalyst and the ruthenium system is therefore recom-
mended for general use. With this system the xantphos ligand
5578 | Org. Biomol. Chem., 2010, 8, 5576–5582 This journal is © The Royal Society of Chemistry 2010
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Table 4 Synthesis of indoles from aniline and various diolsa
Entry R R¢ Yieldb [Cp*IrCl2]2 Yieldb RuCl3/PPh3 Yieldb RuCl3/xantphos
1 Me Et 70% (5 : 1)c 49% (1 : 0)c ,d 57% (1 : 0)c ,d
2 Me nBu 65% (7 : 1)c 54% (7 : 1)c 61% (1 : 0)c ,d
3 Me iPr 58% (1 : 0) 32% (1 : 0)e —
4 Me Ph 31% (1 : 0)c 27% (1 : 0) 28% (1 : 0)
5 -(CH2)4- 53% 50%f 52%f
6 Ph Ph 29% — —
a See experimental section for reaction procedures. b Isolated yield (A :B ratio in parenthesis). c Aniline : diol ratio 2 : 3. d Minor isomer not isolated.
e Reaction time 3 days. f 3% MsOH was also added.
usually gives a slightly better yield than the triphenylphosphine
ligand.
The regioselectivity was also investigated with respect to the
diol by reacting different diols with aniline in the presence of the
iridium and the ruthenium catalyst. Remarkably, unsymmetric
diols gave excellent selectivity for the indole isomer where the
large substituent is placed in the 2-position (Table 4, entries 1–4).
With the iridium catalyst pentane-2,3-diol and heptane-2,3-diol
gave the two indoles in ratios of 5 : 1 and 7 : 1, respectively (entry 1
and 2). More unsymmetrical diols afforded exclusively the isomer
with the aryl or large alkyl group in the 2-position (entries 3 and
4). A cyclic diol and a diol with two aryl groups also reacted with
aniline although the latter gave a lower yield due to the instability
of the diol under the reaction conditions (entries 5 and 6).With the
ruthenium catalyst cyclohexane-1,2-diol reacted quite sluggishly
with aniline and only afforded the tetrahydrocarbazole in low
yield.However, by co-catalysing the reactionwithmethanesulfonic
acid the yield increased to the same level as with the iridium
catalyst (entry 5). Ethylene glycol and diols containing a primary
alcohol gave complex mixtures with both the iridium and the
ruthenium catalyst. The reason may be the poor stability of the
products under the reaction conditions. Control experiments with
the iridium catalyst showed that indole, 2-methylindole and 3-
methylindole all underwent further reactions when exposed to the
diol and methanesulfonic acid.
Themechanism for the condensation presumably involves initial
formation of the a-hydroxyketone which then reacts with the
aniline to furnish the imineC (Scheme 2). The a-hydroxyimine can
either isomerise to the corresponding a-aminoketone D or react
with the catalyst and hydrogen to generate the a-aminoalcohol E.
Since a-hydroxyimines are known to isomerise readily in reﬂuxing
benzene18 the former reaction is the most likely pathway. This
was further conﬁrmed by preparing a-aminoalcohol E (with
R,R¢ = -(CH2)4-) from aniline and cyclohexene oxide. When this
compoundwas treatedwith [Cp*IrCl2]2 andmethanesulfonic acid,
a complex mixture was observed with only little indole formation
indicating that the a-aminoalcohol E is not part of the main
reaction pathway. The same experiment was carried out with a-
aminoalcoholE (withR = R¢ = Me) andRuCl3·xH2O/PPh3. In this
case, the reaction did not go to completion in 24 h and afforded
an equal mixture of aniline and 2,3-dimethylindole, which again
Scheme 2 Suggested mechanism for indole formation.
indicates thatE is not part of themainpathway.When the reactions
in Table 1–3 were monitored by GC-MS, the a-aminoalcohol E
was observed, butmainly in caseswhere aweak acid or an electron-
withdrawing group on the aniline made the cyclisation difﬁcult.
This suggests that a-aminoalcohol E is formed in a side reaction
by reduction of a-aminoketone D and the success of the overall
reaction depends on the ability of D to undergo electrophilic ring-
closure under the acidic conditions. a-Aminoketone D (with R =
R¢ = Me) can be prepared by reacting aniline with acetoin in the
absence of an acid.19 When this aminoketone was heated with 5%
methanesulfonic acid at 170 ◦C, the conversion into the indole
was complete in 15 min while the reaction at 100 ◦C took about
2 h. When a-aminoketone D (with R = R¢ = Me) was treated
with 1% RuCl3·xH2O/PPh3 at 170 ◦C complete conversion into
the indole was observed in less than 2 h. It is unlikely, that the
reaction goes through an indoline followed by dehydrogenation
to the indole. Control experiments have shown that the iridium
catalyst is rather slow at dehydrogenating indoline to indole (2 days
at 170 ◦C) and since indolines are not observed by GC-MS during
the course of the reaction they are most likely not intermediates
in the cyclocondensation.
The excellent regioselectivity with the unsymmetrical diols in
Table 4 is most likely determined in the last cyclisation step.
Aminoketone D is also formed as an intermediate in the Bischler
indole synthesis7,8 and related transformations20 and in these cases
the cyclisation to the indole is not regiospeciﬁc, but occurs in such
a way that the aryl or large alkyl group is placed in the 2-position
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 5576–5582 | 5579
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of the indole. For example, 2-phenylindole is formed exclusively
when aniline is reacted with phenacyl bromide21 indicating a
complete rearrangement of the initially formed aminoketone.
Therefore, aminoketone D will only be prone to cyclisation into
the indole when R is a small alkyl group, and if this is not the
case isomerisation into the opposite regioisomer and subsequent
cyclisation will be more favourable.
Conclusion
In summary, we have developed a simple and atom-economical
synthesis of 2,3-disubstituted indoles by cyclocondensation of
equimolar amounts of anilines and 1,2-diols in the presence of
catalytic amounts of [Cp*IrCl2]2/MsOH or RuCl3/phosphine.
The reaction does not require any solvent or stoichiometric
additives and only produces water and dihydrogen as byproducts.
Experimental
GC yields were obtained on a Shimadzu GC2010 instrument
equipped with an EquityTM 1 column (15 m ¥ 0.1 mm, 0.1 mm
ﬁlm) using naphthalene as the internal standard. Melting points
are uncorrected. Solvents used for chromatography were of HPLC
grade. Thin layer chromatography was performed on aluminium
plates coatedwith silica gel 60. Visualisationwas done byUVor by
dipping in a solution of cerium(IV)sulfate (2.5 g) and ammonium
molybdate (6.25 g) in 10% sulfuric acid (250 mL) followed by
charring with a heatgun. Flash chromatography was performed
with silica gel 60 (35–70 mm). NMR spectra were recorded on a
Varian Mercury 300 instrument. Chemical shifts were measured
relative to the signals of residual CHCl3 (7.26 ppm)/CDCl3
(77.0 ppm) or DMSO-d5 (2.50 ppm)/DMSO-d6 (39.4 ppm). Mass
spectrometrywas performedbydirect inlet on aShimadzuGCMS-
QP5000 instrument.High resolutionmass spectrawere recorded at
the Department of Physics and Chemistry, University of Southern
Denmark.
General procedure for iridium-catalysed preparation of indoles.
In an oven-dried heavy-walled vial (11 mL) equipped with a
screw cap were placed the aniline (1 mmol), the diol (1 mmol),
[Cp*IrCl2]2 (8 mg, 0.01 mmol) and MsOH (3 mL, 0.05 mmol)
under an argon atmosphere. The vial was closed and immediately
placed in an aluminium block pre-heated to 170 ◦C and heated
for 2 days. The mixture was quenched with triethylamine (15 mL,
0.1 mmol) and puriﬁed by column chromatography on silica gel
(hexane–CH2Cl2 2 : 1 or heptane/EtOAc 5 : 1) to afford the desired
indole.
General procedure for ruthenium-catalysed preparation of in-
doles. In an oven-dried heavy-walled vial equipped with a
screw cap were placed the aniline (2 mmol), the diol (2 mmol),
RuCl3·xH2O (4.8 mg, 0.02 mmol) and triphenylphosphine
(15.7 mg, 0.06 mmol) (or xantphos (17.4 mg, 0.03 mmol)). The
vial was closed and placed in an aluminium block for 1 h at 110 ◦C
and then heated to 170 ◦C for 24 h. The reaction mixture was
worked up as described above.
2,3-Dimethylindole. mp 98–101 ◦C (lit.19 106–108 ◦C, lit.22
107–108 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.22 (s, 3H), 2.35
(s, 3H), 7.05–7.14 (m, 2H), 7.22–7.27 (m, 1H), 7.44–7.49 (m, 1H),
7.60–7.75 (br s, 1H). 13C NMR (CDCl3, 75 MHz): d 8.4, 11.5,
107.0, 110.0, 117.9, 118.9, 120.8, 129.3, 130.6, 135.1. MS: m/z 145
[M]. NMR data are in accordance with literature values.23,24
2,3,5-Trimethylindole. mp 115–120 ◦C (lit.22 118–120 ◦C, lit.19
120–122 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.19 (s, 3H), 2.33
(s, 3H), 2.44 (s, 3H), 6.92 (dd, 1H, J = 8.1, 1.5 Hz), 7.13 (d,
1H, J = 8.1 Hz), 7.24 (s, 1H), 7.55 (br s, 1H). 13C NMR (CDCl3,
75 MHz): d 8.4, 11.5, 21.5, 106.5, 109.6, 117.7, 122.3, 128.1, 129.6,
130.7, 133.4. MS: m/z 159 [M]. NMR data are in accordance with
literature values.22
5-Methoxy-2,3-dimethylindole. mp 105–108 ◦C (lit.19 110–
112 ◦C, lit.25 106–108 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.19 (s,
3H), 2.34 (s, 3H), 3.86 (s, 3H), 6.76 (dd, 1H, J = 8.7, 2.4 Hz), 6.92
(d, 1H, J = 2.4 Hz), 7.13 (d, 1H, J = 8.7 Hz), 7.58 (br s, 1H). 1H
NMR (DMSO-d6, 300 MHz): d 2.11 (s, 3H), 2.27 (s, 3H), 3.73 (s,
3H), 6.60 (dd, 1H, J = 8.6, 2.4 Hz), 6.83 (d, 1H, J = 2.3 Hz), 7.09
(d, 1H, J = 8.6 Hz), 10.45 (s, NH). 13C NMR (CDCl3, 75 MHz):
d 8.5, 11.6, 55.9, 100.3, 106.9, 110.4, 110.6, 129.8, 130.2, 131.6,
153.8. 13C NMR (DMSO-d6, 75 MHz): d 8.4, 11.3, 55.2, 99.6,
104.8, 109.4, 110.7, 129.2, 130.1, 132.0, 152.8. MS: m/z 175 [M].
1H NMR data are in accordance with literature values.25,26
5-Chloro-2,3-dimethylindole. mp 138–140 ◦C (lit.19,24 142–
143 ◦C, lit.27 141–142 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.16
(s, 3H), 2.32 (s, 3H), 7.00–7.14 (m, 2H), 7.40–7.41 (m, 1H), 7.62
(br s, 1H). 13C NMR (CDCl3, 75 MHz): d 8.3, 11.5, 106.9, 110.9,
117.5, 120.9, 125.1, 130.5, 132.3, 133.4. MS: m/z 179 [M]. NMR
data are in accordance with literature values.24
5-Fluoro-2,3-dimethylindole. mp 98–99 ◦C (lit.28 98 ◦C). 1H
NMR (CDCl3, 300 MHz): d 2.17 (s, 3H), 2.33 (s, 3H), 6.83 (td,
1H, J = 11.7, 2.4 Hz), 7.06–7.16 (m, 2H), 7.50–7.70 (br s, 1H). 13C
NMR (CDCl3, 75 MHz): d 8.4, 11.6, 102.9 (d, J = 23 Hz), 107.4
(d, J = 4.5 Hz), 108.7 (d, J = 26 Hz), 110.4 (d, J = 9.6 Hz), 129.8
(d, J = 9.5 Hz), 131.5, 132.8, 157.7 (d, J = 233 Hz). MS: m/z 163
[M]. 1H NMR data are in accordance with literature values.26
2,3,6-Trimethylindole. mp 98–104 ◦C (lit.27 117–118 ◦C). 1H
NMR (CDCl3, 300 MHz): d 2.19 (s, 3H), 2.30 (s, 3H), 2.43 (s, 3H),
6.90 (d, 1H, J = 8.1 Hz), 7.00 (s, 1H), 7.35 (d, 1H, J = 8.1 Hz), 7.43
(br s, 1H). 13C NMR (CDCl3, 75 MHz): d 8.6, 11.5, 21.7, 106.8,
110.2, 117.7, 120.6, 127.3, 129.9, 130.5, 135.7. MS: m/z 159 [M].
6-Methoxy-2,3-dimethylindole. mp 129–132 ◦C (lit.29 130 ◦C).
1H NMR (CDCl3, 300 MHz): d 2.21 (s, 3H), 2.31 (s, 3H), 3.85 (s,
3H), 6.75 (d, 1H, J = 2.2 Hz), 6.78 (dd, 1H, J = 8.5, 2.2 Hz), 7.35
(d, 1H, J = 8.5 Hz), 7.48 (br s, 1H). 13C NMR (CDCl3, 75 MHz): d
8.5, 11.5, 55.7, 94.3, 106.8, 108.2, 118.4, 123.9, 129.2, 135.7, 155.7.
MS: m/z 175 [M]. 1H NMR data are in accordance with literature
values.29
6-Chloro-2,3-dimethylindole. 1H NMR (CDCl3, 300 MHz): d
2.21 (s, 3H), 2.34 (s, 3H), 7.06 (dd, 1H, J = 8.4, 1.8Hz), 7.19 (d, 1H,
J = 1.8 Hz), 7.36 (d, 1H, J = 8.4 Hz). 13C NMR (CDCl3, 75 MHz):
d 8.4, 11.5, 107.2, 109.9, 118.7, 119.5, 126.6, 128.0, 131.4, 135.4.
HRMS: calcd for C10H9ClN: 178.0428 [M - H]-, found: 178.0426.
6-Fluoro-2,3-dimethylindole. 1H NMR (CDCl3, 300 MHz): d
2.15 (s, 3H), 2.23 (s, 3H), 6.78–6.84 (m, 2H), 7.30 (dd, 1H, J =
9.2, 5.3 Hz), 7.55 (s, NH). 13C NMR (CDCl3, 75 MHz): d 8.3,
11.3, 96.5 (d, J = 26 Hz), 106.8, 107.1 (d, J = 24 Hz), 118.3 (d,
5580 | Org. Biomol. Chem., 2010, 8, 5576–5582 This journal is © The Royal Society of Chemistry 2010
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J = 10 Hz), 125.9, 130.9 (d, J = 3.6 Hz), 134.9 (d, J = 12 Hz), 159.2
(d, J = 235 Hz). HRMS: calcd for C10H9FN: 162.0724 [M - H]-,
found: 162.0722.
2,3,7-Trimethylindole. mp 64–65 ◦C (lit.19 79 ◦C, lit.24,30 75–
76 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.21 (s, 3H), 2.37 (s, 3H),
2.44 (s, 3H), 6.89–6.93 (m, 1H), 7.00 (dd, 1H, J = 7.8, 6.3 Hz), 7.32
(d, 1H, J = 7.8 Hz), 7.60 (br s, 1H). 13C NMR (CDCl3, 75 MHz): d
8.6, 11.6, 16.5, 107.6, 115.7, 119.1, 119.2, 121.5, 128.8, 130.2, 134.5.
MS: m/z 159 [M]. NMR data are in accordance with literature
values.24
7-Methoxy-2,3-dimethylindole. 1H NMR (CDCl3, 300 MHz):
d 2.20 (s, 3H), 2.33 (s, 3H), 3.93 (s, 3H), 6.58 (d, 1H, J = 7.5 Hz),
6.99 (t, 1H, J = 7.8 Hz), 7.90 (d, 1H, J = 7.8 Hz), 7.90 (br s, 1H).
13C NMR (CDCl3, 75 MHz): d 8.7, 11.5, 55.3, 101.2, 107.5, 111.0,
119.3, 125.2, 130.2, 130.7, 145.3. HRMS: calcd for C11H12NO:
174.0924 [M - H]-, found: 174.0928.
2,3-Dimethyl-1H-benzo[g]indole. mp 149 ◦C (lit.19 153–
155 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.29 (s, 3H), 2.45 (s,
3H), 7.36 (ddd, 1H, J = 7.8, 6.9, 1.2 Hz), 7.45 (ddd, 1H, J = 8.2,
6.9, 1.2 Hz), 7.47 (d, 1H, J = 8.2 Hz), 7.61 (d, 1H, J = 8.4 Hz),
7.87–7.95 (m, 2H), 8.40 (br s, 1H). 13C NMR (CDCl3, 75 MHz):
d 8.6, 11.6, 118.6, 119.0, 119.7, 121.2, 123.0, 125.1, 128.8, 129.9.
MS: m/z 195 [M]. 1H NMR data are in accordance with literature
values.31
1,2-Dimethyl-3H-benzo[e]indole. mp 118–121 ◦C (lit.32
131 ◦C). 1H NMR (CDCl3, 300 MHz): d 2.39 (s, 3H), 2.61 (s,
3H), 7.37 (d, 1H, J = 8.7 Hz), 7.37 (ddd, 1H, J = 8.4, 6.9, 1.5 Hz),
7.50 (d, 1H, J = 8.7 Hz), 7.51 (ddd, 1H, J = 8.4, 6.9, 1.5 Hz), 7.90
(d, 1H, J = 8.8 Hz), 7.94 (br s, 1H), 8.49 (d, 1H, J = 8.4 Hz). 13C
NMR (CDCl3, 75 MHz): d 11.5, 12.4, 109.7 (2C), 112.2, 121.8,
122.5, 131.1, 125.2, 128.6, 128.9, 129.1, 129.6, 131.3. MS: m/z
195 [M].
2-Ethyl-3-methylindole (major)a and 3-ethyl-2-methylindole
(minor)b. 1H NMR (CDCl3, 300 MHz): d 1.21 (t, 3H, J =
7.8 Hz)b, 1.26 (t, 3H, J = 7.8 Hz)a, 2.23 (s, 3H)a, 2.35 (s, 3H)b, 2.70
(q, 2H, J = 7.8 Hz)b, 2.74 (q, 2H, J = 7.5 Hz)a, 7.04–7.14 (m, 4H)a,b,
7.22–7.28 (m, 2H)a,b, 7.46–7.54 (m, 2H)a,b, 7.68 (br s, 2H)a,b. 13C
NMR (CDCl3, 75 MHz): d 8.3a, 11.5b, 14.0a, 15.4b, 17.3b, 19.4a,
106.2a, 110.1a,b, 113.9b, 118.0a,b, 119.0a,b, 120.9a,b, 128.5b, 129.4a,
130.1b, 135.0a,b, 136.4a. MS: m/z: 159 [M]. NMR data for 2-ethyl-
3-methylindolea are in accordance with literature values.33 NMR
data for 3-ethyl-2-methylindoleb are in accordance with literature
values.24
2-Butyl-3-methylindole. 1H NMR (CDCl3, 300 MHz): d 0.92
(t, 3H, J = 7.3 Hz), 1.35 (sextet, 2H, J = 7.3 Hz), 1.57 (p, 2H, J =
7.2 Hz), 2.22 (s, 3H), 2.66 (t, 3H, J = 7.3 Hz), 7.09 (m, 2H), 7.20
(d, 1H, J = 7.1 Hz), 7.50 (d, 1H, J = 7.5 Hz), 7.55 (br s, 1H). 13C
NMR (CDCl3, 75 MHz): d 8.4, 13.9, 22.4, 25.8, 31.8, 106.7, 110.1,
118.0, 118.9, 120.8, 129.3, 135.0, 135.3. MS: m/z 187 [M]. NMR
data are in accordance with literature values.34
2-Isopropyl-3-methylindole. 1H NMR (CDCl3, 300 MHz): d
1.31 (d, 6H, J = 7.0 Hz), 2.25 (s, 3H), 3.25 (septet, 1H, J = 7.0 Hz),
7.04–7.14 (m, 2H), 7.26–7.30 (m, 1H), 7.47–7.50 (m, 1H), 7.72
(br s, NH). 13C NMR (CDCl3, 75 MHz): d 8.4, 22.3, 25.6, 105.2,
110.2, 118.0, 119.0, 120.8, 129.4, 134.8, 140.2. MS: m/z 173 [M].
NMR data are in accordance with literature values.35
3-Methyl-2-phenylindole. mp 87–90 ◦C (lit.22 90–91 ◦C). 1H
NMR (CDCl3, 300 MHz): d 2.46 (s, 3H), 7.11–7.24 (m, 2H), 7.32–
7.36 (m, 2H), 7.44–7.50 (m, 2H), 7.55–7.62 (m, 3H), 8.00 (br s,
1H). 13C NMR (CDCl3, 75 MHz): d 9.6, 108.6, 110.6, 119.0, 119.5,
122.2, 127.2, 127.7, 128.7, 129.9, 133.2, 134.0, 135.7. MS: m/z 207
[M]. NMR data are in accordance with literature values.20a,23
1,2,3,4-Tetrahydrocarbazole. mp 111–113 ◦C (lit.19 114 ◦C,
lit.30 116–118 ◦C). 1H NMR (CDCl3, 300 MHz): d 1.80–1.94
(m, 4H), 2.64–2.74 (m, 4H), 7.02–7.14 (m, 2H), 7.20–7.26 (m,
1H), 7.42–7.48 (m, 1H), 7.52–7.66 (br s, 1H). 13C NMR (CDCl3,
75MHz): d 21.4, 23.7, 23.8, 110.6, 110.8, 118.2, 119.5, 121.4, 128.3,
134.5, 136.1. MS: m/z 171 [M]. NMR data are in accordance with
literature values.23,24
2,3-Diphenylindole. mp 108–109 ◦C (lit.36 109 ◦C). 1H NMR
(CDCl3, 300 MHz): d 7.10–7.50 (m, 13H), 7.69 (d, 1H, J = 7.8 Hz),
8.18 (br s, 1H). 13C NMR (CDCl3, 75 MHz): d 110.9, 115.0, 119.7,
120.4, 122.7, 126.2, 127.7, 128.1, 128.5, 128.7 (2C), 130.1, 132.6,
134.0, 135.0, 135.8 ppm. MS: m/z 269 [M]. NMR data are in
accordance with literature values.36
Acknowledgements
We thank the Danish National Research Foundation for ﬁnancial
support.
Notes and references
1 (a) S.-M. Li, Nat. Prod. Rep., 2010, 27, 57–78; (b) M. Ishikura and K.
Yamada, Nat. Prod. Rep., 2009, 26, 803–852; (c) K. Higuchi and T.
Kawasaki, Nat. Prod. Rep., 2007, 24, 843–868.
2 (a) W. Gul and M. T. Hamann, Life Sci., 2005, 78, 442–453; (b) A.
Aygu¨n and U. Pindur, Curr. Med. Chem., 2003, 10, 1113–1127.
3 (a) A. Brancale and R. Silvestri, Med. Res. Rev., 2007, 27, 209–238;
(b) R. W. DeSimone, K. S. Currie, S. A. Mitchell, J. W. Darrow and
D. A. Pippin, Comb. Chem. High Throughput Screening, 2004, 7, 473–
493.
4 (a) S. A. Patil, R. Patil and D. D. Miller, Curr. Med. Chem., 2009, 16,
2531–2565; (b) J. Barluenga, F. Rodrı´guez and F. J. Fan˜ana´s, Chem.–
Asian J., 2009, 4, 1036–1048; (c) K. Kru¨ger, A. Tillack and M. Beller,
Adv. Synth. Catal., 2008, 350, 2153–2167; (d) L. Ackermann, Synlett,
2007, 507–526; (e) G. R. Humphrey and J. T. Kuethe,Chem. Rev., 2006,
106, 2875–2911; (f) J. Campo, M. Garcı´a-Valverde, S. Marcaccini, M.
J. Rojo and T. Torroba, Org. Biomol. Chem., 2006, 4, 757–765; (g) J.
Tois, R. Franze´n and A. Koskinen, Tetrahedron, 2003, 59, 5395–5405;
(h) G. W. Gribble, J. Chem. Soc., Perkin Trans. 1, 2000, 1045–1075.
5 E. Fischer andF. Jourdan,Ber. Dtsch. Chem. Ges., 1883, 16, 2241–2245.
6 (a) D. L. Hughes, Org. Prep. Proced. Int., 1993, 25, 607–632; (b) B.
Robinson, Chem. Rev., 1963, 63, 373–401.
7 A. Bischler, Ber. Dtsch. Chem. Ges., 1892, 25, 2860–2879.
8 For recent examples, see: (a) Y. Vara, E. Aldaba, A. Arrieta, J. L.
Pizarro, M. I. Arriortua and F. P. Cossı´o, Org. Biomol. Chem., 2008,
6, 1763–1772; (b) V. Sridharan, S. Perumal, C. Avendan˜o and J. C.
Mene´ndez, Synlett, 2006, 91–95.
9 (a) S. Patil and J. K. Buolamwini, Curr. Org. Chem., 2006, 3, 477–498;
(b) S. Cacchi and G. Fabrizi, Chem. Rev., 2005, 105, 2873–2920.
10 (a) C.-J. Li and B. M. Trost, Proc. Natl. Acad. Sci. U. S. A., 2008,
105, 13197–13202; (b) R. A. Sheldon, Chem. Commun., 2008, 3352–
3365.
11 (a) Y. Tsuji, K.-T. Huh and Y. Watanabe, J. Org. Chem., 1987, 52, 1673–
1680; (b) Y. Tsuji, K.-T. Huh and Y. Watanabe,Tetrahedron Lett., 1986,
27, 377–380.
12 H. Aramoto, Y. Obora and Y. Ishii, J. Org. Chem., 2009, 74, 628–633.
This journal is © The Royal Society of Chemistry 2010 Org. Biomol. Chem., 2010, 8, 5576–5582 | 5581
D
ow
nl
oa
de
d 
by
 D
TU
 L
ib
ra
ry
 o
n 
17
 O
ct
ob
er
 2
01
1
Pu
bl
ish
ed
 o
n 
20
 O
ct
ob
er
 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
OB
001
06F
View Online
13 C. S. Cho, J. H. Kim, T.-J. Kim and S. C. Shim, Tetrahedron, 2001, 57,
3321–3329.
14 L. U. Nordstrøm and R. Madsen, Chem. Commun., 2007, 5034–5036.
15 (a) G. E. Dobereiner and R. H. Crabtree, Chem. Rev., 2010, 110, 681–
703; (b) M. H. S. A. Hamid, P. A. Slatford and J. M. J. Williams, Adv.
Synth. Catal., 2007, 349, 1555–1575; (c) K.-i. Fujita andR. Yamaguchi,
Synlett, 2005, 560–571.
16 For recent examples of metal-catalysed alkylations of amines with
alcohols, see: (a) B. Blank, S. Michlik and R. Kempe, Adv. Synth.
Catal., 2009, 351, 2903–2911; (b) P. R. Likhar, R. Arundhathi, M. L.
Kantam and P. S. Prathima,Eur. J. Org. Chem., 2009, 5383–5389; (c) K.
Shimizu, M. Nishimura and A. Satsuma,ChemCatChem, 2009, 1, 497–
503; (d) R. Martı´nez, D. J. Ramo´n and M. Yus, Org. Biomol. Chem.,
2009, 7, 2176–2181; (e) S. Ba¨hn, A. Tillack, S. Imm, K. Mevius, D.
Michalik, D. Hollmann, L. Neubert and M. Beller, ChemSusChem,
2009, 2, 551–557; (f) M. H. S. A. Hamid, C. L. Allen, G. W. Lamb, A.
C. Maxwell, H. C. Maytum, A. J. A. Watson and J. M. J. Williams, J.
Am. Chem. Soc., 2009, 131, 1766–1774; (g) A. Prades, R. Corbera´n, M.
Poyatos and E. Peris, Chem.–Eur. J., 2008, 14, 11474–11479; (h) K.-i.
Fujita, Y. Enoki and R. Yamaguchi, Tetrahedron, 2008, 64, 1943–1954.
17 T. Jensen and R. Madsen, J. Org. Chem., 2009, 74, 3990–3992.
18 E. F. Pratt and M. J. Kamlet, J. Org. Chem., 1963, 28, 1366–1368.
19 H. J. Roth and P. Lepke, Arch. Pharm., 1972, 305, 159–171.
20 (a) M. P. Kumar and R.-S. Liu, J. Org. Chem., 2006, 71, 4951–4955;
(b) M. Tokunaga, M. Ota, M.-a. Haga and Y. Wakatsuki, Tetrahedron
Lett., 2001, 42, 3865–3868.
21 D. S. C. Black, B. M. K. C. Gatehouse, F. The´obald and L. C. H. Wong,
Aust. J. Chem., 1980, 33, 343–350.
22 G. L. Rebeiro and B. M. Khadilkar, Synthesis, 2001, 370–372.
23 K. G. Liu, A. J. Robichaud, J. R. Lo, J. F. Mattes and Y. Cai, Org. Lett.,
2006, 8, 5769–5771.
24 R. C. Morales, V. Tambyrajah, P. R. Jenkins, D. L. Davies and A. P.
Abbott, Chem. Commun., 2004, 158–159.
25 J. S. Swenton, C. Shih, C.-P. Chen and C.-T. Chou, J. Org. Chem., 1990,
55, 2019–2026.
26 P. P. Varma, B. S. Sherigara, K. M. Mahadevan and V. Hulikal, Synth.
Commun., 2009, 39, 158–165.
27 D. W. Ockenden and K. Schoﬁeld, J. Chem. Soc., 1957, 3175–3180.
28 R. N. Castle, R. R. Shoup, K. Adachi and D. L. Aldous, J. Heterocycl.
Chem., 1964, 1, 98–106.
29 E. V. Vorob’ev, E. S. Karbatov, V. V. Krasnikov, V. V. Mezheritskii and
E. V. Usova, Russ. Chem. Bull., 2006, 55, 1492–1497.
30 D.-Q. Xu, W.-L. Yang, S.-P. Luo, B.-T. Wang, J. Wu and Z.-Y. Xu, Eur.
J. Org. Chem., 2007, 1007–1012.
31 M. Alajarı´n, A´. Vidal and M.-M. Ortı´n, Tetrahedron, 2005, 61, 7613–
7621.
32 S. G. P. Plant and M. W. Thompson, J. Chem. Soc., 1950, 1065–1067.
33 Y. Naruse, Y. Ito and S. Inagaki, J. Org. Chem., 1991, 56, 2256–2258.
34 C. A. Simoneau and B. Ganem, Tetrahedron, 2005, 61, 11374–11379.
35 R. C. Larock, E. K. Yum and M. D. Refvik, J. Org. Chem., 1998, 63,
7652–7662.
36 O. Leogane and H. Lebel, Angew. Chem., Int. Ed., 2008, 47, 350–352.
5582 | Org. Biomol. Chem., 2010, 8, 5576–5582 This journal is © The Royal Society of Chemistry 2010
D
ow
nl
oa
de
d 
by
 D
TU
 L
ib
ra
ry
 o
n 
17
 O
ct
ob
er
 2
01
1
Pu
bl
ish
ed
 o
n 
20
 O
ct
ob
er
 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
OB
001
06F
View Online
